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ABSTRACT

The oleaginous yeast, Yarrowia lipolytica, is becoming a popular host for
industrial biotechnology because of its ability to grow on non-conventional feedstocks
and naturally accumulate significant amounts of lipids. With new genome editing
technologies, engineering novel pathways to produce lipid-derived oleochemicals has
become easier. The goal, however, is to expand the genetic toolbox to improve the
efficiency of metabolic engineering such that production capacities could expand from
proof-of-concept shake flasks to an industrial scale.
Building efficient metabolic circuits require controlling strength and timing of
several enzymes in a metabolic pathway. One method to do this is through transcription –
using suitable promoters to control the expression of genes that code for enzymes. Native
promoters have limited application because of complex regulation and non-tunable
expression. Engineering hybrid promoters alleviate these issues to obtain predictable and
tunable gene expression. In Y. lipolytica, how to design these promoters is not fully
understood, resulting in only a handful of engineered promoters to date.
In this work, we aim to develop tools for gene expression by investigating
promoter architecture and designing tunable systems. In addition to Upstream Activating
Sequences (UAS), tuning promoter strength can be achieved by varying sequence in the
core promoter, TATA motif, and adjacent proximal sequences.
UASs can modulate transcription strength and inducibility, enabling controlled
timing of expression. A promoter of the acyl-CoA oxidase 2 (POX2) from the βoxidation pathway was truncated heuristically to identify oleic acid (OA) UAS
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sequences. By fusing tandem repeats of the OA UAS elements, tunable yet inducible
fatty acid hybrid promoters were engineered.
The current approaches to identify novel UAS elements in Y. lipolytica are
laborious. Therefore, we investigated DNA accessibility through nucleosome positioning
to determine if a relationship between POX2 UASs and DNA accessibility can be
inferred. The goal is to eventually apply this approach develop newer hybrid promoters
efficiently.
Finally, the hybrid fatty acid inducible promoter we developed was used to
rationally engineering a Y. lipolytica strain capable of producing high amounts of free
fatty acids. By localizing the fatty acyl / fatty aldehyde reductase in the peroxisome, we
compartmentalized fatty alcohol production. This strategy led to upwards of 500 mg/L of
fatty alcohols produced. It is a promising route to eventually make short to medium chain
fatty alcohols in Y. lipolytica by utilizing the native β-oxidation machinery.
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CHAPTER ONE
INTRODUCTION
Today, most industrial chemicals used to produce materials, plastics, surfactants,
and solvents are derived from the non-renewable petroleum feedstock which leaves
environmental problems and threats for human beings. As a result, the paradigm of
research has shifted towards exploiting methods for production of sustainable and green
products. Bio-based technology can be a good alternative to address this problem. While
petrochemical based chemical production dominates much of the commodity chemical
market, biochemical production has already shown promise for chemical production at
commercial scale [1-3] requiring lower capital investments, therefore, providing a
competitive edge. Furthermore, several commodity-scale chemicals have also been
produced using biomass at costs lower than petrochemical processes [4, 5].
Industrial biotechnology is a rapidly expanding industry built upon a biological
foundry to solve global challenges, offering new potential to meet demands for
chemicals, fuel, and food with significantly reduced impact on the environment. The
problems to be tackled can be broadly categorized in two sets, not mutually exclusive of
one another. To minimize fossil-fuel based dependence for chemical production, a core
challenge is to be able to tap into a biological, yet efficient means to utilize naturally
abundant feedstocks such as plant biomass and sunlight as a fuel to drive the biochemical
process. The second challenge is optimizing biological platforms for the production of
selective chemicals in a cost-effective, economically feasible manner. To date, both
concepts have been explored using plants, algae, and microbes.
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1.1. Plants for Sustainable Chemical Production
Plants and algae are unique biological platforms because of their ability to harness
energy from sunlight to drive photosynthesis making food in the form of carbohydrates to
sustain physiological processes. Phototrophic systems, in theory, are a robust
economically feasible process, however, there are limitations to harnessing solar energy.
The theoretical efficiency is limited to the range of wavelengths applicable to
photosynthesis and the quantum requirements of the photosynthetic process. The
photosynthetically active radiation from solar energy is in the range of 400 and 700 nm,
accounting for about 45% of the suns light energy. In combination with the quantum
requirements for CO2 fixation in photosynthesis, the theoretical maximum efficiency is
around 11% of solar energy [6]. Practically, the magnitude of photosynthetic efficiency is
further decreased due to reflection of the sun’s wavelengths, respiration requirements for
photosynthesis and the lack of optimal solar radiation. This drops efficiency to between
3% and 6% of the total solar energy that is harnessed. For crops, it should be noted that if
only agriculturally relevant products such as seeds, fruits, and tubulars are considered
rather than total biomass, this amounts to lower photosynthetic efficiencies.
In addition to growing crops for primary metabolites such as carbohydrates, fats,
oils, and proteins, plants also naturally produce a variety of secondary metabolites which
are industrially relevant and important for human health. Flavonoids, terpenoids,
carotenoids, and phenolics are some of the compounds that encompass the broad range of
chemicals that are produced in plants [7]. In recent decades, advances in genetic tools
have improved the ability to engineer transgenic crops for not only maximizing yields of
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primary metabolites but increasing the landscape for production of valuable
pharmaceuticals [8-10].
While promising, metabolic engineering of plants has its drawbacks. If
sustainable chemical production to replace current methods is the goal, then exploiting
plants as a production platform requires consideration of the long growth times and small
production capacity of secondary metabolites. Chemical production can be maximized by
growing more genetically engineered crops but the limitation is arable landmass creating
competition with crops grown for food. From the approximately 2.3 billion acres of land
in the United States, around 349 million acres are utilized for growing crops [11].
Increasing growth capacity of select crops for biochemical production would only
increase competition for arable land against crops grown for food or be in direct
competition with land mass used for urbanization.
Although plants may not be the best solution for biochemical production, there is
a lot that can be learned about the biosynthetic pathways to produce a diversity of
chemicals. These pathways can be applied to more feasible biological platforms such as
microbes via heterologous expression of enzymes to engineer novel production pathways.
Table 1.1 summarizes some of the more successful application of plant biosynthetic
pathways in microbial systems for sustainable chemical production. Escherichia coli and
Saccharomyces cerevisiae are the predominant conventional microbes for heterologous
expression of plant pathways because of the wide array of genetic tools that facilitate
engineering efforts. If transgenic crops were to become feasible for biochemical
production in the future, there is still the backlash from the public perception about using
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genetically modified organisms (GMOs), particularly applying to transgenic crops that
need to be addressed and resolved [12, 13].

1.2. Algae for Sustainable Chemical Production
Algae are phototrophic organisms requiring solar energy and CO2, to grow and
thrive in nutrient-depleted conditions. Unlike common crops such as wheat and barley,
algae grow faster and occupy less space making it a better system for the development of
sustainable, biorenewable production practices. The fact that some algae can gown in salt
water conditions and tolerate wide pH conditions makes it more advantageous than
agriculture practices that require large quantities of fresh water. Furthermore, algae can
be grown more densely than plants reducing arable land use.
One of the major applications of algae in industrial biotechnology is biofuel
production [14]. However, algae have also been explored extensively to produce high
value-added chemicals. The world market of products from macroalgae has been
estimated to be close to USD 6 billion per year while the retail price of products from
microalgae was estimated at USD 5 to 6.5 billion [15, 16]. Hydrocolloids such as agar,
alginate, and carrageenans are produced at industrial scale using algae. These chemicals
are used as gelation and thickening agents in different food, pharmaceutical and
biotechnological applications with a current estimated global value of over USD 1.1
billion [17]. Hydrocolloids are extracted from the cell wall of red seaweed algae at
industrial scale since algae grow robustly and accumulate significant biomass.
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Other valuable products that have been produced from algae at commercial scale
include proteins, polyunsaturated fatty acids, the keto-carotenoid astaxanthin, and food
dyes such as phycoerythrin and phycocyanin [18-21]. The ability to produce these
chemicals economically is a result of their natural production capabilities and to a lesser
effect, metabolic engineering efforts. The development of better genetic tools to facilitate
efficient metabolic engineering could make algae a more promising host for sustainable
chemical production. Currently, some of the tools available are transformation protocols,
stable expression of transgenes [22], targeted microRNA mediated gene knockdown and
silencing [23] and more recently, efficient CRISPR-Cas9 mediated genome engineering
[24]. A majority of these genetic tools have been developed in the green algae,
Chlamydomonas reinhardtii; however, they are being rapidly translated and developed
for diatoms and other algal species that are of industrial importance.
One of the criticisms of engineering metabolic pathways in algae is the difficulty
in scale-up that causes a loss in productivity. Although technically and economically
more viable than crops, there is still a lot of work that needs to be done to make chemical
production feasible and reduce the cost of downstream processes such as chemical
extraction and separation. The future of microalgae scale-up requires optimization and
design of advanced bioreactors and developing low-cost technologies for biomass
harvesting, drying, and oil extraction. Furthermore, since algae show a strong dependence
on a variety of environmental stress conditions, advancing the genetic toolbox to elicit
more controlled expression under different stress signals is required to enhance metabolic
engineering capabilities and make it a sustainable platform for chemical production. In
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the meantime, like plants, there are important biosynthetic pathways from algae that can
be translated into microbes to produce a plethora of industrially relevant chemicals. Table
1.1 highlights some of these biosynthetic pathways engineered into microbes.
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Table 1.1. Engineering biosynthetic pathways in conventional microbes for intricate
biochemical synthesis using plant and algal enzymes.
Host
Enzymes for pathway biosynthesis
Product
E. coli
4-coumarate: CoA ligase:
Stilbene synthesis
Lithospermum erythrorhizon (gromwell)
[25]
stilbene synthase:
Arachis hypogaea (peanut)
E. coli
4-coumarate: CoA ligase:
Flavone synthesis
chalcone synthase:
[25]
Glycyrrhiza echinata (licorice)
chalcone isomerase:
Pueraria lobata (kudzu)
flavone synthase:
Petroselinum crispum (parsley)
E.coli
Geranylgeranyl pyrophosphate synthase:
Advancements in
Taxadiene synthase:
taxol synthesis
taxadiene 5a-hydroxylase:
[26]
Taxus brevifolia (Pacific yew tree)
E. coli
phytoene desaturase:
Pro-lycopene
ζ-carotene desaturase:
production
Arabidopsis thaliana (Thale cress)
[27]
S. cerevisiae
Δ4-desaturase:
Docosahexaenoic acid
Euglena gracilis (micro algae)
(22:ω3) production
from C18:3
Δ5-desaturase:
[28]
Phaeodactylum tricornutum (diatom)
Δ5-elongase:
Thalassiosira pseudonana (marine diatom)
Δ6-elongase:
Ostreococcus tauri (marine algae)
E. coli
norcoclaurine synthase:
Reticuline production
norcoclaurine 6-O-methyltransferase:
from dopamine
coclaurine-N-methyltransferase:
3-hydroxy-Nmethylcoclaurine-4-Omethyltransferase:
Coptis japonica (Japanese Goldthread)
benzylisoquinoline
S. cerevisiae
Cytochrome P450 (CYP80G2):
alkaloid biosynthesis
Corytuberine N-methyltransferase:
from reticuline
Coptis japonica (Japanese Goldthread)
[29]
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1.3. Exploiting Microbes for Biochemical Production
Microorganisms have been used in industrial biotechnology for decades. Bacteria,
yeast, and fungi are predominant platforms for this purpose. A few of the earliest
discoveries of microbial potential to making chemicals date back to the production of
yogurt and cheese using probiotic microbe genus Lactobacillus [30], and production of
the antibiotic, penicillin from the ascomycetes fungal genus, Penicillium [31]. Microbes
have since been engineered to make numerous industrially relevant chemicals. In
microbial metabolic engineering, E. coli and S. cerevisiae are used extensively as cellular
factories to produce a diversity of commodity and specialty chemicals that can be
produced in a renewable, eco-friendly manner. The potential to engineer metabolic
pathways in these microbes is driven by the genetic toolbox that enables engineering,
heterologous expression from well-characterized promoters with tunable strength and
inducibility, and their natural propensity to grow and thrive [32-36].

1.3.1. Metabolic Engineering of Conventional Microbes
Advancements in metabolic engineering are driven by the ability to efficiently
engineer microbes by developing biosynthetic pathways using nature’s remarkable
catalysts called enzymes. Having robust gene expression platforms and being able to
fine-tune the expression of enzymes in a biosynthetic pathway is what contributes to
improving the efficiency of metabolic pathways. While developing these novel pathways,
a microbe’s native regulatory mechanisms needs to be considered. The native regulatory
mechanisms enable cells to maintain homeostasis that can occur on either a transcription,
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translation or metabolite level. While identification of these bottlenecks is crucial, having
a library of genetic tools with various expression capabilities can alleviate issues at nodes
to elegantly engineer foreign pathways with high efficiency.
As a result, E. coli and S. cerevisiae have both been established as safe,
conventional microbes to produce industrially relevant chemicals. Butanol, for example,
is a chemical feedstock that has gained much attention as a next-generation biofuel
replacement to ethanol due to higher energy content and lower volatility. Previous
attempts to produce improve butanol using Clostridium have been unsuccessful due to
difficulty in genetically manipulating clostridial strains [37]. However, in recent years, it
was demonstrated that 1-butanol can be produced in E. coli at titers as high as 30 g/L and
70% to 88% of its theoretical maximum via anaerobic fermentation [38]. Similar
metabolic engineering feats have been accomplished with the production of 1,3propanediol in E. coli attaining titers of 135 g/L and productivity of 3.5 g/L/h in a 10 L
fed-batch reactor [1].
Saccharomyces cerevisiae has also been explored as a robust metabolic
engineering platform to produce several chemicals relevant to industry [39, 40]. The
development of an extensive genetic toolbox has enabled efficient production of natural
compounds by transferring product-specific enzymes or entire metabolic pathways from
other biological systems that either grow slow or are genetically intractable [41, 42].
Even though quantification metrics such as yields, titers and productivities may not
always be up to par for industrial production, this microbe is best at demonstrating the
ability to produce value-added specialty chemicals. Terpenoids, alkaloids, flavonoids and
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non-ribosomal peptides synthesis are some examples where biosynthetic pathways have
been successfully constructed in S. cerevisiae.
Terpenoids are the largest class of naturally occurring molecules. The production
of terpenoids has already been patented in the plant, Arabidopsis thaliana [43]. Although
structurally diverse, terpenoids can be synthesized from two isoprene precursors,
isopentenyl pyrophosphate (IPP) and dimethylallyl diphosphate (DMAPP). The
modification of IPP and its derivates to produce more complex terpentine molecules has
been demonstrated in S. cerevisiae. One such molecule is artemisinic acid, a precursor to
the antimalarial drug, artemisinin [44]. Polyketides are yet another molecule where
structural complexity precludes chemical synthesis as an economically feasible route for
large-scale production. S. cerevisiae has proven to be a promising host for pathway
engineering complex polyketides because it already has already been leveraged to
produce large amounts of fungal polyketides such as 6-methylsalicylic acid [45].

1.3.2 Genetic Regulation for Conventional Microbes
The development of genetic tools to fine-tune strength and timing of expression is
what enables much of the metabolic engineering accomplishments in a microbe. The
expression of an enzyme in a cell is determined by two biological processes, transcription
and translation. Transcription is the genetic level control of expression that deals with
controlling how much mRNA is produced from a gene. The primary step of transcription
occurs at the promoter where specific proteins bind to upstream of the gene of interest to
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regulate the amount of the gene that is transcribed by RNA polymerase II. Therefore, at
the base of enzyme expression is transcriptional regulation via promoters.
Promoter regulation is the most commonly studied approach to regulating gene
expression. In both, E. coli and S. cerevisiae, a large library of promoters have been
identified, studied and engineered for new properties [46-49]. Since eukaryotic gene
regulation is the basis of this dissertation, a perspective on S. cerevisiae promoters and
promoter engineering will be summarized. Native promoters are extensively well
characterized in the microbe from constitutive to inducible [50]. Table 1.2 summarizes
some of the commonly used native promoters in S. cerevisiae.
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Table 1.2. Commonly used promoters used in metabolic engineering of S. cerevisiae [5052]. * represents a subset of promoters from genes that are involved in global regulatory
processes for cell survival. Other similar promoters can be found from genes involved in
the expression of ribosomal proteins and chaperone proteins in S. cerevisiae.
Constitutive Native Promoters
Promoter
Enzyme
Function
PPGK1
3-phosphoglycerate kinase
1,3-bisphosphoglycerate
to
glycerate 3-phosphate
PTDH3
Glyceraldehyde- 3-phosphate
Glyceraldehyde 3-phosphate
dehydrogenase
to
(GAPDH)
D-glycerate 1,3-bisphosphate
PTPI1

PENO2

PADH1

*PTEF1
*PTEF2

PGAL1/GAL10

PCUP1
PHXT7
PADH2
PPHO5

Triosephosphate isomerase

Dihydroxyacetone phosphate
to
D-glyceraldehyde 3-phosphate
Phospho-pyruvate hydratase
2-phosphoglycerate
to
phosphoenolpyruvate (PEP)
Alcohol dehydrogenase
Alcohol
to
ketones
Translational elongation factor EF-1
Delivery of aminoacyl-tRNA to
alpha (TEF1-α)
ribosome
Translational elongation factor EF-2
Delivery of aminoacyl-tRNA to
alpha (TEF2-α)
ribosome
Inducible Native Promoters
Galactokinase/UDP-glucose-4UDP Galactose
epimerase
to
UDP-Glucose
Copper thionein (Metallothionein)
Chelates copper at high
concentration
High-affinity hexose transporter
Active at low glucose
concentration
Alcohol dehydrogenase 2
Repressed in glucose
Repressible acid phosphatase
Active under low inorganic
phosphate
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1.3.3. Promoter Engineering – A Page from the Conventional Yeast
Predictable expression from promoters is necessary for rational design and
optimization of microbial cell factories; however, the use of native promoters in this
context can be challenging because most promoters exhibit complex expression patterns.
The complexity is a result of having spatially distributed regulatory motifs on a single
promoter that recruit transcription factors to regulate transcription in response to changes
to the environment (pH, temperature), nutrients (carbon, nitrogen) or cell physiology
(early vs. late phase) etc. The PIS1 gene in S. cerevisiae is an essential gene for de novo
synthesis of the phospholipid, phosphatidylinositol and has been reported to have
differential responses to fermentable versus non-fermentable carbon sources [53]. In
addition, the PIS1 promoter has regulatory regions for transcriptional factor ScROX1p,
that represses promoters under hypoxic conditions [54]. Promoters form ScACC1, and
genes involved in oxidative stress response have also shown similar complexities with
multiple regulatory motifs on the promoter eliciting complex regulation to carbon
conditions [55, 56].
The complexity of native regulatory systems, therefore, motivates the need to
develop better promoters with predictable and defined expression patterns that can be
then used to engineer more optimized metabolic processes. Engineering promoters in S.
cerevisiae serve as the basis for understanding how yeast promoters function. Promoter
engineering is an umbrella term used to describe many facets of developing new
promoters.
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One method is using error-prone PCR to create a library of random mutations on
the native promoter and then screen for promoter function using a reporter gene (Figure
1.1). This has been demonstrated with PTEF1 (Table 1.2). Two hundred promoter mutants
were screened that varied in expression strength from very weak to promoters two-fold
stronger than the native promoter [57]. This approach to promoter engineering is efficient
when high transformation efficiencies are attainable enabling a larger, more diverse
library of mutants.
The other approach to promoter engineering in S. cerevisiae is based off rational
design. By fusing modular elements, the core promoter and Upstream Activating
Sequences (UASs), a library of “hybrid” promoters can be engineered (Figure 1.1).
Variable levels of promoter inducibility and strength are achieved by changing the type
and number of UAS sequences. In S. cerevisiae the authors showed that strongest
constitutive native promoter, PTDH3 (Table 1.2), was made almost three-fold stronger by
fusing disparate constitutive UAS elements from other promoters upstream of the native
PTDH3 [58]. Galactose-inducible hybrid promoters spanning a fifty-fold dynamic range in
galactose was demonstrated by fusing tandem ScGal4p binding upstream of a core
promoter [58]. Finally, the catabolite repression of PGAL1 was alleviated by placing
constitutive UAS sequences upstream of the inducible promoter [58].
Hybrid promoters are effective tools but the challenge lies in identifying UASs in
native promoters. Determining UASs in yeast has traditionally relied on truncations of
promoters fused to a reporter gene (Table 1.2). The loss of transcription activity is then
correlated to a potential UAS element in the native promoter [59-61]. However, with
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today’s high throughput technologies such as Chip-Seq and large transcription factor
database for S. cerevisiae, the process of identifying transcription factor binding sites
(TFBs) surpasses single promoter analysis to scanning all variations of the binding motifs
in the genome [62].
One of the more interesting developments of S. cerevisiae hybrid promoter
engineering is next-level regulation such as chimeric systems, fusing yeast UASs with
bacterial operons to engineer dynamic regulation (Figure 1.1). Tet repression in a
galactose-inducible promoter has been tested to investigate how number and positioning
of tet repressor sites in the core promoter of a galactose-inducible promoter can affect
gene expression [63]. Similarly, an E. coli FadR operator placed in the core promoter
region of a yeast promoter fused to different UASs (inducible and constitutive) shows
how dynamic promoter regulation can be used to only turn on metabolic pathways once
there is sufficient buildup of the fatty acid precursor, relieving FadR repression to turn on
the yeast promoter [64]. Studying these types of hybrid promoter systems in S. cerevisiae
provides novel insight to building efficient metabolic circuits in eukaryotes and would
better inform strategies for genetic tool development in newer, non-conventional
microbes.
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Figure 1.1. Schematic of three promoter engineering strategies used in S. cerevisiae. The
heuristic approach is a more fundamental strategy for identifying promoter regions called
Upstream Activating Sequences (UASs). Results from the first two methods can then be
applied to experiments aimed at (1) determining specific transcription factors and binding
motifs (2) developing tunable and dynamic hybrid promoters for metabolic engineering.

1.4. Non-Conventional Microbes in Biotechnology
In the past two decades, microbial engineering has mostly relied on conventional
microbes for synthetic biology because of its genetic tractability and ease of genome
editing. The development of bioinformatic tools during the same time enabled engineers
to screen for suitable enzyme candidates to create pathways for target products. But, as
biomolecular engineers, our goal is to develop a sustainable chemical engineering process
within a biological context. In doing so, we are interested in two general parameters,
successful transition of an engineered strain from the benchtop to a bioreactor and
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meeting key performance indicators, yield (mass of product / mass of substrate), titer
(mass of product / reaction volume), and productivity (mass of product / reaction volume
/ time). Reaching such metrics for commercial feasibility can be challenging because
synthetic circuits via heterologous pathways are not as reliable and robust as native
pathways due to the microbe’s innate regulation. This could lead to additional issues such
as co-factor imbalances and allosteric inhibition that would need to be teased out using
high throughput proteomics and metabolomics [65, 66].
Exploiting newer non-conventional microbes with capabilities to innately produce
desired products has become increasingly popular in industrial biotechnology. This
transition is greatly facilitated by tremendous advancements in synthetic biology over the
past few years. Now, large-scale genome sequencing has become relatively inexpensive
and coupled with the library of bioinformatic tools, developing genome-scale metabolic
models for novel microbes has become more feasible and reliable. This has resulted in
the exploration of non-model microbes to produce a wide variety of industrially relevant
chemicals (Table 1.3). With little engineering efforts, sustainable production capacities
can be achieved. Non-conventional microbes are also able to grow on less-traditional
feedstocks to produce value-added products. This ability is very beneficial for not only
developing economically feasible biochemical processes but also contributing to a
cleaner environment by feeding on substrates found in waste streams. Amongst nonconventional yeasts, Yarrowia lipolytica leads the efforts to demonstrate the importance
of exploring novel microbes for industrial biotechnology.
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Table 1.3. Highlight of non-conventional microbes used for production of a wide range of
industrially relevant products utilizing mainly non-traditional feedstocks
Microbe
Feed
Product
Titer (g/L)
Ref.
Aspergillus niger
Corn stover
Citric acid
100
[67]
Rhodosporidium
Sucrose
Fatty alcohols
8
[68]
toruloides
Kluyverimyces marxianus Wheat Straw
Ethanol
36
[69]
Trichosporon oleaginosus
Resorcinol
Lipids
1.64
[70]
Yarrowia lipolytica
Glycerol
Erythritol
220
[71]
Yarrowia lipolytica
Xylose
Citric acid
80
[72]
Yarrowia lipolytica
Glycerol
Citric acid
32
[73]
Xanthomonas campestris
Cassava
Xanthun gum
17
[74]
starch
1.5. Yarrowia lipolytica: An Industrial Front Runner for Non-Conventional Microbes
The non-conventional oleaginous yeast, Y. lipolytica, has been used in industry
for the past 60 years. Its broad applications include single cell protein production, citric
acid production, and cell biomass as animal feed [75, 76]. Advances in synthetic biology
and metabolic engineering have increased the overall utility of microorganisms by
enabling custom built genetic engineering tools allowing for the manipulation of
metabolism to produce valuable chemicals. The oleaginous property of Y. lipolytica
allows this yeast to naturally accumulate lipids greater than 20% of dry cell weight [75].
This trait along with continued improvements in genetic engineering tools has led to
increased interest in engineering this host to produce lipid-based products.
Over the years, significant effort has been made to understand the genetics of Y.
lipolytica and to develop novel expression systems. Transformation protocols, basic
expression cassettes, and gene deletion tools have been established for several years [77,
78]. More recently, episomal vectors, high expression synthetic promoters, and CRISPR-
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Cas9 genome editing have been developed for use in Y. lipolytica [79-83]. This has
resulted in accelerated metabolic engineering efforts in Y. lipolytica. In addition to high
engineered lipid production capacities to reach titers close to 100 g/L [84], Y. lipolytica
has been engineered to produce specific high-value products such as omega-3 fatty acids
[85], dicarboxylic acids [86], polyhydroxyalkanoates (PHA) [87], itaconic acid [88], free
fatty acids [89, 90], alkanes [90], esters [91], and alcohols [90, 92, 93].
Efforts have also been made to engineer Y. lipolytica for utilization of alternative
sugars such as xylose, galactose, and starch [72, 94-100]. Alternative sugar substrates
have become increasingly abundant due to advances in lignocellulose degradation [91].
The native xylose pathway of Y. lipolytica has been recently elucidated, which led to
several studies achieving robust xylose utilization [72, 94, 95, 97].

1.5.1. Genetic Tool Development in Y. lipolytica
Efficient transformation protocols in tandem with access to a fully annotated and
sequenced genomes of Y. lipolytica strains have greatly facilitated the development of
genetic engineering tools over the past three decades [79, 101, 102]. These genetic
engineering tools include but are not limited to the creation of hybrid, carbon responsive,
and inducible promoter systems alongside quick and efficient genome editing techniques.

1.5.1.1. Transformation Methods for Y. lipolytica
Original transformation methods developed for Y. lipolytica utilized a PEGprotoplast transformation [103]. Advances to this protocol soon followed with a lithium
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acetate (LiAc) protocol adapted from Saccharomyces cerevisiae to obtain site-directed
integrative transformation efficiencies of up to 1x104 transformants/ug of linearized DNA
[104]. Modifications to the LiAc transformation and development of an electroporation
protocol superseded the above technique, allowing for highly efficient replicative
transformation [105]. To date, the LiAc protocol is the more commonly practiced method
for transformation of plasmids and electroporation is more efficient for transforming
linearized integrative vectors [77, 106]. Recently, improvements to the overall
transformation efficiency of linearized integrative DNA has been accomplished by using
a combinatorial approach of LiAc and electroporation, with yields reaching 2 x 104
transformants / μg of linearized DNA [107].
Although considerable work has been done to build transformation strategies in
this oleaginous yeast, efficiencies remain about 2 orders of magnitude lower than the
conventional yeast, S. cerevisiae. Despite this, it has been demonstrated that given the
current efficiencies, Y. lipolytica could still be used as a suitable host for molecular
evolution of proteins using both rational and directed evolution strategies [108, 109].

1.5.1.2. Native Promoters and Terminators for Regulating Gene Expression
Studies of metabolic pathways in Y. lipolytica have revealed several highly
expressed native genes that are induced and/or repressed by different carbon sources and
physiological conditions [110]. The best characterized native promoters are from the
genes of Glycerol-3-phosphate dehydrogenase (G3P), isocitrate lyase (ICL1), 3-oxo-acylCoA thiolase (POT1), aceto-acetyl-CoA thiolase (PAT1), the acyl-CoA oxidases (POX1-
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POX6), extracellular lipase 2 (LIP2), and alkaline extracellular protease (XPR2). A list of
the native promoters commonly used and their responsiveness to different carbon
conditions are summarized in Table 1.4.
In the scope of gene regulation, terminators are another important regulatory point
since the sequences dictate completion of transcription and determine the half-life of
synthesized mRNA. The terminator from the gene encoding cytochrome c oxidase from
S. cerevisiae (ScCYC1t) is a commonly used terminator sequence in Y. lipolytica
alongside native Y. lipolytica terminators [80-83, 95, 111, 112]. The use of short synthetic
terminators to improve gene expression has also been explored in Y. lipolytica recently
[112]. The synthetic terminator designs were first constructed in S. cerevisiae and
translated into Y. lipolytica to attain a 2-fold improvement relative to the native TEF
terminator of Y. lipolytica. Terminators and promoters can interact to form loops that
regulate gene expression [113] however, this phenomenon has not been explored in Y.
lipolytica.

21

Table 1.4. Commonly used native promoters for constitutive and native inducible
expression in Y. lipolytica [110, 114-118]
Substrate(s)

Glycerol

Glucose

Induced Promoter Systems

Repressed Promoter Systems

Glycerol-3-phosphate
dehydrogenase (PG3P)

Acyl-CoA-oxidase 2 (PPOX2)
3-oxo-acyl-CoA thiolase
(PPOT1)

Translation Elongation Factor1α (PTEF1)
Glycerol-3-phosphate
dehydrogenase (PG3P)

Acyl-CoA-oxidase 2 (PPOX2)
3-oxo-acyl-CoA thiolase
(PPOT1)

Acyl-CoA-oxidase 2 (PPOX2)
Oleic acid

Isocitrate lyase 1 (PICL1)

Ricinoleic acid
methyl ester

3-oxo-acyl-CoA thiolase
(PPOT1)

n-Decane

Translation Elongation Factor1α (PTEF1)

Glycerol-3-phosphate
dehydrogenase (PG3P)

Acyl-CoA-oxidase 2 (PPOX2)
Ethanol

Cytochrome P450

Isocitrate lyase 1 (PICL1)

Acetone

(PICL1)

Glycerol-3-phosphate
dehydrogenase (PG3P)

1.5.1.3. Hybrid Promoters for Regulating Gene Expression
Native promoters in Y. lipolytica have been used to control metabolic pathways,
however, the regulation associated with these promoters can be complex and exhibit
unpredictable behavior. Furthermore, the need to construct both strong and varied
promoter strengths for metabolic and pathway engineering is the desired outcome that
cannot be met exclusively by native promoters. Over the past decade, there have been
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several lines of work aimed at developing and characterizing the next generation hybrid
promoters that confer very high and tunable expression [119-121]; however, hybrid
promoters that have programmed regulatory behavior have not been reported.
Hybrid promoters are created in Y. lipolytica by deconstructing the native
promoters to identify upstream activating sequences (UAS) that confer transcriptional
activation and creating repeats of these sequences in tandem to accomplish high levels of
transcription. One commonly used UAS in Y. lipolytica is the UAS1B that was first
isolated from the complexly regulated XPR2 promoter [122]. Functional dissection of the
XPR2 promoter was used to identify the UAS1B sequence that was devoid of regulation
by pH, nitrogen and peptone levels [123]. Placing 4 UAS1B elements tandemly in front
of a minimal LEU2 core promoter containing a TATA box demonstrated the first efforts
at creating a constitutive, synthetic hybrid hp4d promoter that conferred stronger
transcriptional activation to the native PXPR2 [123, 124]. Since then, UAS1B elements
have been used in tandem to create promoter libraries that exhibited more than a 400-fold
increase in transcriptional levels relative to core promoters, effectively bypassing
enhancer limitations associated with natural eukaryotic promoter systems [82]. We
recently described that the UAS1B elements, while constitutive with respect to nitrogen,
elicit carbon source-dependent regulation of expression with oleic acid being able to
create the strongest transcriptional activation. Expression from the UAS1B hybrid
promoters with glucose in the media is strong, albeit weaker than oleic acid. Using
glycerol as a carbon source confers very weak transcriptional activation [80].
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An interesting feature of the UAS1B hybrid promoters is that they are growth
phase-dependent promoters. These promoters confer limited in gene expression during
cell growth, or exponential phase, but increase significantly during late exponential /
early stationary phase [80, 124]. This characteristic can be beneficial for heterologous
protein production when segregating cell growth and protein expression. This segregation
can contribute to cell productivity and alleviate toxic effects associated with heterologous
protein expression. The UAS1B hybrid promoter would be less than optimal for
metabolic engineering efforts to rewire pathways for substrate utilization, as the desired
outcome, in this context, would be early phase enzyme expression while nitrogen is not
depleted in the media. For this purpose, strong constitutive promoters from genes TEF1-α
and RPS7 in Y. lipolytica is better suited [125].
Another widely used constitutive activator sequence used to create hybrid
promoters is UAS(TEF), which was systematically dissected from truncations of the
native TEF promoter [121]. These elements also demonstrated that tandem usage leads to
a 4-fold increase in expression relative to the TEF (404) promoter. Other interesting
features of the UAS (TEF) elements were the earlier growth phase transcriptional
activation and a more consistent expression level independent of the carbon substrate
(sucrose, glucose, glycerol and oleic acid) used compared to the UAS1B elements [121].
The discovery of UAS elements, which have become important modular tools for
significantly improved gene expression in Y. lipolytica, have aided metabolic engineering
and heterologous protein production efforts. However, there is little known to date about
the regulatory sequences embedded within these sequences. A conceptual understanding
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of the enhancers and/or repressors within these elements could enable the development of
smaller and more tightly regulatable/inducible hybrid promoters. The only example of a
hybrid promoter designed from tandem enhancer sequences in Y. lipolytica is the use of
Alkane Responsive Element 1 (ARE1) [126]. An n-decane inducible hybrid promoter
could be designed by using tandem ARE1 sequences upstream of a minimal core
promoter.
The work described this dissertation uses a heuristic approach to develop a fatty
acid inducible promoter from fatty acid inducible native YlPOX2 (YALI0F10857g)
promoter. We revealed more than one UAS region in the POX2 promoter and used
tandem repeats of the different UASPOX elements to create a tunable hybrid promoter
devoid of carbon catabolite repression [116]. More recently, an erythritol/erythrulose
hybrid promoter was developed from identified UAS elements in the erythrulose kinase
(YlEYK1) gene (YALI0F1606g) of Y. lipolytica [127]. The approach to identifying UASs
in the native promoter was different to what was shown with the POX2 promoter. Here,
the nucleotide sequence of the EYK1 promoter from different Yarrowia clades was
aligned to discover two conserved motifs. Mutational studies of the conserved motifs
revealed that these sites were responsive to erythritol and erythrulose [127]. Tunable
expression was demonstrated using tandem repeats of the UASEYK1.
Kozak sequences present proximal to the ATG initiator codon could serve as
another modular genetic component to control expression. These small sequences play a
major role in the initiation of translation in eukaryotic systems [128, 129]. A commonly
used Kozak sequence in Y. lipolytica that confers strong ribosome recognition affinity is
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CCACC [130, 131]. Other modified Kozak sequences used for enhanced translational
include AC(A/C)AAA [132, 133] and a CACA sequence [134]. In most examples of
potential Kozak sequences used in Y. lipolytica, it is desired to have an A in the +3
position. A separate study showed that there was a strong bias towards having A/G at the
-3 position and an A/C in the -2 position amongst 47 eukaryotic species [135]. However,
more experimental data is required to determine whether this downstream consensus
sequence improves the efficiency of translational initiation in Y. lipolytica.

1.5.1.4. Genome Editing Capacity for Yarrowia lipolytica
Double-stranded break (DSB) repair in yeast can occur via homologous
recombination (HR), single strand annealing (SSA), and non-homologous end-joining
(NHEJ) mechanisms such as micro-homology mediated end joining (MMEJ) and
illegitimate recombination (IR) [136-138]. A comparative genetic analysis with DNA
repair proteins in S. cerevisiae revealed that hemiascomycetous species such as Y.
lipolytica would predominantly utilize the NHEJ pathway for DSB repair [139]. Previous
studies aimed at using HR for genome editing and repair required up to 1 kb of
homologous flanking fragments for site-directed gene insertion [140]. Long homologous
flanking regions are required to yield ~ 50% for site-specific insertion frequency in Y.
lipolytica. Otherwise, exogenous DNA would integrate randomly into the genome to
repair DSB. This suggests that NHEJ is dominant over HR, although the two repair
mechanisms are known to work independently in yeast [141].
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To improve the frequency of HR in Y. lipolytica, the core component of the NHEJ
pathway, the ku70 / ku80 heterodimer, was knocked out [142, 143]. In both papers cited
above, the ∆KU70 strain alone led to decreased transformation efficiencies but improved
HR frequencies with 1 kb flanking homologies on both ends. Meanwhile, reducing the
length of the flanking homology from 1000 bp to 50 bp did not have a dramatic effect HR
frequencies, reducing it from 56% to 43%, respectively [142]. The use of short homology
lengths (~50-40 bp) for homologous recombination has been demonstrated by using
hydroxyurea to arrest and thereby enrich the cells in S-phase cells. This led to gene
targeting frequencies between 4-9% in comparison to the untreated cells, where no
targeted integration was observed [144].
Further improvements to HR efficiency for genome integration could be
accomplished by using the CRISPR-Cas9 mediated system from Streptococcus pyogenes
in Y. lipolytica [83]. Using CRISP-Cas9 directed HR, targeted gene integration occurred
higher than 64% in the wildtype while in the ∆KU70 strain, the frequency was 100%.
Meanwhile, studies have shown low dependency of HR frequency to genomic loci [105,
143, 145].
The examples above describe improvements on strategies to perform scarless
single copy integrations in Y. lipolytica. The use of an auxotrophic marker for selection of
genome integration makes screening easy; however, the number of marker genes are
limited in Y. lipolytica. In some instances, conserving the selectable marker is of interest
for future applications and therefore one must rescue the marker post-integration. For this
purpose, the Cre-Lox system has been explored in this yeast species [140]. The selectable
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marker in the disruption cassette is flanked by the LoxP/ LoxR sites which are 34 bp
sequences containing 13 bp identical, inverted repeats separated by an 8 bp spacer [146].
Activation of the heterologous bacteriophage Cre-recombinase allows for the excision of
the selectable marker after screening for site-directed integration, enabling for the marker
to be used again. This editing mechanism, however, leaves a genomic scar but the
CRISPR-Cas9 genome editing mechanism is a scar-free. An alternative means of marker
recovery is to replace the selectable marker with an inactive gene by HR [85]. Using this
method, single copy and multicopy integrations are possible. For multicopy integrations,
the rDNA or zeta sites, which are repetitive DNA regions dispersed across the genome of
Y. lipolytica can be targeted using flanking DNA regions homologous to these site to
achieve as high as 30 copies of the gene per cell. [147, 148] Figure 1.2 summarizes the
different modules of genetic engineering that have been investigated in Y. lipolytica.
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Figure 1.2. General modules applied towards the development of genetic tools and
genome editing. A. At the promoter level, genetic tools can be engineered by constructing
strong hybrid responsive or inducible systems. Kozak sequence modifications enable
improved post-transcriptional expression. Furthermore, engineering synthetic promoters
could help to improve mRNA stability and half-life, thereby improving expression levels.
B. CRISPR Cas9 for knockouts and homologous recombination of DNA at high
efficiencies. Homology mediated recombination requiring the use of large flanking DNA
homologies are most efficient in ∆ku70 strain. C. Multi-copy integration performed using
zeta docking sites, rDNA sites or restoring URA3 function by multi-copy integration
DNA fragments containing URA3 alleles with the gene of interest [118].
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1.6. Metabolic Engineering in Yarrowia lipolytica
Lipid accumulation and degradation are two processes that are innately superior
in Y. lipolytica. Further engineering of these two natural processes has been promising to
produce biofuels and fatty acid derived bioproducts. This host has already been
engineered to produce a number of key products via engineering its native oleaginous and
lipolytic capabilities (Table 1.5) and therefore understanding the engineering scope of
lipid accumulation and degradation is important to understanding how novel products can
be produced using these pathways.

Table 1.5. Production of lipids and lipid-derived biochemicals in Y. lipolytica.
Products

Maximum Titer (g/L)

Reference

TAG Lipids

99 g/L

[84]

Free Fatty Acids (FFA)

10.4 g/L

[149]

Alcohols

2.15 g/L

[91]

Alkanes

23.3 mg/L

[91]

Fatty Acid Ethyl Esters (FAEE)

142.5 mg/L

[91]

Polyhydroxy Alkanoates (PHAs)

1.11 g/L

[150]

Itaconic Acid

4.6 g/L

[88]

1.6.1. Engineering Advanced Oleaginous Capabilities
Lipid accumulation can be induced by nitrogen limited conditions or by high
carbon to nitrogen (C/N) ratios. It is proposed that nitrogen exhaustion leads to increased
activity of AMP deaminase (YlAMPD), which decreases the concentration of cytosolic
AMP. The activity of AMP-dependent isocitrate dehydrogenase (IDH) is therefore
inhibited, resulting in the accumulation of isocitrate. Citrate generated from accumulated
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isocitrate by aconitase then exits the mitochondria and is cleaved by cytosolic ATPcitrate lyase (YlACL1) for the generation of acetyl-CoA [151, 152]. From the metabolic
overview in Figure 1.3., the first committed step of fatty acid synthesis is the
carboxylation of acetyl-CoA to malonyl-CoA by acetyl-CoA carboxylase (YlACC1).
NADPH generated by malic enzyme (ME) provides the reducing power for fatty acid
synthesis. However, recent research has demonstrated that for Y. lipolytica, the pentose
phosphate pathway is the major source for NADPH generation [153, 154]. When acetate
is used as a substrate, NADPH for fatty acid synthesis is produced through
gluconeogenesis and the oxidative pentose phosphate pathway [155]. A recent study
showed no significant change in the YlIDH expression during lipid accumulation.
However, the gene encoding isocitrate lyase (ICL), which is involved in converting
isocitrate to glyoxylate, was observed to be strongly up-regulated in Y. lipolytica [156].
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Figure 1.3. Lipid biosynthesis in Y. lipolytica. Triacylglyceride (TAG) biosynthesis in Y.
lipolytica. GPD1: glycerol-3-phosphate dehydrogenase, GUT2: glycerol-3-phosphate
dehydrogenase, ACL: ATP-citrate lyase, ACC1: acetyl-CoA carboxylase, ME: malic
enzyme, DGA1&2: diacylglycerol acyltransferase, TGL3&4: triacylglyceride lyase,
PEX10: peroxisomal biogenesis factor, POX1-6: Peroxisomal Acyl-CoA Oxidase, MFE:
β-oxidation multi-function enzyme
TAG synthesis in Y. lipolytica involves three acyltransferases. The first step is the
incorporation of fatty acyl-CoA into glycerol-3-phosphate (G3P) by glycerol-3-phosphate
acyltransferase (YlGPAT), forming lysophosphatidic acid (LPA). LPA and fatty acylCoA can be converted to phosphatidic acid (PA) by lysophosphatidic acid acyltransferase
(YlLPAT). The phosphate group is then removed from PA to form diacylglycerol (DAG)
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by phosphatidic acid phosphatase (YlPAP). The last step of TAG synthesis is conducted
by one of two types of diacylglycerol acyltransferases that incorporate an acyl group into
a DAG. Diacylglycerol acyltransferase (YlDGA1) transfers an acyl group from acyl-CoA
to a DAG, while diacyltransferase (YlPDAT) transfers an acyl group from a phospholipid
to a DAG.
Early attempts to improve lipid accumulation focused on redirecting the carbon
flux towards the glycerol pathway by deleting GUT2, preventing the reaction of glycerol3-P to DHAP, and thereby generating more precursor glycerol-3-P for TAG synthesis. In
this study, lipid degradation through β-oxidation was also hindered by deletion of POX16 which encode six acyl-coenzyme A oxidases [157]. In Y. lipolytica, DGA1 which
encodes the DGA1 enzyme, and DGA2, encoding the DGAT2 enzyme are the only genes
contributing to the acylation of DAG. The latter gene is suggested to be the major
contributor to TAG synthesis. However, DGA1 showed great potential in acyltransferase
activity when expressed in the quadruple mutant strain under a strong constitutive
promoter [158]. A push-and-pull strategy was developed by overexpression of both ACC
and DGA1 to enable high levels of lipid accumulation. Double expression of ACC and
DGA1 under the control of a strong TEF-intron promoter carries out the first and last step
of TAG synthesis, providing an enhanced driving force to redirect the carbon flux toward
lipid synthesis, resulting in an increased lipid content of 41.4% [159]. A further
enhancement of lipid accumulation was achieved by simultaneous expression of SCD
(delta-9 stearoyl-CoA desaturase) gene, ACC1, and DGA1. SCD was identified as rate
limiting step and target for the metabolic engineering of lipid synthesis pathway by
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reverse engineering the mammalian cellular obese phenotypes. The high flux created by
overexpression of ACC and DGA1 is encouraged and sustained by preventing allosteric
pathway inhibition. Overexpression of SCD enables the conversion of saturated to
monounsaturated fatty acids, providing increased sequestration of the pathway products
towards a lipid sink. Moreover, the engineered strain obtained other favorable phenotypes
including fast growth, high sugar tolerance, and lipid productivity up to 22 g/l/d [160].
Several efforts have focused on redirecting carbon flux to fatty acid synthesis by
modifying glucose repression regulators. Disruption of the MIG1 gene, encoding a
transcriptional regulator that binds to several glucose repression genes, enhanced
lipogenesis through depression of several genes relevant to lipid synthesis including
GPD1, ICL, ME1 and ACL1, and through repression of β-oxidation genes including
MFE1 [161]. Another glucose repression regulator Snf1 from the Snf1/AMP-activated
protein kinase (AMPK) pathway was identified as a lipid accumulation regulator.
Deletion of SNF1 led to the accumulation of lipid up to 2.6-fold higher than those of the
wild-type [162]. Disruption of β-oxidation has been explored to prevent TAG
degradation. Pex10p, encoded by the PEX10 gene, is involved in peroxisome biogenesis.
Deletion of PEX10 in an eicosapentaenoic acid (EPA) producing strain, resulted in
inactivation of β-oxidation and increased total lipid accumulation as well as EPA
production [85].
The MFE1 gene is another target for disruption of β-oxidation. Coupling deletion
of MFE1 and improvement of G3P synthesis increased both de novo and ex novo TAG
synthesis [163]. Combinatorial multiplexing of several lipogenesis targets, including
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deletion of both MFE1 and PEX10 genes, overexpression of DGA1, and restoration of a
complete leucine biosynthetic pathway, generated a significantly lipogenic strain with a
lipid content of 74% [164]. This study also demonstrated that lipid accumulation could be
uncoupled from nitrogen starvation and established links between leucine-mediated
signaling and lipogenesis. In Y. lipolytica, the only source of cytosolic acetyl-CoA is
from splitting citrate by ACL when the TCA cycle is repressed under nitrogen-limited
conditions. Therefore, uncoupling lipid accumulation and nitrogen starvation can also be
achieved by rewiring the acetyl-CoA pathway. Five alternative cytosolic acetyl-CoA
pathways were engineered separately, including the pyruvate-acetate route, pyruvatealdehyde route, pyruvate formate lyase, acetyl-CoA shuttling pathway, and nonoxidative
pentose-phosphate pathway [91]. The engineered strains not only show improved lipid
production but were also less sensitive to C/N ratio regulation. TGL3 and TGL4 are
intracellular lipases responsible for the degradation of TAG in the lipid body. Deletion of
the TGL3 gene has a positive effect on preventing the degradation of TAGs in the later
phases of lipid accumulation, and thus increased the overall lipid titer [165]. By
combining TGL3 knockout with overexpression of a heterologous DGA1 (R. toruloides)
and DGA2 (Claviceps purpurea), 77% lipid content and 0.21 g/g lipid yield were
achieved in a batch fermentation.
Aside from rational metabolic engineering efforts, a rapid evolutionary metabolic
engineering approach linked with a floating cell enrichment process was used to develop
highly lipogenic strains. This screen led to a strain with a mutation of the succinate
semialdehyde dehydrogenase, UGA2, achieving a high lipid content of 78% [166], and
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suggesting an important role of gamma-aminobutyric acid assimilation in lipogenesis.
Another evolved strain had a mutant MGA2 protein, Mga2p, that served as a regulator of
desaturase gene expression, and exhibited high lipid content with elevated unsaturated
fatty acid levels. The mutant MGA2 regulator resulted in a drastically altered
transcriptome, with glycolysis upregulated and the TCA cycle downregulated. This
suggested that imbalance between glycolysis and the TCA cycle could serve as a driving
force for lipogenesis [167].

1.6.2. Understanding FA Metabolism in Y. lipolytica
The process of fatty acid degradation for energy is β-oxidation and it primarily
occurs within specialized organelles known as peroxisomes (Figure 1.4). The number,
size, and content of peroxisomes vary with environmental and genetic stimuli. Some βoxidation has also been reported to occur within the mitochondria [168]. The peroxisomal
β-oxidation cycle consists of five major steps. First, the substrate of interest, often a fatty
acid (FA), is transported into the peroxisome with the aid of Acyl-CoA Binding Proteins
(ACBP) [168]. During transport, the FA is acetylated by the two peroxisomal acyl-CoA
Synthases (PXA1/ PXA2) in an ATP-dependent reaction [169]. The newly acylated fatty
acid is then desaturated by acyl-CoA oxidases (POX) at the vinyl position, consuming
FAD+ and producing H2O2 as a byproduct. Yarrowia lipolytica has six POX genes
(POX1-POX6) which have been shown to different chain length and substrate
specificities [170]. The newly formed desaturated FA-CoA ester is then hydrated across
the double bond by Multi-Function Enzyme 2 (MFE2 – C domain) (encoded by the
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MFE1 gene) such that the addition of a hydroxyl occurs at the β-carbon position, forming
a 3-hydroxyacyl-CoA intermediate. From here, the MFE2 enzyme (A/B domains) acts
again to oxidize the 3-hydroxy intermediate to 3-ketoacyl-CoA and forms NADH in the
process. Finally, the 3-ketoacyl-CoA is cleaved at the alpha carbon by peroxisomal 3oxyacyl-thiolase (POT1), releasing a molecule of acetyl-CoA and producing a fatty acylCoA which is two carbons shorter than the substrate that entered the cycle. From this
point, the product that is now 2 carbons shorter, can loop back into the cycle beginning
with the POX reaction.

Figure 1.4. β-oxidation in Y. lipolytica. The enzymes involved in β-oxidation in Y.
lipolytica. ACBP: Acyl-CoA Binding Proteins, ACS: acyl-CoA synthase, POX1-POX6:
peroxisomal acyl-CoA oxidases, MFE2: multi-function enzyme 2, POT1: peroxisomal 3oxoacyl-CoA thiolase, PhaC: polyhydroxyalkanoate synthase [118].
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1.6.3. Advancing Metabolic Engineering of Alcohols and Other Oleochemicals
Recently several groups have begun producing other oleochemicals including
alcohols, alkanes, and esters [91-93]. Medium and long-chain alcohols are used as
moisturizers in cosmetics as well as lubricants and surfactants. Alcohol production in Y.
lipolytica is typically achieved using a fatty acyl-CoA reductase and aldehyde reductase
or carboxylic acid reductase (CAR) and aldehyde reductase. The bifunctional fatty acylCoA / aldehyde reductase from Tyto alba (TaFAR1) was used to enable the production of
hexadecanol [92]. The deletion of the fatty alcohol oxidase (FAO1) gene from Y.
lipolytica and increasing the copy number of the Tafar1 gene lead to a ~5-fold increase in
titers. Deletion of the DGA1 gene responsible for TAG synthesis and the introduction of
5 copies of the Tafar1 gene led to a titer of ~690 mg/L from 160 g/L glucose after 6 days.
The production of 1-decanol was demonstrated using the FAR from Arabidopsis
thaliana using a previously engineered Y. lipolytica for C8–C10 medium chain fatty acids
[93]. The deletion of the PEX10 gene while expressing FAR greatly increased 1-decanol
titers by preventing peroxisome formation and thus alcohol degradation. A number of
fatty acyl-ACP thioesterase (FAT) enzymes were also tested to release fatty acids from
biosynthesis. The FAT enzyme from Cuphea palustris yielded the best decanol titers
(550 mg/L). The majority of the decanol (~90%) was found to be secreted outside the cell
and into the media.
More recently, a range of oleochemicals was produced by targeting various
pathways to the different organelles involving fatty acid biosynthesis and degradation
[91]. Fatty acid ethyl ester (FAEEs) production was achieved by expression of
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acetyltransferase, AtfA, from Acinetobacter Baylyi. When targeting this enzyme to the
ER or Peroxisome, 136 mg/L and 111 mg/L of FAEE was produced, respectively,
whereas only 7 mg/L was produced when targeted to the cytosol. Alkanes were produced
using a similar organelle targeting approach by expressing the aldehyde-deformylating
oxygenase (ADO) and CAR. Up to 23 mg/L of fatty alkanes were made by expressing
CAR from Mycobacterium marinum and ADO from Prochlorococcus marinus. Alcohol
production has also been demonstrated in E. coli were also produced by expression of E.
coli fatty acyl-CoA synthetase, FadD, and Marinobacter aquaeolei FAR. In yeasts,
however, the highest scale-up titers are reported in a 3 L bioreactor for Y. lipolytica,
reaching 2.15 g/L.

†

A part of this chapter is published in AIMS Bioengineering 2016, 3(4), 493-514, with co-authors Gabriel
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CHAPTER TWO
ENGINEERING PROMOTER ARCHITECTURE IN YARROWIA LIPOLYTICA

Abstract
Eukaryotic promoters have a complex architecture to control both the strength and
timing of gene transcription spanning up to thousands of bases from the initiation site.
This complexity makes rational fine-tuning of promoters in fungi difficult to predict;
however, this very same complexity enables multiple possible strategies for engineering
promoter strength. Here, we studied promoter architecture in the oleaginous yeast,
Yarrowia lipolytica. While recent studies have focused on upstream activating sequences,
we systematically examined various components common in fungal promoters. Here, we
examine several promoter components including upstream activating sequences,
proximal promoter sequences, core promoters, and the TATA box in autonomously
replicating expression plasmids and integrated into the genome. Our findings show that
promoter strength can be fine-tuned through the engineering of the TATA box sequence,
core promoter, and upstream activating sequences. Additionally, we identified a
previously unreported oleic acid-responsive transcription enhancement in the XPR2
upstream activating sequences, which illustrates the complexity of fungal promoters. The
promoters engineered here provide new genetic tools for metabolic engineering in Y.
lipolytica and provide promoter engineering strategies that may be useful in engineering
other non-model fungal systems.
†

A version of this chapter is published in ACS Synthetic Biology 2015, 5, 213-223, with co-authors Lauren
Gambill, Spencer Smith, and Mark Blenner.
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Introduction
The complexity of eukaryotic promoter architecture is fundamental for the diverse
pattern of gene expression that can be obtained from a relatively small number of
transcription factors (TFs) [171-173]. Even in eukaryotes as exhaustively studied as S.
cerevisiae, fine-tuned and predictive promoter design has been elusive.[58, 174, 175] As
a result, metabolic engineering in eukaryotes has relied on a small number of welldefined endogenous promoters, such as the GAL1-10, TEF, and LEU2 promoters [176178]. This problem is exacerbated by recent progress towards utilizing non-model yeasts
from biochemical production [179-182]. In order to push titers, yields, and productivities
to their limits, reaction fluxes need to be well-balanced, and even responsive to
intermediate metabolite concentration [183-186]. Such advanced metabolic engineering
strategies may be enabled if promoters were designed from the bottom up to have specific
transcriptional activities. Central to the development of finely tuned promoters is a better
understanding of how different promoters’ elements influence promoter strength.
This work focuses on engineering promoters for the oleaginous and lipolytic
hemiascomycetes yeast Yarrowia lipolytica. Y. lipolytica has long been studied as a
model organism for dimorphism and as an alkane metabolizing yeast [187, 188]. It is also
known to metabolize diverse substrates including fatty acids, triacylglycerides, glucose,
and glycerol [189]. As an oleaginous yeast, it is able to accumulate greater than 20% of
its mass as neutral lipids. Recent efforts to increase the lipid content of these cells grown
on glucose have been successful, with resulting strains engineered to produce up to 90%
w/w [160, 190]. As these lipids are useful precursors for biofuels, fatty acids, and fatty
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alcohols, Y. lipolytica has gained attention as a useful industrial microbe for the
production of omega-3 oils, ricinoleic acid, and triacylglycerides [85, 191]. Recent efforts
have greatly improved de novo production of TAGs for conversion to biodiesel [160,
190]. Other products produced include single cell protein, citric acid, lipase, lycopene,
and -ketoglutarate [192-196].
Overexpression of endogenous or heterologous enzymes to form new metabolic
pathways requires functional promoters. Endogenous promoters are frequently used
because promoter architecture in eukaryotes can be complex and transcriptional
responses can be difficult to predict [197, 198]. Endogenous promoters used for
overexpression include TEF1, FBA1, TDH1, GPM1, LEU2, POX2, XPR2. These
promoters are typically over 1000 bp long and were identified by analysis of genomic and
gene expression data. Unfortunately, this precludes tuning the level of gene expression
since promoter strength is fixed by the endogenous promoter architecture. Without
additional engineering, endogenous promoters cannot produce transcripts at levels higher
than naturally occurring. Furthermore, the complex regulation of endogenous promoters
is often ignored and can complicate metabolic engineering efforts.
The promoter strength is determined by several factors, including the TATA box,
core promoter sequence, proximal promoter sequences, and enhancer regions in the
upstream activating sequences (UAS) (Figure 2.1C). The most attention has been given to
engineering hybrid promoters, built by combining repeats of UASs with downstream
minimal promoters comprised of truncated promoters [81, 82, 199]. Madzak et al. [200]
showed the promoter of extracellular protease (XPR2) can be described as two regions:
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UAS1 and UAS2, with UAS2 being closer to the start codon and UAS1 being farther
from the start codon. The endogenous XPR2 promoter is regulated by the media pH and
nitrogen content. When only UAS2 was used to drive the expression of XPR2, the same
pH and nitrogen regulation was observed. On the contrary, when only UAS1B, a 90 bp
region of UAS1 was used to drive expression, transcription was independent of pH and
nitrogen indicating regulatory features of the UAS were localized to UAS2, while UAS1
was a general amplifier of the downstream promoter. Blazeck et al.[82] made tandem
repeats of UAS1B to drive expression of GFP from two minimal constitutive promoters,
TEF and LEU. Increasing the number of repeats monotonically and cooperatively
increased the transcription from the downstream core promoter. UAS repeats have been
shown to be genetically stable in Y. lipolytica [82]. This modular architecture suggests
that promoter strength and induction properties should be predictably engineerable using
defined UASs, however, considerably less attention has been given to the TATA box,
core promoter, and proximal promoter sequences.
In this study, we have taken a systematic look at the promoter architecture in
order to engineer a new panel of hybrid promoters for metabolic engineering
applications. We chose to study promoter structure in the context of autonomously
replicating plasmids for two reasons. First, it allows us to study promoter architecture in
the absence of epigenetic effects that commonly influence expression profiles in
chromosomal DNA; and secondly, plasmids are useful vehicles for rapid testing of
metabolic engineering strategies. We made several truncations to the acyl CoA oxidase
(POX2) endogenous promoter and built hybrid promoters. We characterized a new
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substrate responsiveness from the XPR2 UAS1B sequences and showed that UAS1B
enhancers are more induced by oleic acid compared to glycerol or glucose. We also tuned
promoter strength through engineering of the TATA box and the proximal promoter
regions. While TATA box engineering resulted in similar effects in different promoters,
the proximal promoter sequences did not appear modular. In sum, these studies have
helped elucidate the importance of each of the regions comprising the overall promoter
architecture.

Figure 2.1. Promoter architecture. (A) Eukaryotic promoters contain a core promoter
sequence that may have a TATA box, a proximal promoter sequence, and enhancer
sequences located farther upstream. (B) Hybrid promoters were created by placing eight
UAS1B sequences (UAS1B8) upstream of a promoter. The promoter consists of a core
promoter and 5′ truncations of the native promoter to identify regulatory sequences
upstream of the proximal and core promoter. Humanized Renilla reinformis GFP was
used as a reporter to characterize promoter strength. (C) Different UAS, proximal, TATA
box, and core promoter sequences tested throughout the course of this study. The
promoter components are ordered from top to bottom in decreasing strength.
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Experimental Procedures
Chemicals and Enzymes
All chemicals were purchased from Sigma unless otherwise stated. All restriction
enzymes, DNA ligases, and DNA polymerases used for cloning and PCR were purchased
from New England Biolabs (NEB) unless otherwise stated. Plasmid minipreps, PCR
purifications, and gel extractions were done using the QIAprep spin miniprep kit and
QIAquick PCR purification and gel extraction kit (Qiagen). Genomic DNA from Y.
lipolytica was extracted using the E.Z.N.A. yeast DNA kit (Omega Biotek). All
oligonucleotides and gBlocks were purchased from IDT.

Strains and Cultures
DH10β cells (NEB) were used for cloning and propagation of plasmids in
Luria−Bertani (LB) media supplemented with 100 μg/mL ampicillin. Y. lipolytica strain
PO1f (MATa leu2−270 ura3−302 xpr2−322 axp1) was used for GFP expression studies.
Transformed was cultivated at 28 °C and 215 rpm in 20 mL volumes using 250 mL
baffled flasks with YSC-LEU selective media consisting of 6.7 g/L YNB without amino
acids (Difco), 0.69 g/L CSM-LEU (MP Biomedicals). Data in Figure 6 was collected in 2
mL volumes grown in 14 mL culture tubes under the same rotational speed and
incubation temperature. The carbon source for YSC-LEU media contained either 2%
(w/v) glucose (Sigma), 2% (v/v) glycerol (Fisher Scientific), or 2% (v/v) emulsified oleic
acid (EMD Millipore) in 0.1% (v/v) Tween 80. Agar plates for post-transformation
applications in E. coli and Y. lipolytica were prepared by adding 15 g/L agar to either LB
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or YSC-LEU media, respectively. Y. lipolytica transformations were done using the
lithium acetate method as described previously [106].

General Plasmid Construction
Procedures for restriction enzyme digestions and PCR amplification were
performed as recommended by supplier protocols. Ligations were incubated at room
temperature for 20 min using T4 DNA ligase prior to transformation into DH10β E. coli
using the heat shock method. Post-ligation transformants were grown overnight in LB
media supplemented with 100 μg/mL ampicillin. All vectors used in this study were
derived from a skeletal plasmid containing a centromeric site and autonomous replicative
sequence (CEN/ ARS) pSL16-cen1-1(227) [173]. A gBlock containing a multiple cloning
sites (MCS), hrGFP, and CYC1 terminator was synthesized (Supplementary Table 2.1)
with flanking 5′ BamHI and 3′ HindIII restriction sites and ligated into the pSL16-cen11(227) skeletal vector to create pSL16-cen1-1(227)-MCS-hrGFP-CYC1t. Eight tandem
repeats of UAS1B elements were PCR amplified from pUC-UAS1B8-TEF(136) [82]
using primer pair F1/R1 (Supplementary Table 2.1). The F1 mutagenesis forward primer
was used to introduce a BstBI restriction site and mutate the SphI site adjacent to 5′ of the
UAS1B sequences, while the reverse primer retained the SphI site. The PCR amplified
UAS1B8 fragment was ligated into the pSL16-cen1-1(227)-MCS-TEF(136)-hrGFPCYC1t to create pSL16-UAS1B8-TEF(136)-hrGFP.
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Construction of POX2 Promoter Truncation Plasmids
The native POX2 promoter, POX2 (2147 bp), and subsequent truncations, POX2
(1591 bp), POX2 (513 bp), POX2 (438 bp), POX2 (147 bp), and POX2 (100 bp), were
PCR amplified from PO1f genomic DNA using primer pairs F2/R2, F3/R2, F4/R2,
F5/R2, F6/R2, and F7/R2, respectively (Supplementary Table 2.2). The POX2 promoter
truncations were ligated in place of the TEF(136) promoter using restriction sites
SphI/AscI to make a series of POX2 hybrid promoters, pSL16-UAS1B8-POX2 (x bp)hrGFP. Unless otherwise stated, all hybrid promoter constructs utilized 5′ SphI and 3′
AscI sites for ligation into the pSL16-UAS1B8- TEF(136)-hrGFP vector by replacing the
TEF(136) minimal core promoter. To create a series of vectors containing truncations of
the native POX2 promoter without the UAS1B elements, the series of POX2 promoter
truncations were PCR amplified from PO1f genomic DNA using primer pairs F8/R2,
F9/R2, F10/R2, F11/R2, F12/R2, and F13/R2 (Supplementary Table 2.2). The forward
primers had a 5′ flanking XmaI site for ligation into the pSL16-cen1-1(227)-MCShrGFP-CYC1t vector to create the series of pSL16-POX2 (x bp)-hrGFP vectors.

Construction of Hybrid Core Promoter Plasmids
Four hybrid core promoter systems were constructed using core promoters of the
TEF, LEU2, POX2, and PAT1 genes. Primer pairs F14/R3 and F15/R4 were used to
amplify the TEF (111 bp) and LEU2 (78 bp) core TATA promoters, while synthesized
oligonucleotide pairs F16/R5 and F17/R6 (Supplementary Table 2.2) were annealed to
make the core TATA promoters, POX2 (48 bp) and PAT1 (61 bp), respectively. These
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promoters were digested and ligated into pSL16-UAS1B8-TEF-hrGFP in place of the
TEF(136) promoter to construct the hybrid core promoters, pSL16-UAS1B8-POX2 (x
bp)-hrGFP.

Construction of Hybrid TATA Box Promoter Plasmids

The TATA box in TEF core hybrid promoter was replaced with the POX2 and
LEU2 TATA box motifs using mutagenesis forward primers F18 and F19 paired with R3.
The template used for PCR was pSL16-UAS1B8-TEF (111 bp)-hrGFP. Mutations to the
TATA box in the POX2 core promoter to substitute in the TEF and LEU2 TATA motifs
were accomplished by purchasing synthesized oligonucleotides F20/R7 and F21/R8,
respectively. pSL16-UAS1B8-POX2 (2147 bp)-hrGFP was digested to remove the POX2
(2147 bp) promoter, and the abovementioned annealed oligos were ligated in its place.
Sequence and ligation-independent cloning (SLIC) [201] was used to replace the TATA
box of the native POX2 promoter with the canonical TEF and the LEU2 TATA motifs.
The vector template was pSL16-POX2 (2147 bp)-hrGFP. Primer pairs F22/R9 and F23/
R10 were used for the TEF TATA substitution, whereas F23/ R11 and F24/R10 were
used to make LEU2 TATA motif substitutions (Supplementary Table 2.2). The base
vector for mutagenesis and PCR amplification was pSL16-POX2 (2147 bp)-hrGFP.

Construction of Hybrid Proximal Promoter Plasmids
The effect of the proximal sequence in the TEF minimal core promoter was tested
by placing proximal motif upstream of the POX2 and LEU2 core promoters, respectively.
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Two separate gBlocks containing the respective core promoters and the 26 bp proximal
sequence 5′ of the TEF core promoter, F25, and F36 were purchased. To test the effect of
various TATA box associations with the TEF proximal sequence, gBlocks of the POX2
core promoters with modified TATA boxes containing the TEF proximal sequence (F32
and F33) were also purchased (Supplementary Table 2.2). SLIC was used to insert the
oligonucleotides into a SphI/AscI double-digested pSL16-UAS1B8-POX2 (2147 bp)hrGFP vector.

Construction of UAS1B8 Hybrid Promoters for Genome Integration
Hybrid promoter cassettes with TATA box modifications were made for
integration into the leu2 locus of Y. lipolytica Δku70. The Δku70 strain has previously
been shown to improve the efficiency of homologous recombination events.51 pSL16cen1-1(227) was digested with AatII to insert a 500 bp front-end homology to the leu2
locus and new restriction site, AvrII, in the vector. The 500 bp front-end homology was
PCR amplified from the Y. lipolytica genome using SLIC primer pairs F26/R12
(Supplementary Table 2.2). The new vector containing the frontend homology was
digested with HindIII-HF to insert a 500 bp back-end homology to the leu2 locus and a
new restriction site, MfeI. The 500 bp back-end homology was PCR amplified from the
Y. lipolytica genome using SLIC primer pairs F27/R13 (Supplementary Table 2.2). The
new vector was termed pSL16-cen1-1(227) [LEU2 homologous ends]. The three hybrid
TEF core promoter cassettes containing the TEF, LEU, and POX2 TATA boxes,
respectively, were digested with BstBI and AatII, and an insert containing the LEU2
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promoter, gene, and terminator was PCR amplified from the Y. lipolytica W29 genome
using SLIC primer pairs F28/R14 and inserted into the double-digested vectors above
(Supplementary Table 2.2). The purpose of this step was to remove the centromeric
CEN1-1 DNA sequence that makes the plasmid replicative. These three vectors were
then doubled-digested with AatII and HindIII to add in an insert containing leu2
homologous ends that were PCR amplified from pSL16-cen1-1(227) [LEU2 homologous
ends] using primer pairs F27/R12 (Supplementary Table 2.2). Integration at the leu2
locus was verified by PCR and DNA sequencing.

Construction of Vectors Containing Three Tandem UAS(TEF) Elements
A pUC vector was used to first make three tandem UAS(TEF)#2 sequences33
prior to transferring these elements into a pSL16 hybrid vector. The UAS(TEF) from the
first UAS(TEF) element was PCR amplified from the Y. lipolytica PO1f genome using
SLIC primer pair F29/R15 (Supplementary Table 2.2) and inserted into pUCUAS1B8(TEF136) (Addgene no. 44380) double-digested with SphI and BamHI to
remove the 8UAS1B elements, creating pUC-UAS(TEF)#1. The second UAS(TEF)
element was PCR amplified from the Y. lipolytica PO1f genome using SLIC primer pair
F30/R16 (Supplementary Table 2.2) and inserted into the pUC-UAS(TEF)#1 vector
double-digested with NdeI and BamHI to create pUC-UAS(TEF)#2. Finally, the third
UAS- (TEF) element was PCR amplified from the Y. lipolytica PO1f genome using SLIC
primer pair F30/R17 (Supplementary Table 2.2) and inserted into the pUC-UAS(TEF)#2
vector double-digested with NdeI and EcoRI to create pUC-UAS(TEF)#3. The three
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tandem UAS(TEF) elements were digested out of the pUC-UAS(TEF)#3 vector using
SphI/BstBI and inserted into the double-digested pSL16-UAS1B8-TEF(TATA)-hrGFP,
pSL16- UAS1B8-TEF(LEU2 TATA)-hrGFP, and pSL16-UAS1B8- TEF(POX2 TATA)hrGFP core promoter hybrid cassettes to create counterpart vectors containing
3UAS(TEF) elements.

Flow Cytometry
Humanized Renilla reinformis GFP (hrGFP), codon optimized for Y. lipolytica,
was used as the fluorescence reporter protein to measure promoter strength.
Transformants from selective media plates were first propagated in 2 mL precultures for
48 h prior to inoculating 10 mL cultures at an OD600 of 0.3. The cultures were grown
under constant agitation for 48 h, which was reported as the optimal incubation time for
high expression levels.32 Prior to flow cytometry analysis, cultures were grown in
glucose and glycerol and were spun at 12000xg for 2 min and resuspended in 0.1 M
phosphate-buffered saline (PBS) at pH 7.4. Cultures grown in emulsified oleic acid were
spun at 12 000gfor 2 min and suspended in YSC-LEU containing 5% (v/v) Tween 80.
The resuspended pellet was agitated by vigorous shaking prior to centrifuging the sample
at 12 000gfor 1 min and resuspending the pellet in 0.1 M PBS, pH 7.4. All samples were
kept on ice during sample preparation and analysis. Flow cytometry analysis was
performed using the BD Accuri C6 flow cytometer (BD Biosciences) with the standard
detector, FL1 filter (533/30), used to capture fluorescence from the GFP fluorophore. The
VIRTUALGAIN module in the BD Accuri C6 software was used to adjust peak position
and account for normalizing gains across samples during analysis. Population gates were
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applied to account for the mean fluorescence from the GFP expressing population and
negate autofluorescence.

Quantitative Reverse Transcription PCR (qRT-PCR)
Transformants grown under different carbon source conditions were subject to
RNA extraction 48 h post-growth. The transformants across each of the selected cultures
were normalized to an OD600 of 5 prior to RNA extraction procedures. The cells were
pelleted, and total RNA was extracted using the E.Z.N.A yeast RNA kit (Omega Biotek).
RNA extracts were placed in aliquots and stored at −80 °C until further use. For absolute
RT-qPCR, a two-step protocol was employed. 500 ng of total RNA was used in cDNA
synthesis that was performed using gene-specific priming with maxima reverse
transcriptase (Thermo Scientific). 1.5 μL from the cDNA synthesis mix was subject to
qPCR with the Maxima SYBR Green/Fluorescein qPCR master mix (Thermo Scientific).
qPCR was performed in biological triplicates from the cDNA mix in a 96-well plate
using a CFX Connect real-time (Bio-Rad). The primer pair, GFPF/ GFPR, used in RTqPCR is listed in Supplementary Table 2.2. A standard curve was developed using a
linearized vector containing the hrGFP gene to relate Cq values to copy number. This
calibration curve was used to calculate mRNA copy numbers of qPCR analyzed samples.
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Results
Oleic Acid Inducible Enhancers Are Upstream in the Native POX2 Promoter
While the whole POX2 promoter has proven to be useful for heterologous
expression in Y. lipolytica, there is little known about the mechanism or localization of
elements that confer oleic acid responsiveness in this relatively large promoter. To
identify such oleic acid response elements (OREs) in the promoter, a series of 5′ deletions
were made to the endogenous POX2 promoter, based on homology to S. cerevisiae
OREs. These promoter truncations were placed upstream of a humanized R. reinformis
GFP (hrGFP) reporter gene to quantify expression via cellular fluorescence (Figure
2.1A). The significant drop in fluorescence was observed from the POX2 (1591 bp) to the
POX2 (513 bp) promoter. This indicates that most of the OREs reside in this 1 kb
window, significantly upstream of the TATA box, where the preinitiation complex (PIC)
is known to form (Figure 2.1A) in RNA polymerase II promoters.

UAS1B Sequences Act in a Distance-Dependent Manner
The UAS1B element in Y. lipolytica has previously been shown to be a
constitutive transcriptional amplifier that is independent of the nitrogen content and pH of
the media [199] and fusion of greater than four UAS1B elements in tandem could lead to
a cooperative and significant amplification [199]. We combined eight tandem UAS1B
(UAS1B8) repeats with truncations of the POX2 inducible promoter system and observed
the strongest expression from the shortest POX2 truncations. Several short POX2
promoter truncations (100, 147, and 438 bp) resulted in minimal GFP fluorescence;
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however, when they were combined with UAS1B8, these promoters were stronger than
longer hybrid POX2 promoters. We observed that the UAS1B8 sequences conferred
weaker transcriptional amplification as they were moved farther away from the gene
(Figure 2.2B). A significant decrease in fluorescence is observed from the UAS1B8POX2 (513 bp) to the UAS1B8-POX2 (1591 bp) hybrid promoter, which is an opposite
effect to what was observed with the truncations of the native promoter.

Figure 2.2. Truncated POX2 promoters and hybrid POX2 promoters. (A) Length of 5′
truncations of the native POX2 promoter (gray; left) and oleic acid induced fluorescence
from the corresponding truncations of the endogenous POX2 promoter (right). (B) Eight
UAS1B elements (orange) fused upstream of the 5′ POX2 promoter truncations (gray) to
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create a series of POX2 hybrid promoter systems (left) and oleic acid induced
fluorescence (black) from the corresponding hybrid POX2 promoter constructs (right).

Core Promoter Sequence Modulates Expression Level
A complete understanding of the mechanism for TFIID-dependent transcription
and TSS localization in yeast promoters is still unclear; therefore, a range of TATA
promoters containing different distributions of predicted initiator sequences were used in
this study. Transcriptional effects from the types of initiator sequences (Supplementary
Figure 2.1) and distances from TATA box still remain to be fully elucidated in yeast
TATA-containing promoters [202]. Our hybrid POX2 promoter studies indicate that
UAS1B8 sequences placed upstream of the core promoter truncated down to the TATA
box still result in high levels of transcription and therefore we hypothesized that these
sequences can similarly amplify other core promoters. The UAS1B8 elements were fused
upstream of core promoters from the PAT1, POX2 inducible promoters and the TEF1-α,
LEU2 constitutive promoters. The core promoters constructed in this chapter are
designated as the truncated promoter sequence to a functional TATA box (Figure 2.3A),
which acts as the binding site of the PIC in TATA-containing promoters [202]. The
functional TATA boxes in these promoters were identified by scanning the promoter
sequence between 40 and 100 bp from the start codon [203]. GFP reporter expression and
quantitative PCR results indicate that, indeed, the UAS1B8 sequence enhances
transcription from all core promoters tested and that transcript levels scale with core
promoter strength, with TEF1 being the strongest and PAT1 and LEU2, the weakest. We
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also observed that the TEF1 core promoter is the longest functional core promoter
(Figure 2.3A), whereas the shortest core promoter (POX2) had similarly high expression.

UAS1B from XPR2 Confers Substrate-Specific Responsiveness
The UAS1B sequence was originally described as lacking regulation by media
conditions when compared to the full XPR2 promoter; however, an investigation of
UAS1B hybrid promoter strength when using different carbon sources was not performed
[199]. We compared the expression levels of GFP by flow cytometry and qPCR of
cultures grown in either YSC media containing glucose, glycerol, or oleic acid. Oleic acid
substrate resulted in the highest levels of promoter activation. UAS1B8 hybrid promoters
were less activated in glucose and were minimally activated in glycerol. All four
promoter systems exhibited a similar trend in substrate-specific responsiveness, largely
following the pattern of core promoter strength (Figure 2.3B, C).
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Figure 2.3. UAS1B8 enhancers are oleic acid responsive. (A) Core promoter sequences
of TEF, POX2, LEU2, and PAT1 shows the variability of the TATA box sequence. (B,
C) Substrate-specific transcriptional responsiveness (fluorescence, B; absolute qPCR, C)
from the various hybrid core promoter constructs.

TATA Box Sequence Has a Large Influence on Expression Level
To study the effect of TATA elements on transcriptional regulation, we chose
TATA boxes as 8 bp sequences, with 2 additional bases downstream of the 6 bp core
TATA box from four sequentially different Y. lipolytica promoters. The TEF promoter
contains a TATAAA[AG] sequence that is reported to be one of the strongest TATA box
sequences in S. cerevisiae, while the LEU2 TATA box sequence, TATATA[TA], is also
considered to be a strong sequence for TFIID binding, albeit to a weaker extent than the
TEF TATA box [204]. Expression from these hybrid promoters was strong (Figure 2.4A,
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B, C). The POX2 TATA box sequence, TATACTTATATA, is not prevalent or highly
uncommon in S. cerevisiae promoters; however, in Y. lipolytica, we observed strong
expression from this hybrid promoter as well. When these TATA boxes were applied to
the native POX2 promoter, we observed small changes in expression strength strongly
suggesting that the strong UAS elements are predominantly important to confer strong
expression (Figure 2.4D).
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Figure 2.4. TATA box sequence impacts promoter strength. (A) Schematic of 8 bp TATA
box mutations in the TEF (purple) and POX2 (lilac) hybrid core promoters. The
consensus TEF TATA box, TATAAAAG, was substituted with lower affinity binding
TATA boxes from the LEU2 and POX2 promoters. Furthermore, the POX2* TATA box
was replaced with the LEU2 and the consensus TEF TATA box. (B) Qualitative
representation of fluorescence strength from hybrid core promoters containing different
core TATA boxes. (C) Fluorescence profiles for substitutions of the TATA boxes in the
hybrid core promoters of POX2 and TEF. (D) Fluorescence profiles for when the TATA
box from the endogenous POX2 (2147 bp) promoter was substituted with the TEF and
LEU2 TATA boxes. * Indicates that a weaker, truncated version of the fully functional
POX2 TATA box (TATACTTATATACC) was used in these experiments to create a
series of hybrid promoter constructs with varying degrees of strength.

TEF Proximal Promoter Sequence Enhances Expression of Engineered Promoters
A comparison of the oleic acid-induced expression between the hybrid UAS1B8TEF (136 bp) and UAS1B8-TEF (111 bp) transformants revealed that the UAS1B8-TEF
(136 bp) showed a significant increase in fluorescence (Figure 2.5B). The difference
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between the two constructs is a 26 bp fragment adjacent to the 5′ end of the TATA box in
the TEF core promoter. We wanted to understand if this proximal sequence could be used
in a modular fashion for transcriptional enhancement in other TATA box containing
promoters. We placed the TEF proximal sequence upstream of the hybrid POX2 core
promoter containing a fully functional TATA box, UAS1B8-POX2 (TEF proximal)
(Figure 2.5A). An insignificant increase in fluorescence was observed from this
engineered promoter in comparison to the UAS1B8-POX2 (55 bp) construct without the
TEF proximal sequence (Figure 2.5C), suggesting proximal sequences affect
transcription in a nonmodular manner. The exact mechanism for how proximal sequences
can enhance transcription is not well-understood and is likely context-dependent. To
investigate this, we constructed UAS1B8 hybrid promoters containing the TEF proximal
sequence upstream of TEF, LEU2, or POX2 core promoters. This data shows that the
relative increase in transcriptional activity due to the TEF proximal sequence was
insignificant for POX2 core promoters, higher in LEU2 core promoters, and highest in
TEF core promoters (Figure 2.6A). Additionally, we showed that the TEF proximal
sequence continues to exert no significant transcriptional enhancement when paired with
the POX2 core promoter regardless of TATA sequence (Figure 2.6B), suggesting that
proximal sequences interact with the core promoter sequence downstream of the TATA
sequence. It is important to note that the effect of TATA sequence on GFP expression
was preserved.
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Figure 2.5. Proximal promoter sequences impact promoter strength but are not modular.
(A) Schematic of TEF minimal core promoter with proximal promoter sequences
adjacent to the core promoter. The schematic also shows insertion of the TEF proximal
promoter motif directly upstream of the POX2 core promoter (UAS1B8-POX2 (TEF
Proximal)). (B) Comparison of hrGFP fluorescence from TEF promoter including the
proximal promoter sequence, including just the core promoter, and truncated past the
TATA box. (C) Comparison of hrGFP fluorescence from POX2 core promoter TEF and
native proximal sequence (TEF proximal and 100 bp) with core promoter (55 bp) and
truncation (42 bp) that lacks the TATA box
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Figure 2.6. Modularity of the TEF proximal sequence in different promoter
environments. (A) Comparison of hrGFP fluorescence from UAS1B8 hybrid promoters
containing the TEF, LEU2, or POX2 core promoter with and without the TEF proximal
sequence shows different levels of transcription enhancement based on core promoter
sequence. (B) Comparison of hrGFP fluorescence from UAS1B8 hybrid promoters with
POX2 core promoter sequence with and without the TEF proximal sequence shows that
changing the TATA sequence does not alter the interaction between TEF proximal
sequence and core promoter sequence.

Utility of the TATA Box Mutations in Different Episomal and Genomic Contexts
We investigated the utility of the TATA elements in transcriptional regulation of
RNA polymerase II promoters. In hybrid promoters with three tandem repeats of
UAS(TEF) and a TEF core promoter, the effect of TATA box sequences from TEF,
LEU2, and POX2 followed the trend observed in hybrid promoters using UAS1B8 from
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XPR2 (Figure 2.7A). Regardless of the type of UAS element used, the strongest
expression levels were observed from the TEF TATA consensus box, followed by the
LEU2 TATA box and the POX2 TATA box. The relative expression strengths among the
TATA box modifications translate well across the UAS(TEF)3 and UAS1B8 elements,
with the TEF hybrid core promoter containing the canonical TATAAAA box showing an
approximately greater than 2-fold increase in comparison to the TEF hybrid core
promoter with the LEU2 TATA motif. We also observed that the absolute promoter
strength dropped approximately 2-fold when integrated into the genome, consistent with
previous work showing lower expression of integrated promoters [205]. The relative
differences in strength among the hybrid promoters with different TATA boxes follow
the same trend in expression observed in UAS1B8 an UASTEF3 containing hybrid
promoters. The TEF core promoter containing the TEF TATA box is still the strongest
expressing system, followed by the LEU2 TATA box and the POX2 TATA box (Figure
2.7B). The decrease in promoter strength upon integration is consistent with additional
repression of promoter strength due to genomic context.
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Figure 2.7. Modularity of the TATA box in different promoter environments. (A) hrGFP
fluorescence from UAS(TEF)3 hybrid promoter containing TEF core promoter with
either TEF, LEU2, or POX2* TATA box shows the same trend in promoter strength
compared to identical episomal expression with UAS1B8 hybrid promoters. (B) hrGFP
fluorescence from a UAS1B8 hybrid promoter containing TEF core promoter with either
TEF, LEU2, or POX2* TATA box shows the same trend in promoter when integrated
into the genome at the leu2 locus.
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Table 2.1. Summary of promoters built from different component sequences
UAS TYPE

PROXIMAL
TATA
CORE
EXPRESSION
SEQUENCE
SEQUENCE
PROMOTER
STRENGTH
TATA modifications in TEF hybrid promoters (Episomal Expression)
UAS1B8
NONE
TEF
TEF
++++
UAS1B8
NONE
LEU2
TEF
+++
UAS1B8
NONE
POX2*
TEF
++
UAS(TEF)3
NONE
TEF
TEF
++++
UAS(TEF)3
NONE
LEU2
TEF
+++
UAS(TEF)3
NONE
POX2*
TEF
++
TATA modifications in TEF hybrid promoters (Genomic Expression)
UAS1B8
NONE
TEF
TEF
+++
UAS1B8
NONE
LEU2
TEF
++
UAS1B8
NONE
POX2*
TEF
+
TATA modifications in POX2 hybrid promoters (Episomal Expression)
UAS1B8
NONE
POX2
POX2
+++
UAS1B8
NONE
TEF
POX2
++++
UAS1B8
NONE
LEU2
POX2
+++
UAS1B8
NONE
POX2*
POX2
+
TATA modifications in native promoters (Episomal Expression)
POX2
POX2
POX2
POX2
+
POX2
POX2
TEF
POX2
+
POX2
POX2
LEU2
POX2
+
CORE PROMOTER modifications in hybrid promoters
UAS1B8
NONE
TEF
TEF
++++
UAS1B8
NONE
LEU2
LEU2
+++
UAS1B8
NONE
POX2
POX2
+++
PROXIMAL SEQUENCE modifications in hybrid promoters
UAS1B8
TEF
TEF
TEF
+++++
UAS1B8
TEF
LEU2
LEU2
++++
UAS1B8
TEF
POX2
POX2
+++
UAS1B8
TEF
LEU2
POX2
+++
UAS1B8
TEF
TEF
POX2
++++
Comparison of hybrid promoters
UAS1B8
NONE
TEF
TEF
++++
UAS1B8
NONE
POX2
POX2
+++
UAS1B8
NONE
LEU2
LEU2
+++
UAS1B8
NONE
PAT1
PAT1
++

Discussion and Conclusion
Table 2.1 summarizes the library of promoters with varying degrees of expression
that can be engineering by investigating promoter architecture. There are several
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components that can be used to fine-tune promoter strength and responsiveness. This
chapter explores the contribution from each of these promoters to transcription.
The role of UASs sequences to promoter activation is studied in the context
proximity to the core promoter and responsiveness to carbon. The native POX2 promoter
is the most commonly described oleic acid inducible promoter in Y. lipolytica [110]. The
inducibility and expression strength of the endogenous POX2 promoter have been wellcharacterized, and it has been used to drive inducible heterologous protein expression in
Y. lipolytica [206, 207]. Although the promoter is weak, there is no understanding of
where these UAS elements exist on the native promoter. From truncations, we observed
that most of the ORE sites exist in a ~1000 bp region on the POX2 promoter. The lack of
concordance between truncation data and predicted ORE sites is consistent with the
observations of Poopanitpan et al. that showed predicted S. cerevisiae OREs in Y.
lipolytica were nonfunctional [208]. Instead, the genetics of Y. lipolytica appear to be
more closely related to filamentous fungi such as Aspergillus nidulans instead of S.
cerevisiae.
In eukaryotes, enhancer sequences are located several hundred to thousands of
kilobases upstream from a transcriptional start site (TSS). These sequences are
hypothesized to recruit TFs to the TSS through a looping mechanism, suggesting that
their position relative to the TSS is important for function. Tandem repeats of upstream
activating sequences (UAS1B) from the XPR2 promoter have previously been used to
create hybrid promoters (Figure 2.1B) that amplify downstream minimal promoter
transcriptional activity [200]. Placing 8 tandem UAS1B sequences upstream of the POX2
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truncation showed that as these sequences moved further away from the core promoter,
the expression strength became weaker, elucidating that there is a distance dependence of
UAS sequences for transcriptional activation. Interesting, we observed an increase in
expression between the UAS1B8-POX2 (513 bp) and UAS1B8-POX2 (1591 bp) which
correlated well with the increase in the expression between POX2 (513 bp) and POX2
(1591 bp) further supporting the potential for OREs in this ∼1 kb POX2 promoter
fragment. These experiments suggest that transcriptional factors from enhancer regions of
different promoter systems can work cooperatively to amplify transcription.
In addition to amplifying transcription, the UAS1B sequence from the XPR2
promoter contains elements that are highly responsive to regulation by oleic acid, in
contrast to the notion that they are not regulated by media conditions. This observation
underscores the need to be cautious about the possibility of unintended promoter
regulation when engineering eukaryotic promoters.
Regulation at the core promoter level in eukaryotic systems can be complex as
there are several elements within the core promoter that modulate promoter activity and
strength. For example, in S. cerevisiae promoters, core promoters of both constitutive and
regulated genes confer the highest activity when the sequence has a low G/C content,
with T-rich motifs upstream of the TSS and A-rich motifs downstream of the TSS [209].
Such conditions are better suited for RNA polymerase II scanning downstream of the
TATA box and selecting the most suitable TSS to initiate transcription. Our selection of
TATA-containing core promoters in Y. lipolytica took into account sequences of varying
degrees of G/C content, with the TEF1-α core promoter containing the lowest G/C
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content (∼39%) and the PAT1 promoter having the highest percentage (∼49%) (Figure
2.3A). Core promoters from POX2 and LEU2 both contain a G/C content that is
approximately 43%. The TEF core promoter exhibits the strongest transcription while the
PAT1 core promoter shows weakest expression but these promoters also contain
distinctly different TATA elements that need to be considered. These results show that
that promoter strength is a complex function of elements near core promoter sequence
and distance of UAS sequences from the core promoter.
Distance from the TATA box and the core promoter strength can be used to finetune transcriptional levels, leading not only to multiple transcription levels but also to
redundant transcriptional levels, as seen for UAS1B8-LEU2, UAS1B8-POX2, and
UAS1BTEF (Figure 2.3B). However, to fully elucidate the role of initiator sequences in
core promoters, we would need to test these sequences independently of the TATA boxes
used as different TATA boxes can elicit different transcription strengths making it
difficult to interpret the role of initiator sequences.
The TATA box is perhaps the most studied component of the eukaryotic promoter
and is well-appreciated for its role determining the strength of eukaryotic core promoters,
for example, in S. cerevisiae synthetic GAL4 enhanced promoter systems [210]. Two
well-studied consensus core TATA boxes, TATAAA and TATATA, have previously
been shown to have a high affinity to TFIID binding both in vitro and in vivo in S.
cerevisiae, with the former being the strongest [204]. Furthermore, the nucleotide
sequence that is immediately downstream TATA element has been shown to strongly
affect transcription levels. Therefore, to test TATA elements, we considered 2 bp
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downstream of the 6 bp elements we considered TATA boxes based on comparison to S.
cerevisiae sequences. The TATA motif from the TEF promoter showed strongest
transcriptional strength while a mutation of one TATA box in the POX2 promoter that
houses two TATA elements severely weakened transcription. This raises interesting
questions about the most optimal TATA sequence for Y. lipolytica, which can be studied
by increasing the sequence space from what we initially considered a TATA element in
this study.
Modifications of the TATA box across hybrid promoters containing different
UAS element types showed that expression from the different TATA boxes is
independent of the UAS elements used to enhance expression. This suggests that
promoter strength and therefore expression can be tuned using TATA box modifications
independent of the type of enhancer used. To determine if the TATA box promoter
tuning strategy would translate to engineered promoters integrated into the genome,
hybrid UAS1B8-TEF core promoter cassettes containing the TATA box modifications
were integrated into the genome at the leu2 locus and similar trends were observed,
albeit, weaker than the hybrid promoter. This demonstrates the importance of strong
UASs to amplify the variations of base transcription from TATA elements.
There was less success, however, in attaining predictable expression strength by
translating proximal sequences from one core promoter to another. A potential reason for
this lack of modularity is that the proximal sequence works cooperatively with the
surrounding DNA sequences to provide a favorable nucleosome-depleted region near the
TSS. In constitutive promoters, the DNA directly upstream of the TSS is typically
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nucleosome-depleted, whereas upstream of regulated promoters are more occupied [211].
A simple analysis of the POX2 and TEF core promoters clearly shows that, in addition to
TATA box variability, there is a significant difference in the distribution and localization
of the predicted yeast initiator sequences [212-214] and length of each core promoter
(Supplementary Figure 2.1). We were unable to find any potential S. cerevisiae
homologous transcriptional factors that could be associated with binding to the 26 bp
proximal sequence.
This study has generated several new plasmids useful for episomal expression of
genes in Y. lipolytica. We have identified a region of the native POX2 promoter that
contains oleic acid responsive enhancers, we have shown that UAS1B8 repeats from
XPR2 are sensitive to the carbon source, and we have examined the effect of the different
core promoter and proximal promoter sequences on regulating transcript levels. We have
also shown that by engineering different components of the promoter architecture a series
of vectors with varying degrees of expression can be obtained (Table 2.1). Our study has
shown that eukaryotic promoter engineering approaches can be focused at the enhancer
region, at proximal sequences, the TATA box, and the core promoter, leading to a diverse
and finely tunable level of gene expression. Future efforts to incorporate other responsive
enhancers may lead to promoter engineering approaches that can finely tune both the
transcription level as well as the environmental signal needed to activate transcription.
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CHAPTER THREE
DEVELOPMENT OF A STRONG YET TUNABLE FATTY ACID INDUCIBLE
PROMOTER IN YARROWIA LIPOLYTICA

Abstract
The engineering of Yarrowia lipolytica to accumulate lipids with high titers and
productivities has been enabled with a handful of constitutive promoters for pathway
engineering. However, the development of promoters that are both strong and lipid
responsive could greatly benefit the bioproduction efficiency of lipid-derived
oleochemicals in oleaginous yeast. In this study, we sought to engineer a fatty acidregulated hybrid promoter for use in Y. lipolytica. We identified a 200 bp upstream
regulatory sequence in the peroxisomal acyl CoA oxidase 2 (POX2) promoter. Further
analysis of the promoter sequence revealed a regulatory sequence, that when used in
tandem repeats, led to a 48-fold induction of gene expression relative to glucose and 4fold higher than the native POX2 promoter. To date, this is the strongest inducible
promoter reported in Y. lipolytica. Taken together, our results show that it is possible to
engineer strong promoters that retain strong inducibility. These types of promoters will
be useful in controlling metabolism and as fatty acid sensors.

†

A version of this chapter is published in Biotechnology Journal 2017, 12(10), 1-11, with co-authors Ian
Wheeldon, and Mark Blenner.
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Introduction
Metabolic engineering of microorganisms for bioproduction greatly benefits from
transcriptional control of native or heterologous genes [215, 216]. Precision control of
gene expression enables rapid pathway optimization [217]. To that end, significant work
has been put into developing libraries of promoters with predictable strength for a
number of microorganisms [32, 215, 218]; however, in even well-characterized
eukaryotes, such as Saccharomyces cerevisiae, the toolkit of promoters remains small
compared to bacteria. Given the benefits of metabolic engineering in yeast [219, 220],
additional focus on expanding the yeast promoter toolkit is warranted. Random
mutagenesis of promoters has resulted in only modest improvements in promoter strength
[215]. Similarly, it has been quite simple to identify loss-of-strength mutations in
promoters [215, 218]. Rational approaches to increasing promoter strength have focused
on hybrid promoters, where heuristically identified, well-defined DNA elements called
upstream activating sequences (UASs) are placed in front of a core promoter sequence
and can be used in a modular fashion to tune transcription strength [80-82, 199, 221].
While improving the strength of yeast promoters has been successful, the toolkit is
currently lacking many options for inducible promoters.
Libraries of constitutive promoters with different strength can be used to tune
gene expression; however, the expression level is statically set. Inducible promoters are
useful genetic tools for metabolic engineering because, in addition to the benefits of
being able to tune the transcriptional output, the expression level can be changed
dynamically by metabolites or inducers. Inducible promoters can be especially important
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to improve the carbon flux efficiencies in a metabolic process by separating the growth
phase from the production phase of a cell [222, 223]. Additionally, if the excess
production of an enzyme or a product is toxic to the cell, it would be beneficial to have
production switched off so cell growth would not be inhibited until the desired biomass is
made [184, 186]. Inducible promoters used in metabolic engineering of yeast have largely
been endogenous promoters responsive to small molecules such as copper, methionine,
tryptophan, and phosphate [224-227]. Unfortunately, these promoters exhibit complex
regulation patterns and are of modest strength at best. One notable exception is the Gal
promoter from S. cerevisiae, which is both strongly repressed by glucose and strongly
activated by galactose [224]. An upstream regulatory sequence (URS) from the GAL1-10
promoter has been used with a strong endogenous promoter, TDH, to confer galactose
inducible control of the TDH promoter to create an inducible chimeric promoter [228].
Recently, a tryptophan inducible TDH promoter was engineered, using a mutant ARO80
transcription factor and tandem repeats of the URSARO9, resulting in promoters that are
both strong and induced by tryptophan [229].
In recent years, there has been an increase in genetic tools for metabolic
engineering in the oleaginous yeast, Y. lipolytica. The advancement of genetic tools [80,
82, 83, 230] has enabled metabolic engineering in this microorganism to produce a
significant amount of FAs [89] and lipids [190, 231, 232] from different substrates [95,
233, 234]. Given the relative weakness of endogenous promoters, hybrid promoters have
had great success in heterologous gene expression [82]. This success stems from the
ability to tune expression strengths in hybrid systems. Whereas high expression is often
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desired [190], the option to tune transcriptional strength to lower levels can be critical to
attaining optimal heterologous protein production [235]. An important set of hybrid
promoters developed in Y. lipolytica contain the UAS1B element originally derived from
the nitrogen and pH regulated XPR2 promoter [199, 200]. When used in tandem, the
UAS1B elements provide enhancement in expression independent of nitrogen level and
pH [81, 82, 199]. Another hybrid promoter used for metabolic engineering contains
UASTEF from the constitutive promoter of the translation elongation factor 1-α (TEF1-α)
gene [81]. Strong expression of genes is enabled by hybrid promoters; however, the
current set of strong hybrid promoters is limited. Although tunable in expression strength,
hybrid promoters sometimes elicit carbon source dependent regulation from the UAS, as
was previously demonstrated using the POX2 UAS1B [80]. While this property might be
used to create regulated promoters, the inducibility is neither rational nor tightly
regulated. There has only been one report of a rationally designed inducible hybrid
promoter in Y. lipolytica. This alkane inducible promoter was constructed from repeats of
an alkane response element, but confers relatively weak expression when grown on
alkanes [114, 115, 120, 236]. Therefore, development of hybrid promoters that are
inducible to a biomolecule that is both readily metabolized in Y. lipolytica and acts as a
precursor molecule for the synthesis of several other important biomolecules is desirable.
Fatty acids are ideally suited for this task.
The native promoters from the peroxisomal acyl-CoA oxidase 2 (POX2),
peroxisomal 3-ketoacyl-thiolase (POT1), and lipase 2 (LIP2) genes are commonly used
as fatty acid inducible systems for metabolic engineering [117, 148, 206, 207, 237-239].
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While the expression strength of the inducible promoter of POX2 has previously been
characterized as strong [110, 148, 240], we show that the POX2 promoter is relatively
weak compared to the beta-actin promoter and engineered hybrid promoters. In this work,
we performed a series of truncations to identify fatty acid-responsive UASs and URSs
that were combined to construct a library of hybrid promoters. A URS, called R1, was
initially found to be critically important for fatty acid responsiveness and promoter
strength. The amplifying effect of the R1 sequence was shown to be synergistic with a
UAS, called A1. Tandem repeats of the R1 sequences from the POX2 promoter were
used to create a strong fatty acid inducible system. This new hybrid promoter was
approximately four-times the strength of the native POX2 promoter and smaller in size.
This promoter had a 48-fold oleic acid induction of expression relative to glucose. The
promoter was also induced by other fatty acids and lipids but remained strongly repressed
in glycerol and glucose. Stronger inducible promoters were engineered by placing tandem
R1 sequences upstream of either the TEF1-α promoter minimal promoter or the TEF1-α
intron promoter, achieving expression levels greater than 10-fold higher than the native
POX2 promoter. The hybrid promoter described here is the first engineered and strongest
fatty acid inducible promoter system for Y. lipolytica.

Experimental Procedures
Strains & Culture Conditions
Plasmid propagation was performed using Escherichia coli DH10β competent
cells (NEB). Transformations in E. coli were performed using standard methods [241].
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strain PO1f (ATCC MYA-2613; MATa leu2−270 ura3−302 xpr2−322 axp) was
purchased from ATCC. Transformations were done using the lithium acetate method as
previously described with a minor modification for cell propagation after the
transformation [80]. Briefly, following the heat shock step, the cells were mixed with 800
µL of 0.1 M lithium acetate, spun down at 6,000 x g for 2 minutes (4°C) and resuspended in 100 µL of 0.1 M LiAc buffer prior to inoculating 2 mL cultures that were
grown in 14 mL culture tubes. All cultures were grown at 215 rpm and 28 °C.
Transformations and growth were performed in biological triplicates. was grown in
Yeast Synthetic Complete media without leucine (YSC-LEU) comprised of 6.7 g/L yeast
nitrogen base (YNB) without amino acids (Difco) and 0.69 g/L CSM-LEU (Sunrise
Science Products). Carbon substrates used for characterization during the construction of
the hybrid promoter were 2% (v/v) oleic acid (EMD Millipore) emulsified in 0.05% (v/v)
Tween 80, and 2% (w/v) D-glucose. Other substrates that were used to characterize the
substrate responsiveness of the hybrid promoter were all added at 30 mM, an equimolar
concentration equivalent to 2% (v/v) oleic acid. These substrates include glycerol,
linoleic acid (Alfa Aesar), triolein (Tokyo Chemical Industry), chicken fat (Animal
Coproducts Research and Education Center, Clemson University) and n-decane. In cases
where two carbon substrates were used, each was added at a final concentration of 15
mM. The hydrophobic substrates in the dual carbon experiments were emulsified with
Tween 80 at a final concentration of 0.05% (v/v).
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Promoter and Plasmid Design
All primers used to create the hybrid promoters designed in this study are
presented in Supplementary Table 3.1. Unless otherwise stated, sequence and ligation
independent cloning (SLIC) [201, 242] was used for cloning, and all PCRs were
performed from genomic DNA. The base vector used for cloning was pSL16-CEN1UAS1B8-POX2(100 bp)-hrGFP. [80] Our previous work identified a large region of the
POX2 promoter that was important for POX2 promoter fatty acid responsiveness (-1590
bp to -513 bp) [80]. Within this region, we made periodic truncations using the primer
pairs described in Section 1 of Table 3.1. The truncated POX2 promoter PCR fragments
were inserted between the SphI/AscI restriction sites using SLIC. Hybrid promoter
systems containing UAS1POX2 and UAS2POX2 (A1A2), UAS2POX2 and UAS3POX2 (A2A3)
and UAS1POX2 and UAS3POX2 (A1A3) were constructed by performing a three-piece
SLIC with each UAS and the base vector as described in Section 2 of Table 3.1. To
construct A1A2A3, the A2 fragment was PCR amplified and inserted into the A1A3
vector at the MfeI site, as shown in Section 3 of Table 3.1. Inserts A1R1 and A1R1A2R2
were PCR amplified from genomic DNA and inserted in the base vector A1A3 digested
with AvrII / SphI. Promoters containing URS1POX2 (R1) and URS2POX2 (R2) were
constructed by PCR and cloned in between the SphI and AscI sites of the base vector
(Section 4 of Table 3.1). The R1 sequence was inserted between into A2A3 and A1A3
respectively using the MfeI site (Sections 5 and 6 of Table 3.1). Additional R1 sequences
were inserted to make A1(R1x2)A3 and A1(R1x3)A3 (Section 7 and 8 of Table 3.1).
Construction of the R1A3 plasmid required the R1A3 insert be PCR amplified from the

77

A1R1A3 vector and inserted into the A1R1A3 base vector digested with AvrII / SphI.
A1R1A1R1A3 was created by PCR amplifying the A1R1 sequence from gDNA and
inserting it into the A1R1A3 vector digested with MfeI. To create the fatty acid inducible
hybrid promoter containing the TEF(136) (Section 9 of Table 3.1), TEF(136)-hrGFP was
PCRed from a previously constructed vector [243] and the A3 fragment was PCRed from
the POX2 promoter. These fragments were inserted into a MfeI / AscI-digested hybrid
fatty acid vector (Section 8 of Table 3.1). Construction of the fatty acid inducible
promoter containing the TEF-intron utilized the same strategy instead, in this case, the
TEF-intron-hrGFP vector had to first be constructed as described in Sections 10 and 11 of
Table 3.1. The vector constructed in Section 11 of Table 3.1 was then used as the
template to PCR the TEF-intron-hrGFP.
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Table 3.1. Detailed list of vectors and primers used to construct hybrid promoters tested
in this study.
Starting Vector
Restriction
Primer
Final Vector(s)
Enzymes
Pair(s)
1
pSL16-UAS1B8SphI / AscI
F1 / R1
POX2(1590 bp)-hrGFP
POX2(100 bp)-hrGFP
F2 / R1
POX2(1390 bp)-hrGFP
F3 / R1
POX2(1190 bp)-hrGFP
F4 / R1
POX2(990 bp)-hrGFP
F5 / R1
POX2(790 bp)-hrGFP
F6 / R1
POX2(540 bp)-hrGFP
F7 / R1
POX2(513 bp)-hrGFP
F8 / R1
POX2(430 bp)-hrGFP
F9 / R1
POX2(100 bp)-hrGFP
2
pSL16-UAS1B8XmaI / SphI F10 / R2
A1A2-POX2(100bp)POX2(100 bp)-hrGFP
F11 / R3
hrGFP or
F12 / R4
A1A2
F13 / R5
A2A3-POX2(100bp)F10 / R6
hrGFP or
F11 / R5
A2A3
A1A3-POX2(100bp)hrGFP or
A1A3
3
A1A3
MfeI
F11 / R4 A1A2A3-POX2(100bp)hrGFP or A1A2A3
4
A1A3
AvrII / SphI F10 / R11 A1R1-POX2(100bp)hrGFP or
A1R1
5
A1A3
AvrII / SphI F10 / R12
A1R1A2R2POX2(100bp)-hrGFP or
A1R1A2R2
6
pSL16-UAS1B8SphI / AscI
F10 / R3 A1R1A2-POX2(100bp)hrGFP or A1R1A2
POX2(100bp)-hrGFP
F12 / R5 A2R2A3-POX2(100bp)hrGFP or A2R2A3
7
A2A3
MfeI
F15/ R7 A2R1A3-POX2(100bp)hrGFP or A2R1A3
8
A1A3
MfeI
F16 / R7 A1R1A3-POX2(100bp)hrGFP or A1R1A3
9
A1A3
MfeI
F22 / R13 A1R1A1R1A3-Pox2(100
bp)-hrGFP or
A1R1A1R1A3
9
A1R1A3
MfeI
F17 / R7
A1(R1x2)A3POX2(100bp)-hrGFP or
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10

A1R1A3

AvrII / SphI

F21/ R5

11

A1(R1x2)A3

MfeI

F17 / R7

12

A1(R1x3)A3

MfeI / AscI

13

pSL16-UAS1B8TEF(136)-hrGFP
pSL16-UAS1B8-TEFintron
A1(R1x3)A3POX2(100bp)-hrGFP or
A1(R1x3)A3

PstI / NheI

F18 / R8
F19 / R9
gBlock®

BtgZI

F20 / R10

MfeI / NheI

F18 / R8
F19 / R9

14
15

A1(R1x2)A3
R1A3-POX2(100bp)hrGFP or
R1A3
A1(R1x3)A3POX2(100bp)-hrGFP or
A1(R1x3)A3
A1(R1x3)A3TEF(136bp)-hrGFP
pSL16-UAS1B8-TEFintron
pSL16-UAS1B8-TEFintron-hrGFP
A1(R1x3)A3-TEF-intronhrGFP

RNA Extraction and Quantitative PCR
RNA extractions were performed on cell cultures that were grown until midexponential phase. Prior to RNA extraction, all cell cultures were normalized to an
OD600 of 10 and 1 ml was used for the extraction using the Omega Biotek RNA
Extraction Kit with the optional DNaseI digestion step. qPCR was done using the CFX
Manager real-time machine from Bio-Rad. In accordance with MIQE guidelines,
standard curves for quantification of hrGFP and beta-actin were created and the
efficiency of each primer pair was calculated. Two housekeeping genes, beta-actin and
TEF1-α were used as reference genes to initially validate analysis method. An equal mass
of RNA from each of the samples was loaded. Protocols for qPCR conditions are
described in protocols provided by the qPCR kit supplier. A relative quantification
method was used to determine GFP expression. Standard curves were used to calculate
copy numbers for the above-mentioned genes taking into account priming efficiency. The
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ratio of GFP mRNA copy number to beta-actin mRNA copy number was used to quantify
changes in expression strength for the different POX2 promoter truncations. qPCR was
used to measure GFP expression instead of flow cytometry because of its higher
sensitivity.

GFP Fluorescence Analysis
During the development of the POX2 promoter, fluorescence spectroscopy with
the Biotek Synergy MX fluorescence spectrophotometer was the method of choice for
characterization of promoter strength. Cells grown in glucose were spun down at 6000 x
g (4 °C) for 2 minutes and re-suspended in 0.1 M Phosphate Buffered Saline (PBS) (pH
7) while cell cultures from oleic acid were spun down, washed once with 0.1 M PBS
containing 5% (v/v) Tween 80 and re-suspended in 0.1 M PBS. All cell cultures were
grown for 36 hours, between mid and late exponential phase, where OD600 values across
the samples were similar. The harvested cells were placed in 96 well plates and serial
dilutions of the cells were performed to obtain an average fluorescence (Ex. 485 nm and
Em. 510 nm). Serial dilutions were performed to obtain a fluorescence value in the linear
range of detection without changing the gain for each experiment. The same gain was
used for all measurements. The BD Accuri® C6 Flow Cytometer was used for promoter
characterization with different carbon sources. In all flow cytometry measurements,
20,000 single cell events were counted and fluorescence was measured using the GFP
channel. VirtualGain® was used to normalize the gain across all samples post-analysis.
Fluorescent cell populations were gated and the same gate was used across all samples
analyzed in each day. To obtain the specific mean fluorescence, the mean fluorescence of
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the non-fluorescent cells was subtracted from the mean fluorescence of the gated
fluorescent cells.

Results
Identification of Fatty Acid Responsive Upstream Sequences in the POX2 Promoter
The most common approach for identifying UASs and URSs by measuring
expression strength determined by a reporter gene from truncated promoters [81, 221,
244-246]. Such a description of the promoter architecture provides information about
important DNA sequences in the promoter but leaves unanswered questions about the
nature of these sequences and how they contribute to gene regulation patterns.
Nevertheless, in systems such as Y. lipolytica, our lack of understanding of gene
regulation prevents a more informed promoter engineering strategy a priori.
We previously made truncations to the POX2 promoter and identified a large
region upstream (1590 bp) of the POX2 gene that is required for measurable transcription
in glucose-free oleic acid media [80]. As a result, we chose to make truncations from the
5’ end of the POX2(1590 bp) promoter at 200 bp intervals (Figure 3.2A). Our rationale
for choosing these particular truncations was based on the identification of putative Por1p
binding sites (Figure 3.1A). Por1p (YALI0D12628p) is a Y. lipolytica homolog of the
fatty acid-responsive FarA transcriptional factor in Aspergillus nidulans [208, 247].
Homologs for S. cerevisiae fatty acid-responsive transcription factor Oaf1p do not exist
in Y. lipolytica or other oleaginous yeast. Therefore, the well-studied S. cerevisiae
regulatory system does not inform our work.
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Quantitative PCR was used to detect changes in transcriptional profiles resulting
from POX2 truncations (Figure 3.2B). In YSC-LEU media with oleic acid, there is a
general decrease in expression strength with truncations moving towards to the core
promoter. A four-fold decrease in mRNA copy number was observed between POX2
(1590 bp) and POX2 (1190 bp), suggesting the presence of an activating sequence we
call UAS1POX2 or A1. Another significant change in mRNA transcript was observed
between POX2 (990 bp) and POX2 (540 bp); therefore, we call this region UAS2POX2 or
A2. A smaller drop in expression was observed between POX2 (438 bp) and the core
promoter, POX2 (100 bp), defining a third activating sequence, UAS3POX2 or A3. This
truncation strategy also enabled us to identify regions in the native POX2 promoter where
a single 200 bp truncation lead to a three-fold increase of transcriptional activity, as seen
between the POX2 (1190 bp) and POX2 (990 bp) promoters. We call this upstream
regulatory sequence URS1POX2 or R1. A similar repressor sequence was observed for the
truncation between POX2 (540 bp) and POX2 (438 bp), albeit to a weaker extent than
R1, that we call URS2POX2 or R2. Using this truncation strategy, we were able to map
sequences in the native POX2 promoter that were potential fatty acid-responsive
activating sequences and other sequences that appeared to behave as repressor sequences,
although further investigation was required.
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Figure 3.1. Identification of activating and regulatory sequences in the POX2 promoter.
(A) Identification of hypothetical POR1p binding sites in the POX2 native promoter that
were used to guide rational 5’ truncations. (B) Schematic of systematic truncations were
made to the native POX2 promoter to identify DNA fragments containing hypothetical
fatty acid-responsive transcription factor binding sites. (C) Changes in truncated
promoter strength were monitored with real-time PCR measurements of GFP mRNA
relative to control beta-actin. Activating sequences (A1, A2, A3) were defined as those
resulting in loss of transcriptional activity when truncated. Regulatory sequences (R1,
R2) were defined as those resulting in either gain or constant transcriptional activity
when truncated. The data are the average of mRNA copy number relative to beta-actin
determined from biological triplicates. The error bars are the standard deviation of
biological triplicates.

Discovery of a Fatty Acid Inducible Upstream Regulatory Sequence from POX2
By performing promoter truncations, 3 UASs and 2 URSs were identified in the
native POX2 promoter. Our initial hypothesis was that by removing URSs, equivalent to

84

combining the 3 UASs, would increase the fatty acid inducible expression. Furthermore,
we reasoned the loss of UASs unimportant for fatty acid-regulated transcription would
not greatly impact transcription. To test these hypotheses, we constructed promoters with
various combinations of UAS in tandem (Figure 3.2A), expecting to obtain a promoter
more strongly induced by oleic acid. When all three UASs were combined (A1A2A3),
expression in YSC-LEU with oleic acid was diminished compared to the full native
POX2 promoter (Figure 3.2B), suggesting the URSs might have a more complex role
than could be predicted by the truncation experiments. This idea will be explored in
section in the results following this section. When A3 was removed, resulting in promoter
A1A2, transcription was further decreased, suggesting an important role for the A3
sequence. By restoring the A3 sequence and removing the A1 to create promoter A2A3,
expression strength recovered to a value closer to that of the native POX2 promoter,
further validating the importance of A3. When A2 was removed, resulting in promoter
A1A3, gene expression was now comparable to the native POX2 promoter, suggesting
that the A2 is dispensable and actually inhibitory in the context of these hybrid
promoters. The A1A2 hybrid promoter that lacks the A3 sequences confers the weakest
expression while A1A3, which is half the size of the native promoter, confers the
strongest expression. These results suggest that the A1 and A3 sequence combine to
provide an essential function for the A1A3 promoter. It should be noted that two tandem
copies of the either A1 or A3 were tested and expression was significantly weaker than
the native POX2 promoter (Supplementary Figure 3.1). Furthermore, these UAS
sequences elicited a positional dependence as switching the order of A1A3 to A3A1
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resulted in a significant drop in fluorescence (Supplementary Figure 3.1), suggesting
again that substantial complexity exists in these systems. All promoters showed almost
no expression when cells were cultured in YSC-LEU with glucose (Figure 3.2B).
From the initial 5’ truncation data, removal of either the R1 or R2 sequences
conferred an increase in transcriptional activation suggesting their role as repressor
sequences. However, because of the unexpected results from 5’ truncations, we created a
series of 3’ truncations (Figure 3.2C). Promoter A1R1A2R2 has oleic acid-induced
transcription similar to but lower than POX2 (Figure 3.2D), indicating the importance of
A3. Further truncation to create A1R1A2 resulted in increased transcription, producing
GFP similar to the POX2 promoter. This result is consistent with our previous findings
that R2 is a regulatory sequence that acts as a repressor. The relative unimportance of the
A2 sequence is further confirmed by oleic acid-induced expression from A1R1, which is
similar to A1R1A2.
By comparing the results in Figure 2B and D, it became clear R1 also exhibited
complex behaviors not predicted by the original truncation experiment. These data
suggest that R1 can act as an activator when placed after the A1 sequence, contrary to the
repression observed when the A1 sequence was removed from the native POX2 promoter
during our truncation experiments (Figure 3.1). The same amplifying effect of the R1
sequence was not observed when the R2 sequence was placed in its natural position
between the A2 and A3 sequences in promoter A2R2A3 (Supplementary Figure 3.1). The
R1 sequence, when placed between the A2 and A3 sequences (A2R1A3) also did not
confer strong activation of the promoter (Figure 3.2D), suggesting that there is a

86

synergistic effect between the A1 and R1 sequence. The R1A3 promoter shows lower
expression than A1R1, however, the difference is not statistically significant. The results
here demonstrated the importance of the R1 sequence as an enhancer element when
paired with the A1 and perhaps A3 sequence. This is also suggested by the A1R1 data in
Figure 3.2D. To support this hypothesis, we created promoter A1R1A3, which combines
the synergistic effects of A1R1 and the A3 sequence. This promoter was nearly three-fold
stronger than the native POX2 promoter and serves as the foundation for building even
stronger fatty acid inducible promoters.
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Figure 3.2. Discovery of the R1 UAS from the POX2 promoter. (A) New promoters were
designed by combining parts of the POX2 promoter upstream of the POX2 core
promoter. Activating (A1, A2, and A3) sequences were previously identified by 5’
truncations. (B) Promoter strength is determined by expression of hrGFP and measured
as mean fluorescence of an equal number of transformed cells grown in YSC-LEU with
either glucose or oleic acid. Glucose samples are shown on the left and oleic acid on the
right. A1 and A3 are important for oleic acid responsiveness, while A2 appears
dispensable. (C) New promoters were designed by combining 5’ and 3’ truncations of the
POX2 promoter upstream of the POX2 core promoter. Activating (A1, A2, and A3)
sequences previously identified by 5’ truncations. Regulatory (R1 and R2) sequences
were previously defined by 5’ truncations. (D) Promoter strength quantified by
expression of hrGFP shows the R1 sequence results in strong expression in oleic acid
media compared to glucose media. Glucose samples are shown on the left and oleic acid
on the right. The R1 sequence appears to work synergistically with the A1 sequence. The
data are the average of mean fluorescence measurements from biological triplicates. The
error bars are the standard deviations of biological triplicates.

Engineering a Strong Fatty Acid Inducible Hybrid Promoter
Including the R1 in between the A1 and A3 sequences to form hybrid promoter
A1R1A3 resulted in strong oleic acid activation compared to the native POX2 promoter
and was a logical starting point to design a stronger fatty inducible promoter. Based on
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previous hybrid promoter work [81, 82, 248], we hypothesized that we could increase the
oleic acid inducible transcriptional activation using tandem repeats of the R1 sequence.
Therefore, hybrid promoters containing 0-3 copies of the R1 sequences were created
(Figure 3.3A) and compared to the native POX2 promoter. The addition of each copy of
the R1 sequence increased gene expression induced by oleic acid while the expression in
glucose remained significantly and equally repressed, demonstrating the oleic acid
inducible nature of the R1 sequence (Figure 3.3B). Addition of the first R1 sequence
created a 2-fold increase in expression while subsequence additions of R1 sequences lead
to about a 4-fold improvement in expression strength compared to the native POX2
promoter. Furthermore, we were able to improve the fold induction in oleic acid to 48fold in the A1(R1x3)A3 hybrid promoter compared to the 19-fold induction in the native
POX2 promoter (Figure 3.3C). Another promoter, (A1R1)x2A3 was created and had
similar expression levels in oleic acid media as well as similar fold induction (Figure
3.3B, C). Given its larger size compared to A1(R1x3)A3, we chose to move forward with
the smaller promoter. This new inducible hybrid promoter demonstrates the ability to
engineer a tightly regulated oleic acid inducible switch and to tune the transcriptional
output of the activated promoter.
The A1(R1x3)A3 promoter is already comparable in strength to strong hybrid
promoters containing UAS1B8 and the POX2 core promoter (Supplementary Figure 3.2).
We have previously shown that the strength of a hybrid promoter can be tuned by
manipulating the modular elements of the promoter [80]. We demonstrate additional
improvements to the A1(R1x3)A3 promoter by replacing the weaker POX2 core
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promoter with the stronger TEF(136) and TEF-intron core promoter (Supplementary
Figure 3.2A), resulting in an additional two-fold and a three-fold increase in expression,
respectively (Supplementary Figure 3.2B). Engineering the modular core promoter
element allows us to tune the induction strength over a 10-fold range of expression;
however, the increased expression in glucose led to a reduction in the fold induction
(Supplementary Figure 3.2C). The core promoter is likely to exhibit some level of
regulation mediated by regulatory TFs that bridge URS and the core promoter [249].

Figure 3.3. Engineering a strong fatty acid inducible hybrid promoter. (A) Schematic of
hybrid promoters constructed with tandem repeats of the POX2 R1 sequence and A1R1
sequence. (B) Promoter strength is determined by expression of hrGFP and measured as
mean fluorescence of an equal number of transformed cells. Glucose samples are shown
on the left and oleic acid on the right. (C) Promoter induction using oleic acid as the
carbon source relative to glucose as carbon source. In (B) and (C) the data are the average
of mean fluorescence measurements from biological triplicates. The error bars are the
standard deviation of biological triplicates.
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The A1(R1x3)A3 Hybrid Promoter is a Fatty Acid Sensor
To better understand how different substrates affect transcription from the
A1(R1x3)A3 hybrid promoter, we used flow cytometry to measure hrGFP expression
controlled by A1(R1x3)A3 and compared it to the native POX2 promoter. Figure 4A
shows that while both promoters were activated by various fatty acids (oleic and linoleic
acid) and lipids (triolein and chicken fat), the inducible hybrid promoter A1(R1x3)A3 is
consistently stronger than the native POX2 promoter. Linoleic acid elicited the highest
transcriptional response for both promoters (Figure 3.4A). In all fatty acid and lipid
substrates, the A1(R1x3)A3 promoter is two-to-four-fold stronger than the POX2
promoter (Figure 3.4B). Tween 80 was used as an emulsifier for fatty acid media and on
its own does not elicit strong transcriptional activation.
When glucose, glycerol, or n-decane are used as the sole carbon source, the
hybrid promoter remains strongly repressed, with only basal transcriptional activity
similar to the native POX2 promoter. In media containing both glucose and oleic acid, the
native POX2 promoter remained repressed, while the A1(R1x3)A3 hybrid promoter was
strongly activated, suggesting the hybrid promoter is not catabolite repressed.
Interestingly, in media containing both glycerol and oleic acid, both the native POX2
promoter and the A1(R1x3)A3 hybrid promoter were more strongly activated than oleic
acid alone. The mechanism underlying this synergy remains unclear, however, a similar
behavior was reported for the Lip2 promoter [117].
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Figure 3.4. Substrate responsive induction of the A1(R1x3)A3 hybrid promoter. (A)
Promoter strength was measured by hrGFP expression using flow cytometry. The
A1(R1x3)A3 hybrid promoter is most strongly induced by linoleic acid and is strongly
repressed by glucose and glycerol. Interestingly a combination of glycerol and oleic acid
synergistically activated the hybrid promoter. (B) Fatty acids and mixtures of fatty acids
with other carbon sources more strongly activate the hybrid promoter A1(R1x3)A3
compared to the native POX2 promoter. In (A) and (B), the data are the average of mean
fluorescence measurements from biological triplicates. The error bars are the standard
deviation of biological triplicates.

Fatty Acid Induction of the A1(R1x3)A3 Hybrid Promoter
In order to use the A1(R1x3)A3 promoter as an fatty acid inducible promoter, we
grew cells to stationary phase in YSC-LEU glucose media and then induced the
A1(R1x3)A3 promoter by titrating oleic acid into the media, at concentrations ranging
from 0.25% (v/v) to 8%(v/v). The induction was measured using fluorescence
spectroscopy. At all concentrations tested within this range, we observe nearly identical
induction profiles of the hybrid promoter. This suggests the A1(R1x3)A3 promoter can
be induced at oleic acid concentrations as low as 0.25% (v/v) during the stationary phase
(Supplementary Figure 3.3).
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Given the high sensitivity of the hybrid promoter, we determined if other fatty
acids would similarly induce the hybrid promoter at this low concentration. We used
0.25% (v/v) of oleic (OA), linoleic (LA), arachidonic (ARA), and eicosapentaenoic
(EPA) acids in YSC-LEU to induce the hybrid promoter in the stationary phase. The
hybrid promoter is strongly and similarly induced by the different fatty acids (Figure
3.5A-D) while glucose did not induce GFP expression (Figure 3.5E). The fatty acid
induction profiles for the A1(R1x3)A3 promoter, when induced at stationary phase with
EPA, appears stronger than other fatty acids, however, the error associated with these
stationary phase measurements makes the difference of low statistical confidence.

Figure 3.5. Inducibility of the A1(R1x3)A3 hybrid promoter by different fatty acids.
Cells were grown to stationary phase with glucose and induced by the addition of 0.25%
(v/v) of fatty acid. Induction was monitored over 20 hours using a fluorescence plate
reader. Fatty acids used in this experiment include: (A) oleic acid (OA, 18:1), (B) linoleic
acid (LA, 18:2), (C) arachidonic acid (ARA, 20:4 ω-6), (D) eicosapentaenoic acid (EPA,
20:5 ω-3) and (E) Glucose as a control shows no induction. The data are the average of
mean fluorescence measurements from biological triplicates. The error bars are the
standard deviation of biological triplicates.

Discussion and Conclusion
Our work has resulted in the development of a fatty acid inducible hybrid
promoter for Y. lipolytica. UAS and URS sequences were initially identified using a
rational truncation strategy; however, our subsequent experiments resulted in different

93

conclusions about the roles of the A1 and R1 sequences when tested in isolation of the
native POX2 promoter. Therefore, the truncation approach is useful in identifying
functionally important sequences of promoters, but in this case, fails to correctly identify
how these sequences will work in different contexts. This analysis showed that the R1
sequence contains a fatty acid response element and that it acts synergistically with the
A1 sequence. Hybrid promoters with tandem repeats of the R1 sequence lead to increased
transcriptional strength in oleic acid media (four-fold stronger than native POX2) while
maintaining tight repression in glucose media (48-fold induced by oleic acid). These
hybrid promoters are strongly activated by a variety of long chain fatty acid and lipids.
Interestingly, the engineered hybrid promoter is not catabolite repressed in contrast to the
native POX2 promoter and carbon metabolism promoters [227, 250-252].
The only comparable work in Y. lipolytica focuses on alkane responsive elements
(AREs). Prior studies have identified a URS in the ALK1 gene (responsible for alkane
oxidation in alkane metabolism) that contains an ARE that binds the Yas1p/Yas2p TFs
[120]. A hybrid promoter containing three copies of the ARE1 sequence were placed
upstream of the LEU2 core promoter, resulting in 6-fold activation on n-decane
compared to glucose. By comparison, the A1(R1x3)A3 promoter is 48-fold activated by
fatty acids compared to glucose. While differences in assay methods prevent a direct
comparison of the strength of these two promoters, we have shown alkane promoters are
significantly weaker than the beta-oxidation promoters (Supplementary Figure 3.4). This
finding opens opportunities to engineer additional responsive hybrid promoter tools for Y.
lipolytica.
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Enabled by a deeper understanding of its genetics, there has been more work
engineering strong inducible promoters in S. cerevisiae. For example, the most well
studied inducible yeast promoter is the Gal1-Gal10 system. It exhibits remarkably low
basal transcription in glucose-containing media and activated up to four orders of
magnitude by galactose. These levels of regulation are determined by the combination of
six repressing operator sites that overlap four Gal4p binding sites [253]. Analogously,
further improvements to our fatty acid-responsive hybrid promoter may be possible once
the TFs that bind to the R1 sequence of POX2 are identified.
We demonstrated that combining the hybrid promoter containing R1 repeats with
other core promoters, including the TEF(136) and TEF-intron core promoters increased
both the basal level expression and the induced expression. This result was expected in
light of work combining different S. cerevisiae UAS sequences. For example, combining
a constitutive UAS from CYC1 with the Gal1 or Gal10 promoter elements resulted in
galactose regulated expression [228]. Stronger hybrid promoters were engineered by
placing the UASgal upstream of weak core promoters (pLEU and pCYC) leading to
glucose repression and galactose activation; however, when UASgal was placed upstream
of strong core promoters (pTEF and pTDH3), a higher level of basal expression in
glucose was observed [58]. This study also directly used individual Gal4p binding sites to
further tune and enhance promoter regulation. More recently, ultra-strong and tryptophan
regulated promoters were created by placing 5 UASaro sequences upstream of the TDH
core promoter [229]. These promoters were 1.7-fold stronger than the TDH promoter and
had 14-fold induction by tryptophan. Future efforts to increase promoter strength and
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maintain strong inducibility would benefit from an additional focus on upstream
sequences, transcription factor binding sites, and less emphasis on strong core promoters.
UASs and URSs from native promoters have traditionally been identified through
truncation studies [81, 200, 244]. While this method proves to be a solid foundation for
identifying the parts needed for hybrid promoters, it fails to always capture the
complexity of eukaryotic transcription regulation, which is controlled by the association
of multiple transcriptional factors to their cognate binding sites [254, 255]. Because of
the heuristic way in which UASs and URSs are identified, they are inherently subject to
context-dependent behaviors. Our work demonstrates the difficulty encountered as a
result of this disconnect. The UAS/URS sequences contain multiple and often
overlapping transcription factor binding sites enabling higher strength transcription or
regulation of transcription [228]. Unlike S. cerevisiae, there are few studies on Y.
lipolytica TFs or transcription factor binding site motifs, and at least with respect to fatty
acid metabolism, TFs in S. cerevisiae do not always have homologs in Y. lipolytica. To
date, there has been only one transcription factor associated with fatty acid regulation.
Deletion of the POR1 gene causes some growth defect on oleic acid and a reduction in
POX2 mRNA expression [208]. As POR1p is a homolog of FarA from A. nidulans,
POR1p may bind a similar DNA sequence. Putative POR1p binding sites were found in
the R1 region, suggesting a significant role of POR1 in regulating the A1(R1x3)A3
promoter. A better understanding of TFs and their binding sites may lead to a more direct
identification UAS/URS sequences and more rapid design of regulated hybrid promoters.
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The A1(R1x3)A3 promoter is induced by a several different long chain fatty
acids, including OA, LA, ARA, and EPA. Interestingly, stationary phase induction
(Figure 3.5) of this promoter was nearly identical for OA, LA, and ARA, whereas when
cells were grown on the fatty acids (Figure 3.4), LA more strongly induced the promoter.
EPA caused the greatest induction of the hybrid promoter, which was unexpected since
EPA is not synthesized by Y. lipolytica. When measuring induction during growth, the
hybrid promoter was not repressed by glucose or glycerol when co-fed oleic acid,
consistent with recent observations for the native Lip2 promoter; however, the PO1f
strain used in our study does not co-utilize glucose and oleic, so the results shown by
Sassi et al. [117] showing Lip2 promoter induction was strongest with a 40/60 mixture of
glucose and oleic acid (w/w), are not likely to work in all strains. These works do suggest
a potential strategy for fatty acid inducible gene expression when using glucose or
glycerol as a substrate.
The fatty acid-regulated hybrid promoter created in this study represents a
significant advance in the toolkit for engineering. We demonstrated the identification of a
URS, R1, and its construction into a fatty acid-regulated promoter significantly stronger
than the native POX2 promoter. We also showed that the hybrid promoter design can
lead to the tuning of both the transcriptional output as well as the inducibility of the
promoter. This promoter system is one of the strongest identified and is the strongest
inducible promoter for Y. lipolytica. This regulated promoter has great promise for use as
a sensor for strain engineering applications, for dynamic regulation of heterologous gene
expression, or as an inducible promoter for toxic genes. We anticipate further
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development of regulated and strong promoters to expand the genetic engineering tools
available for Y. lipolytica.
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CHAPTER FOUR
USING DNA ACCESSIBILITY AS A ROBUST APPROACH TO ENGINEER NOVEL
HYBRID INDUCIBLE PROMOTERS

Abstract
Inducible promoters are powerful genetic tools in metabolic engineering as they
allow for an added layer of control of metabolic processes. In the yeast, Yarrowia
lipolytica, these types of promoter systems are poorly characterized. Here, we
investigated a novel mechanism to engineer hybrid inducible systems by measuring
changes in DNA accessibility that can result from the interaction of regulatory
transcription factors with DNA and chromatin structure. The Acyl CoA oxidase 2
promoter (POX2) in Y. lipolytica is one of the best understood inducible systems,
activated by fatty acids and repressed by either glucose or glycerol. The DNA binding
sites of the POR1p transcription factor were mapped to the native POX2 promoter. These
binding sites were found at the edges of regions where changes in DNA accessibility was
visible under induced and non-induced conditions. The functionally important binding
sites on the POX2 promoter were elucidated via site-directed mutagenesis studies. The
role of POR1p and CFU1p, both implicated in the regulation of beta-oxidation genes,
were knocked out. The findings presented here provide new insight into the development
of hybrid, tunable inducible promoters in a more robust and efficient manner.
¥

This work will be included in a future publication with co-authors Scott Anglin, Sara Edgecomb, and
Mark Blenner.
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Introduction
Advancements in synthetic biology have revolutionized the field of microbial cell
factories for sustainable chemical production. The ability to efficiently screen, sequence
and annotate genomes of new microbes has enabled the shift from traditional hosts such
as Escherichia coli and Saccharomyces cerevisiae to non-conventional microbes bearing
unique native traits. The growth of Trichosporon oleaginosus on aromatics to accumulate
lipids [70] or the ability of Y. lipolytica to tolerate many environmental factors, above all
pH [256] or grow on hydrocarbons such as alkanes to produce lipids [257] are a few
examples of superior features of non-conventional yeasts.
With recent success in developing genome editing tools, [83, 140, 230],
engineering metabolic pathways and developing stable strains in Y. lipolytica has become
easier. Making these pathways efficient requires tunable expression of enzymes to guide
flux of metabolites. To date, only a handful of hybrid promoters exist to enable this
process [80-82, 116, 127, 217]. The most commonly used hybrid promoters are
constitutive providing one dimension of control that is expression strength. If we are to
improve pathway efficiencies, more means to control enzyme expression by selectively
inducing enzymes at different times during growth is important. This can be
accomplished with inducible promoters.
Inducible promoter systems have gained interest as a “next-level” genetic tool that
can be used to modulate expression strength and control the timing of expression. By
doing so, these systems can significantly improve the efficiency of microbial engineering
processes [258, 259]. In Y. lipolytica, tunable and inducible promoters are poorly
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understood because there is insufficient knowledge on promoters that demonstrate
inducibility. Furthermore, transcription factors and mechanisms for regulation of such
promoters are not known. Understanding how inducible promoters work could motivate
rational engineering of novel metabolite and non-metabolite hybrid inducible promoter
systems.
To date, strategies to engineer hybrid promoters have relied on heuristic methods
such as truncating the promoter from either the 5’ or 3’ end and coupling it to a reporter
gene coding for beta-galactosidase or green fluorescent protein to quantitatively measure
the expression strength [81, 116, 122, 221]. Any loss or gain in reporter activity from
truncations was used to identify the promoter regions as either an enhancer or repressor
sequence. Heuristic approaches can fail for two reasons. First, there is the likelihood of
truncating within the regulatory region of the promoter that can affect the affinity of a
transcription factor to the binding domain. This approach also does not account for
complex regulatory mechanisms typical of eukaryotic promoters resulting from the
interaction of two or more transcription factor binding sites [260, 261]. Second, heuristic
approaches do not account for DNA accessibility that results from dynamic changes in
histone modifications to regulate gene expression, which is covered below.
In this chapter, we describe a new method for the development of next-generation
inducible, yet tunable promoter systems by investigating changes in DNA accessibility of
the promoter on the genome under conditions that induce or repress gene expression.
Nucleosomes are a basic unit of DNA packaging in eukaryotes, made up of 147 bp of
DNA wrapped by an octamer of core histones, H2A-H2B dimers flanking two core H3-
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H4 histone tetramers [262, 263]. The final arrangement of eukaryotic DNA is a
supercoiled structure called chromatin that is comprised of multiple nucleosomes
separated by short linker fragments [264]. The role of nucleosomes in the genome has
been well studied over the years. Structurally, nucleosomes bring about the first level of
genomic compaction, which is 180 bps and then facilitates self-assembly into higherorder compaction of DNA inside the nucleosome [265, 266]. This structural arrangement
protects DNA from damage and the positioning of nucleosomes plays a crucial role in
transcriptional regulation and DNA replication [267-269].
DNA and histone methylation is known to influence nucleosome position and
structure, thereby regulating transcription. CpG DNA methylation represses promoters by
either recruiting transcriptional repressors to bind to the methyl CpG moiety [270] or
inhibiting binding of transcriptional activators from binding to the promoter region [271].
Histone methylation of arginine (R) and lysine (K) residues play a key role in
transcriptional regulation by altering chromatin organization. The methylated amino acids
K4, K9, and R19 on histones H3 or H4 can either cause transcriptional activation of
repression at the promoter of genes [272, 273]. In S. cerevisiae, H3K4, H3K36, and
H3K79 methylation correlates with transcriptional activation [274]. Histone acetylation is
also associated with transcriptional regulation. Remodeling of the PHO5 and PHO8
promoters in S. cerevisiae were initiated by acetylation of the H2B histone, which
recruits ATP-dependent remodelers to evict the nucleosomes creating a nucleosome-free
region (NFR) for transcriptional activation by PHO4 [275, 276]. Similarly, other histone
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modifications can cause nucleosome “sliding” or “loosening” to enable transcriptional
activation (Figure 4.1) [277].

Figure 4.1. Three mechanisms by which nucleosome remodeling can occur to
accommodate transcription factor binding. Mechanisms A and B rely on trans factors
(TF) like ATP-consuming chromatin remodelers that cause either (A) complete
nucleosome disassociation or (B) sliding events. In mechanism C, nucleosome structure
is altered via histone-modifying enzymes. Acetylation of amino acid residues via histone
acetyltransferases (HATs) increases the electronegative charge of the histone residue
causing repulsion between DNA and histones, leading to a “loosening” effect of the
nucleosome thereby making it more accessible to transcription factors. The process is
reversible by histone deacetylases (HDACs) [277].

Nucleosome sliding is a well documented mechanism in S. cerevisiae [278-280].
There are essentially two models that have been proposed to explain how this occurs, the
twist diffusion and the loop/ bulge propagation model [281]. In brief, the twist diffusion
model explains a stepwise movement of a single base pair from the linker that shifts into
the nucleosomal DNA space causing the nucleosomes to twist or untwist to accommodate
the change [282]. Meanwhile, with the loop/ bulge propagation model, larger segments
from the linker are transferred to the nucleosome DNA space creating a loop that causes
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the histone core to quickly diffuse to the opposite end to remain wrapped [283]. The
detached nucleosome DNA can now be exposed to transcriptional regulators. This
mechanism relies on the intrinsic dynamic nature of nucleosomes. Once the proteins bind
to the DNA, it can control the level of nucleosome occupancy at their sides [284].
The affinity of transcription factors to DNA binding sites is another influence on
transcription regulation. The PHO84 promoter of S. cerevisiae contains five copies of the
PHO4p binding site dispersed across its promoter and not all motifs bear similar
affinities. Mutational analysis of the 6 bp binding motifs revealed that only three motifs
are important for transcriptional activation, but only two are necessary for full regulation
of the PHO84 gene [285]. The regions flanking PHO4p binding motifs affected its
binding affinity. Therefore, even though some binding sites may be positioned in NFRs,
if these sites have a low binding affinity, no transcriptional activation will be observed
until the high-affinity sites are relieved from nucleosome compaction under phosphate
starvation conditions. Figure 4.2 depicts a model for how chromatin may influence gene
expression by differentially regulating the accessibility of the PHO4 binding sites on the
promoter. Similar remodeling mechanisms have been shown in other S. cerevisiae
promoters such as GAL1, SUC2, and CUP1 [286, 287].
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Figure 4.2. Model depicting transcription factor affinity and nucleosome positioning on
differentially regulating PHO binding motifs [277]. Red arrows represent transcription
and thickness of arrows represent the strength of transcription. X represents no
transcription. As nucleosome occupancy reduces in and around transcription factor
binding sites, high-affinity binding sites (red) become more accessible to PHO4 binding
resulting in some transcription activation. The same is not true for low-affinity sites
(blue) that require high levels of nucleosome depression to have a cooperative effect with
high-affinity binding sites and elicit strong transcriptional activation.

As described above, each transcription factor can have an inherent affinity to the
DNA and yet its binding probability be affected by competition with nucleosomes.
Therefore, to understand how nucleosomes are affected by transcription factors, it would
be ideal to study a system where all transcription factors regulating a promoter are
known. Understanding the effect of specific transcription factors on nucleosome
positioning can be leveraged to building hybrid promoters regulated via transcription
factor-mediated nucleosome remodeling. This is one interesting application for next-level
hybrid promoters to modulate gene expression, however in Y. lipolytica, this is not
possible because there is no well-established promoter with known regulatory elements
or an understanding of the mechanisms that dictate nucleosome positioning.
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Another application for studying nucleosome positioning is to identify Upstream
Activating Sequences (UASs) rapidly, promoting the development of hybrid promoters
with tunable strength and inducibility. We hypothesize that UASs can be identified by
observing nucleosome repositioning during transition from repression to induction. The
POX2 promoter in Y. lipolytica is a good platform to establish design principles since our
previous work have already elucidated critical activator regions in the native promoter
[116] that can be mapped to the nucleosome profile. The mapping suggested that the
putative transcription factor binding sites from POR1p [208] align to regions adjacent to
significant changes in nucleosome occupancy observed between oleic acid and glucose
samples. This suggests some remodeling may be occurring in POX2 regulation. Of the
four 6 bp binding sites in the POX2 promoter, three mapped near highly nucleosome
occupied regions while the fourth site did not. Mutation to the putative POR1p binding
motifs revealed that two of the three sites that mapped to occupied regions were crucial
for full transcriptional activation. Knockout of POR1p and CFU1p, two transcriptional
factors implicated in the regulation of beta-oxidation caused a significant loss in GFP
expression from the native POX2 promoter. The POX2 promoter in the knockout strain,
PO1fΔpor1Δcfu1, generally had higher DNA occupancy throughout the promoter.
Although the profiles of DNA accessibility between the wild-type and knockout strain
had similarity trends, the knockout strain had widened nucleosome coverage. The
broadening of nucleosome coverage in oleic acid was more evident, particularly at the
upstream-most site. This suggests that different mechanisms of regulation may govern
transcription factor-promoter interactions. A comparison of the profiles between the wild-
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type and knockout strain in different carbon conditions revealed new regulatory regions
that can be used to re-engineer the POX2 promoter, showing promising application as a
strategy to develop other regulatable promoters in Y. lipolytica.

Experimental Methods
Chemicals and Reagents
All restriction enzymes used in cloning were purchased from New England
Biolabs (NEB, Ispwich, MA) unless otherwise stated. Oligos designed for all experiments
were synthesized by Eurofins Genomics or IDTDNA. Plasmid minipreps were performed
using the Zyppy™ Plasmid miniprep kit (Zymo Research, Irvine, CA). PCR purifications
and restriction digest purifications were performed using the DNA Clean and
Concentrator kit (Zymo Research). Micrococcal nuclease solution (Thermo Scientific,
Waltham, MA) was used to prepare mononucleosomal DNA from gDNA. Digestion of
all proteins from cell extract was performed using Proteinase K (Thermo Scientific). A
bicinchoninic assay (BCA) (Thermo Scientific) was used to quantify protein in the cell
lysate. RNA digestions were performed using RNase A (Thermo Scientific). gDNA
extraction was performed using the E. Z. N. A. Yeast DNA Kit (Omega Biotek, Norcross,
GA).

Plasmids and DNA Cloning
Construction of the base plasmid consisting of the POX2 native promoter (1540
bp) fused to a GFP reporter gene that has been described elsewhere [80]. Mutations were
made to the putative POR1p binding sites identified on native promoter as shown in
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Figure 4.3. There are four putative binding sites labeled 1, 2, 3, and 4 that were found in
the A1, R1, A2, and A3 regions identified in Chapter 3, respectively [116]. All cloning
was performed using sequence and ligation independent cloning (SLIC) method unless
otherwise stated. The base vector used was pSL16-POX2(1590bp)-hrGFP, harboring the
native POX2 promoter, in this study referred to as pSL16-POX2-hrGFP. Table 4.1
summarizes the cloning strategy used to make all vectors containing individual and
combinatorial mutations to the POR1p binding sites. Briefly, the base vector and all
preceding constructs containing the desired mutations were first digested with AatII to
linearize DNA prior to PCR. The primers used for amplification of the vector can be
found in Supplementary Table 4.1. First, four individual mutations were made to the
POR1p binding sites in the A1, R1, A2 and A3 sequences of the native promoter.
Combinatorial mutations were then created using these vectors as the base vectors until
all four binding sites were mutated in the native POX2 promoter.
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Table 4.1: Cloning strategy to create vectors containing mutations to the respective
POR1p binding sites in the A1, R1, A2 and A3 sequence.
Base Vector

Mutation
A1
R1

pSL16-POX2-hrGFP
A2
A3
R1
pSL16-POX2
[A1 mutation]-hrGFP

A2
A3

pSL16-POX2
[A1R1 mutation]-hrGFP
pSL16-POX2
[A1A2 mutation]-hrGFP
pSL16-POX2
[A1R1A2 mutation]-hrGFP
pSL16-POX2
[R1 mutation]-hrGFP

A2

A3

Primers
F1/R1
F2/R2
F1/R1
F3/R3
F1/R1
F4/R4
F1/R1
F5/R5
F1/R1
F3/R3
F1/R1
F4/R4
F1/R1
F5/R5
F1/R1
F4/R4

F1/R1
F5/R5

Final Vector
pSL16-POX2
[A1 mutation]-hrGFP
pSL16-POX2
[R1 mutation]-hrGFP
pSL16-POX2
[A2 mutation]-hrGFP
pSL16-POX2
[A3 mutation]-hrGFP
pSL16-POX2
[A1R1 mutation]-hrGFP
pSL16-POX2
[A1A2 mutation]-hrGFP
pSL16-POX2
[A1A3 mutation]-hrGFP
pSL16-POX2
[A1R1A2 mutation]-hrGFP
pSL16-POX2
[A1A2A3 mutation]-hrGFP
pSL16-POX2
[A1R1A2A3 mutation]-hrGFP
pSL16-POX2
[R1A3 mutation]-hrGFP

Transformation, Cell Culture, and Media Formulations
Plasmid propagation and cloning were performed using E. coli DH10β competent
cells (NEB). The heat shock transformation method was used. All transformations of Y.
lipolytica (MATa leu2−270 ura3−302 xpr2−322 axp1) were performed using the lithium
acetate method as previously described [106] with a minor modification to the final step.
In brief, the cells were heat-shocked for 10 minutes at 39ºC and then mixed with 1.2 mL
0.1M LiAc (pH 6.0) solution. The mixture was centrifuged at 3,000xg for 2 mins and the
pellet was re-suspended in 0.1 mL of 0.1 M LiAc (pH 6.0) and 0.03 mL of the mixture
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was transferred into the desired auxotrophic media to propagate cell growth. The
auxotrophic media prepared was Yeast Complete Synthetic (YSC) media – LEU using
6.7 g/L Yeast Nitrogen Base (YNB) w/o amino acids (BD Diagnostic, Hunt Valley, MD)
and 0.69 g/L Complete Supplement Mixture deficient in leucine (CMS-LEU) (MP
Biomedicals, Solon, OH). Yeast Peptone Dextrose (YPD) or Oleic Acid (YPO) media
was prepared using 5 g/L Yeast Extract (BD Diagnostics), Peptone (BD Diagnostics) and
either 2% (w/v) Glucose (Sigma Aldrich, St. Louis, MO) or 2% (v/v) Oleic Acid (EMD
Millipore, Burlington, MA) emulsified with 5% Tween80 (Sigma Aldrich), respectively.
To test the effects of mutations and transcriptional factor knockouts, all cultures were
performed in 2 mL cultures in 14 mL culture tubes. For mononucleosome extraction, 100
mL cultures were grown in a 250 mL baffled flask.

CRISPR-Cas9 to Create Knock-out Strains
The PO1f strain was used for all experiments and further engineering. CRISPR-Cas9
genome editing [83] was used to create all knockout strains used in this study. The
CRISPR vector was modified to contain a NsiI restriction site used to insert the gRNAs
of interest. gRNA oligos containing SLIC overhangs (Supplementary Table 4.2) were
annealed together prior to cloning into the NsiI CRISPR vector that was digested with
NsiI-HF. The strains PO1fΔpor1, PO1fΔcfu1 and PO1f Δpor1Δcfu1 contained frameshift
mutations (Supplementary Figure 4.2). The sites for gRNA targeting sequences were
designed using Benchling software (http://www.benchling.com) to insert the frameshift
in 5’ region the coding sequence of the respective proteins. Verification primers shown in
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Supplementary Table 4.2 were used to perform colony PCR and screen colonies
containing the desired mutation and Sanger sequencing was used to verify the mutations.

Mononucleosome DNA Preparation
Adaptations were made to a mononucleosome DNA preparation protocol
previously described for S. cerevisiae resulting in >90% mononucleosome DNA [288]. In
brief, the respective strains were grown in either YPD or YPO until early exponential
phase (OD600 of ~20-25) and measured using the cuvette function on the NanoDrop
(Thermo Scientific). Cells were chilled on ice prior to centrifugation at 3,000xg and
washed twice with 1x Phosphate Buffered Saline (PBS). The cells were then resuspended
in nuclease digestion buffer (10 mM Tris-HCl (pH 8) and 1 mM CaCl2). For cell lysis
with the bead beater (BioSpec Products, Bartlesville, OK), our modification was seven
rounds of beating, each cycle for a minute with a 2-minute pause in between at 4ºC.
Protein quantification was performed using a Bradford assay. It is essential to run an
optimization step by varying MNase concentration to obtain a final mononucleosome
DNA product (>90%) which can be detected and analyzed as ~146 bp on a 2% DNA gel
run at ~80V (constant voltage, 1xTAE buffer). It should be noted that a histone
immunoprecipitation step was not performed therefore we cannot definitively call this a
nucleosome preparation method, rather technique that provides a DNA accessibility
profile.
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PCR-tiling and PCR to determine CT of each Amplification
PCR tiling primers for the POX2 promoter were designed using the PCT Tiler
v1.42 online tool [289]. The minimum and maximum temperature for primer annealing
were set at 60ºC and 63ºC, respectively. The specifications for minimum and maximum
amplicon length were 100 and 130 bps. A key parameter was designing overlapping
primer pairs where each consecutive primer starts 30 base pairs after the beginning of the
previous primer to obtain a good overlap between each of the primers tiling the promoter.
This resulted in 44 primers pairs constructed for the tiling experiment (Supplementary
Table 4.3). PerfeCTa SYBR Green FastMix (Quantabio) was used for qPCR reactions in
the CFX Connect real-time (Bio-Rad). The reaction volume for each set-up was 20 μL
and total primer concentration in each well was 0.4 μM. The efficiency of each primer
was calculated using a four-point standard curve with gDNA as the template strand. The
efficiency curves were then used to convert CT of each reaction to copy number. For each
tiling experiment, the copy numbers were normalized to a range between 0 and 1 by
dividing the copy number by the maximum copy number within the experimental set to
provide a nucleosome occupancy profile between 0 and 1.

Fluorescence Spectroscopy
To test the effect of mutations on the POX2 promoter, each of the vectors
harboring mutations as described in Table 4.1 were transformed into the PO1f wildtype
strain and grown in YSC-LEU media containing 2% (w/v) glucose for 48 hours until cells
reached stationary phase. Cells from a glucose culture were spun down and resuspended
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in YSC-LEU media with 2% (v/v) oleic acid at a starting OD600 of 0.2 and allowed to
grow for around 36 hours determined to be the optimal time for POX2 expression
(Supplementary Figure 4.1). Cells from the oleic acid culture were spun down and
washed once in 1xPBS containing 5% (v/v) Tween 80 to remove residual oleic acid and
finally resuspended in 1x PBS solution (pH 7.0). After OD600 normalization across all
cultures, 0.2 mL of the cultures were loaded into 96 well black plates and serial dilutions
of this culture were made to calculate the fluorescence as described in the methods
section elsewhere [116]. The excitation/emission wavelengths used were 485 / 510 nm
with a bandwidth of 9 in the Biotek Synergy MX fluorescence spectrophotometer. Since
the strength of the native POX2 promoter is inherently weak, the gain was set to 157 to
obtain reliable measurements of fluorescence. To determine the effects of the
transcription factor knockouts, the respective strains were transformed with the
A1R1x3A3-GFP vector and grown in minimal media containing glucose until early
stationary phase was reached. Cells were then spun down and resuspended in minimal
media containing 2% (v/v) oleic acid and transferred into to a 48-well plate. Fluorescence
from the GFP reporter was measured each hour with continuous shaking for 18 hours
while the cells remained at stationary phase. For these experiments, the gain was set to
140 since the hybrid promoter is significantly stronger than the native POX2 promoter.

Screening for Growth in Oleic Acid
PO1f wild-type and strains, PO1fΔpor1 and PO1fΔcfu1, in biological replicates,
were grown in minimal synthetic media supplemented with 100 mg/L L-leucine (BD
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Diagnostics) (YSC) and 2% (w/v) glucose until stationary phase. Four quadrants were
drawn on YSC plates containing 2% (v/v) emulsified oleic acid and a second set of plates
with 2% (w/v) glucose. Cells from stationary phase cultures were spread on each of the
plates using an inoculating loop and grown at 28ºC for 96 hours (4 days) to observe
growth.

Results
Nucleosome Profiling of POX2 Promoter
Activation of PHO promoters occur due to extensive remodeling and loss of
nucleosome at the upstream activation sites harboring transcription factor binding sites
causing activation of the promoters under cellular phosphate starvation. We wanted to
investigate whether a similar remodeling process can be observed in promoters of Y.
lipolytica. The POX2 promoter in Y. lipolytica is a fatty acid inducible promoter that is
activated by oleic acid and repressed in either glucose or glycerol [110, 116]. The 6 bp
putative binding site for POR1p (CCTCGG) were mapped to the POX2 promoter (Figure
4.3). These motifs, labeled as 1, 2, 3, and 4, are located in the A1, R1, A2, and A3 UAS
regions previously identified via a heuristic approach described in Chapter 3 [116].
All four binding motifs are in regions of the promoter where there is low
nucleosome density. Binding site 1 is near a region that transitions to a higher
nucleosome occupancy in oleic acid. Meanwhile, in oleic acid, the nucleosome profile
near binding site 2 shifts to the right, away from the binding motif. Binding site 3 is
located in a ~90 bp nucleosome-free trough. To the far right of the binding site, however,
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there is a significant increase and shift in nucleosome position in oleic acid. The
nucleosome profile near motif 4 has a higher density of nucleosomes in oleic acid
compared to glucose. At this point, it is difficult to conclude mechanisms that cause these
transitions but note that binding sites 1, 2, and 4 are nearest to the edge of transitions in
nucleosome occupancy between glucose and oleic acid. From PHO5 regulation, UASs do
not have to be wrapped within nucleosomes to be inaccessible but sitting near regions of
high nucleosome density can also prevent accessibility of transcriptional factors [226].
Nucleosome remodeling around the region relieves compaction and makes the binding
site more accessible. We could hypothesize a similar mechanism to explain the shifts in
nucleosome profiles from glucose to oleic acid.

Figure 4.3. Nucleosome occupancy for native POX2 promoter in the PO1f WT strain
grown in YP Glucose (blue) and YP Oleic acid (pink) mapped to POR1p binding sites on
the native POX2 promoter. Putative binding sites for POR1p, 1, 2, 3, and 4 are found in
A1, R1, A2, and A3 regions of the POX2 promoter previously mapped out [116]. Purple
regions indicate overlap of nucleosome profile for both culture conditions.
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Determination of High-Affinity Binding Motifs on the POX2 Promoter
Another important factor to consider alongside nucleosome positioning is binding
site affinity. In the S. cerevisiae PHO5 promoter, all upstream binding sites for
transcription factor promoter activation are not bound by nucleosomes, nor do all binding
sites share the same affinity for transcription factor binding [285, 290]. Low and highaffinity sites binding sites are located in the nucleosome-free linker regions and set the
threshold for promoter activation. This provides an initial binding site for activation
during induction although the threshold is higher for low-affinity binding sites [291].
Having mapped the putative POR1p motifs to DNA accessibility profiles in
glucose and oleic acid, we wanted to determine the high and low-affinity sites in the
POX2 promoter. The palindromic CCTCGG POR1p recognition sequences were mutated
from GC rich to AT-rich (TAAATA) (Figure 4.4A). Vectors containing a GFP reporter
gene driven by a POX2 promoter harboring individual and combinatorial mutations were
episomally expressed in Y. lipolytic and fluorescence was measured after 36 hours of
growth in oleic acid. From individual mutations, sites 2 and 4 were most critical for
expression from the POX2 promoter. Mutating site 1 or 3 had minimal effect on GFP
expression (Figure 4.4B). Interestingly, mutating both the 1 and 2 motifs had a stronger
effect on expression strength compared to mutation of 2 alone suggesting there is a
dependence of binding site 1 on 2. The same effect was not observed when mutations to
site 1 and 3 were made, resulting in approximately the same strength as the promoter
harboring a mutation at site 1. The most striking observation, however, was the near
complete loss in fluorescence with a mutation to sites 2 and 4, demonstrating the

116

importance of these two putative binding motifs (Figure 4.4B). Both 2 and 4 sit in
regions of high DNA accessibility in either glucose or oleic acid, therefore we can
hypothesize that these motifs may have high affinity to POR1p binding.

Figure 4.4. (A) Native POX2 promoter with mapped 1, 2, 3, and 4 binding motifs.
Mutation to the POR1p consensus binding motif was changed from CG rich to AT-rich.
(B) GFP fluorescence of POX2 promoters with individual and combinatorial mutation of
the POR1p binding sites. The error is represented as a standard deviation of replicate size
n=3.

Screening for Transcription Factors
Nucleosome positioning on promoters to regulate transcription is influenced by
competition with transcription factors [292]. Therefore studying how nucleosome form
with and without and transcription factors can elucidate mechanisms for nucleosome
positioning to activate transcription in a UAS region of a promoter. To first study this
mechanism requires us to know the transcription factors and binding motifs on a UAS
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element. We use the POX2 promoter that is the most characterized promoter system in Y.
lipolytica where it is understood that POR1p is involved in transcriptional activatation
and putative binding sites are known. The goal is to eventually translate our knowledge
of nucleosome positioning in UAS regions of the POX2 promoter to identify newer UAS
elements in other promoter systems that would enable of hybrid promoter engineering
efforts.
Our previous results suggest that putative binding POR1p motifs, 1, 2, and 4 are
important for transcriptional activation. Theses motifs are found on UAS elements, A1,
R1, and A3 used to construct a fatty acid inducible hybrid promoter four times stronger
than the native POX2 promoter [116]. Therefore, we use the strong hybrid promoter to
determine the significance of POR1p and identify other transcription factors necessary in
association with POR1p to activate transcription in oleic acid.
Our first strategy was to knockout POR1p in Y. lipolytica and investigate its effect
on growth and transcriptional activation from the hyrid promoter harboring important
UAS elements. The strain harboring a non-functional POR1p, PO1fΔpor1, led to partial
growth in oleic acid (Figure 4.5A). This result complements previous work showing
similar effects of ΔPOR1p on beta-oxidation [208]. Knocking out POR1p resulted in only
partial loss in expression from the hybrid promoter compared to the PO1f wild-type
(Figure 4.5C). A similar effect has been observed with the native POX2 promoter [208].
This suggests that POR1p may not be the only transcription factor activating transcription
from UASs in the POX2 promoter.
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Figure 4.5. Identification of critical transcription factors. (A) PO1fΔpor1 steaked out on
synthetic media plates containing glucose and oleic acid shows severe growth defects in
oleic acid. (B) No growth defects are observed in either carbon sources for PO1fΔcfu1.
(C, D, E) GFP fluorescence experiments for strains PO1fΔpor1, PO1fΔcfu1 and
PO1fΔcfu1Δpor1 grown in glucose until stationary phase and then induced with 2% (v/v)
oleic acid to measure A1R1x3A3-GFP promoter strength over time. The error is
represented as a standard deviation with replicate size n=3.

Therefore, we investigated other potential coregulators of UAS activity in oleic
acid. The transcription factor, ADR1p, is known to be a positive regulator for
transcription of genes encoding peroxisomal proteins [293]. The homolog of ADR1p was
identified as CFU1p (Control of Fatty Acid Utilization) in Y. lipolytica (unpublished
report). Our BLAST analysis showed no sequence homology of YlCFU1p to ScADR1p
(Supplementary Figure 4.3A). The closest homology was to transcription factor, TDA9p,
from the pentose utilizing yeast, Sugiyamaella lignohabitans, a relative to Y. lipolytica
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[294]. However, a BLAST of YlCFU1p against the S. cerevisiae database revealed that
the ScADR1p, chain A, containing the GATA zinc-finger binding domain shared 65%
sequence homology to a similar domain in YlCFU1p (Supplementary Figure 4.3B). To
date, the effect of YlCFU1p on either beta-oxidation or POX2 regulation is unknown. We
were interested to determine whether CFU1p had any effect on the UAS elements from
the POX2 promoter. Knocking out CFU1p did not result in any growth defect on either
media (Figure 4.5B) and no effect on the hybrid promoter (Figure 4.5D). This suggests
that CFU1p alone does not have an direct effect on beta-oxidation or promoter regulation.
Eukaryotic regulation is complex and usually involves the association of more
than one transcription factor. Therefore, we tested the effect on expression of the hybrid
fatty acid inducible promoter in the PO1fΔpor1Δcfu1 strain. A noticeably weaker
fluorescence signal compared PO1fΔpor1 was observed in oleic acid (Figure 4.5C). This
may suggest that that CFU1p is a coregulator requiring POR1p as the main
transcriptional activator in the UAS elements. Since we were unable to get complete loss
of fluorescence from the hybrid promoter suggests that may be other transcription factors
involved in oleic acid activation from the UAS elements that still needs to be identified.
Chapter 6 details experiments to deterimine these transcription factors.

DNA Accessibility in Strains Devoid of Transcription Factors
Although, we were not able to identify all transcription factors involved in oleic
acid activation, we identified two important transcription factors, POR1p and CFU1p, in
combination seem to impact activity of the UASs from the POX2 promoter in oleic acid.
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Therefore, we wanted to investigate if deleting these transcription factors would relieve
the competition with nucleosomes and result in more identical DNA accessibility profiles
in glucose and oleic acid. We anticipate the difference in DNA accessibility between the
wild-type and the PO1fΔpor1Δcfu1 strain in oleic acid would enable us to identify UAS
regions in the POX2 promoter. Using a PCR tiling array, DNA accessibility of the native
POX2 promoter was mapped in PO1fΔpor1Δcfu1 strain (Figure 4.6).
With the exception of nucleosome density, as represented by the area under the
graph, and the region between -578 bp to -278 bp, there is better overall convergence of
the nucleosome profiles in the between the two carbon conditions in the knockout strain
(Figure 4.6) compared to the profiles in the wildtype strain (Figure 4.3). The DNA
accessibility near binding motif 1 is similar between oleic acid and glucose. Meanwhile,
the nucleosome profile shift noted in the wild-type strain next to binding site 2 is less
prominent due to better convergence of the oleic acid and glucose nucleosome data. At
motif 4, nucleosome spread is greater and density is higher under both conditions relative
to the wild-type. Given that motif 4 is close to the core promoter, it would be interesting
to investigate how the increase in nucleosome density near the core promoter would
affect transcriptional regulation since the core promoter contains the crucial TATA
docking site for basal transcription machinery.
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Figure 4.6. Nucleosome occupancy for native POX2 promoter in the PO1fΔpor1Δcfu1
strain grown in YP Glucose (blue) and YP Oleic acid (pink) mapped to POR1p binding
sites on the native POX2 promoter. Purple regions indicate overlap of nucleosome profile
for both culture conditions.
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Figure 4.7. Re-engineering POX2 promoter from differences in DNA accessibility in
glucose and oleic acid. POX2 promoter from (A) wildtype strain and (B)
PO1fΔcfu1Δpor1 strain showing higher nucleosome occupancy in oleic acid (OA) on top
axis and higher nucleosome occupancy in glucose on lower axis. Putative POR1p binding
sites are mapped out to DNA accessibility profile located in previously identified UASs,
A1, R1, A2, and A3 elements on the POX2 promoter. Grey and red regions represent
UAS elements selected from differences in DNA accessibility between both carbon
sources. Yellow represents POX2 core promoter.
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Discussion and Conclusion
The goal of this work is to determine if it is possible to predict locations of UAS
elements in native inducible promoters by investigating changes in DNA accessibility on
promoters under different conditions. If feasible, this method will enable quicker
development of hybrid promoters with tunable and predictable expression. A strategy like
this is especially beneficial for non-conventional microbes such as Y. lipolytica where
there is a need to develop more genetic tools in spite of a limited understanding of
transcriptional regulation of native promoters. RNA seq can be used to determine
inducible and constitutive native promoters but does not inform us how promoters are
regulated. Identifying short segments of UASs in long eukaryotic promoters aids in the
engineering of better expression platforms.
Developing tunable promoters using DNA accessibility is a novel approach that
has not been attempted to date. Constructing promoters in this context requires a
mechanistic understanding of how nucleosomes re-position or displace to accommodate
transcription factors under inducible conditions. Nucleosome positioning on promoters is
largely influenced by DNA diversity that can favor or disfavor nucleosome formation
[295, 296]. For example, in core promoter regions next to the TATA box, the AT-rich
nucleotide region promotes weak base-pair interaction and facilitates DNA unwinding for
basal transcriptional activation. The AT-rich abundance leads to a low propensity for
nucleosome formation leading to NFRs in core promoters [297]. This is also observed in
the tiling experiments for the native POX2 promoter where the core promoter region (-61
to +1), being ~58% AT-rich, has a sharp drop in nucleosome occupancy (Figures 4.3 and
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4.6). However, upstream of the promoter where transcription activators or repressors bind
to amplify or repress genes, the understanding of molecular interplay between histones,
nucleosome remodeling complexes, specific and non-specific TFs is less clear.
The POX2 promoter is one the more well-studied native fatty acid inducible
promoters in Y. lipolytica [110, 116, 208] and is a good candidate promoter to test the
hypothesis. POR1p has previously been shown to be important for POX2 expression in
oleic acid is a close homolog of the fatty acid regulator FarA in Aspergillus nidulans
[208]. Putative binding sites of the YlPOR1p were mapped on the native POX2 promoter
in the wild-type strained tiled to determine nucleosome occupancy in glucose and oleic
acid. The four binding sites, 1,2, 3, and 4 were in low nucleosome occupancy regions for
both glucose and oleic acid but 1, 2, and 4 were at the edge of where transitions of
nucleosome occupancy in oleic acid were observed, either an increase or a shift in profile.
While it has been established that not all transcription factor binding sites bear
similar importance to transcriptional regulation in the PHO promoters of S. cerevisiae, we
wanted to determine which of the putative motifs contributed most to transcriptional
activation of the POX2 promoter. Binding site 1 was interesting because mutating the site
did not contribute to transcriptional loss although in tandem with a mutation binding site
2 or 4 resulted in greater than a four-fold drop in strength. Mutation to 2 and 4 caused
almost near loss of expression. These results inform us that these sites are important but
the reasons are less clear. It would be important to determine if the mutation removes the
POR1p binding site on the DNA or whether there are there are changes in DNA
accessibility that makes the binding sites within the region less accessible. Nucleosome
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profiling of the POX2 promoter harboring these mutations can answer this question. The
region near or at binding site 1 has demonstrated cooperativity to binding motifs 2 and 4.
This result aligns well with our previous finding that demonstrated the importance of
UASs A1, R1 and A3, harboring sites 1, 2, and 4, respectively, to confer strong
transcriptional activation [116]. Binding site 4, ~60 bp away core promoter, also had a
deleterious impact on POX2 expression. Combined with the mutation to binding site 2,
caused near loss of expression. In the future, it would be important to investigate how
surrounding sequences could impact the affinity of the transcription factor to the binding
site in a nucleosome independent context [285].
Knockout studies of the POR1p and CFU1p transcription factors had different
effects on growth and expression of the hybrid promoter. PO1fΔpor1 caused severe
growth defects on oleic and lowered transcription output from the hybrid promoter while
PO1fΔcfu1 had no effect. The double mutant, PO1fΔpor1Δcfu1 showed more significant
down-regulation of the hybrid promoter but did not eliminate expression completely.
More transcription factors would need to be screened to determine the mechanism for
regulation.
We observed a better convergence of the nucleosome profiles of the
PO1fΔpor1Δcfu1 strains in glucose and oleic acid except for the 300 bp region between 578 and -378 bps. For future work, nucleosome profiling in the PO1fΔpor1 strain in
glucose and oleic acid is required to determine the effects ΔCFU1p has on the profile. At
this point, the role of YlCFU1p is less understood and although, it contains a conserved
DNA binding domain (Supplementary Figure 4.3B), whether it directly binds to the
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POX2 promoter is unknown. Preliminary results presented here show that the CFU1p
alone may not have a direct association with POX2 expression or growth (Figure 4.5 B,
D) however, further work is required to elucidate its role. Similarly, YlPOR1p has not
been shown to directly bind to the POX2 promoter in oleic acid. This is a key experiment
needed to validate both transcription factors as nuclear receptors for oleic acid induction.
Figure 4.7A and B presents a new analysis of DNA accessibility in the wildtype
and PO1fΔpor1Δcfu1 strains, respectively. The calculated difference in occupancy
between both substrates enables better visualization of which regions are more occupied
in glucose versus oleic acid and vice versa. The objective of this analysis is to select
regions in the POX2 promoter that could be potential UAS elements. In the grey UAS1
region containing putative POR1p binding site 1, there is generally a lower nucleosome
occupancy in both two carbon conditions. However, once the POR1p and CFU1p are
knocked out in the mutant strain, PO1fΔpor1Δcfu1, we observed a bleed over of
nucleosomes into the region. This selection of this region as a potential UAS is made on
the hypothesis that knocking out competition from these oleic acid inducible transcription
factors would now favor nucleosome formation in oleic acid. The transitions seen here
may hint at one mechanism for how enhancer sites are regulated.
UAS2 and UAS3 elements shaded in red contains putative POR1p binding sites 2
and 3. The selection of these regions is based on the hypothesis that oleic acid-induced
transcription would result in lower nucleosome occupancy in oleic acid than in glucose.
Applying a similar principle helps us identify another potential UAS region (New UAS)
that could be tested. Furthermore, we selected UAS4 based on Figure 4.4B data that
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shows it is the most critical binding motif for transcriptional regulation and it sits in
proximity to the core promoter. These UASs can be used to engineer a new fatty acid
hybrid promoter that would be different to the heuristic approach applied in Chapter 3.
Ultimately, we would like to apply this approach to dissecting new UASs from other
promoters to engineer more hybrid promoters in Y. lipolytica.
Here, we make predictions for new UASs based off DNA accessibility profiles
that account for nucleosomes and transcription factor binding to the DNA. From these
DNA accessibility profiles, it would not be possible to definitively conclude changes as a
result of nucleosome eviction or sliding as transcription factors are also crosslinked to
DNA. This can prevent MNase cleaving DNA at the transcription factor bound sites,
thereby we may see more nucleosome protected regions. However, if transcription factor
binds to DNA wrapped in a nucleosome, which has been reported as another mechanism,
then predictions made from this dataset would be valid. At this moment, we do not know
which mechanisms are more predominant, therefore, the work presented here needs to be
complemented with profiling of pure mononucleosome DNA that can be achieved with
chromatin immunoprecipitation using histone-specific antibodies [298]. This could also
provide insight into histone modifications that contribute to transcriptional regulation.
The work highlighted in this chapter is aimed towards developing methodologies
towards designing new regulatable promoters using predictions from DNA accessibility.
The nucleosome mapping approach is applied on the POX2 promoter that has previously
been studied to identify regulatory regions (A1, R1, A2, A3) and transcription factors
(POR1p, CFU1p) associated with FA-induced expression. The nucleosome profile of the
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wild-type strain under the different conditions enables mapping of key binding sites with
respect to changes in nucleosome profile. Most of the binding sites are located near or
within regions of high nucleosome occupancy in oleic acid growth conditions. The
importance of these binding motifs is tested using via mutational studies. Next,
transcription factors, YlPOR1p and YlCFU1p are knocked out, leading to repressed
expression from the POX2 promoter. The POX2 promoter was tiled in the knockout
strain which showed a significant broadening of nucleosome profiles in oleic acid relative
to the wild-type strain while maintaining a similar profile in glucose. The difference in
nucleosome between oleic acid and glucose between the wild-type and knockout strain
aids new strategies to re-engineer a hybrid promoter from POX2 elements.
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CHAPTER FIVE
A FATTY ACID RESPONSIVE PROMOTER USED TO GUIDE ENGINEERING OF
FATTY ALCOHOL PRODUCTION IN THE OLEAGINOUS YEAST,
YARROWIA LIPOLYTICA

Abstract
Fatty alcohols are an important class of oleochemicals with a wide range of
industrial applications from biofuels to surfactants and detergents. A microbial platform
capable of producing biorenewable fatty alcohols may be competitive with current
production capacities. From an engineering perspective, Yarrowia lipolytica is a
promising microbe for fatty alcohol production because of its natural ability to synthesize
and metabolize lipids that are precursors to fatty alcohols. The strategy described here
utilizes a fatty acid-responsive promoter developed in Chapter 3 to detect intracellular
pools of free fatty acids. A strain capable of producing upwards of 1 g/L intracellular free
fatty acids was first engineered. By expressing a heterologous fatty acyl-CoA/aldehyde
reductase from Marinobacter aquaeolei, MAACR, localized to the peroxisome, we
produced over 530 mg/L fatty alcohols in the engineered strain, a yield close to 7.5 mg/g
glucose. While there is more work that needs to be done to make production more
efficient, this is first time peroxisomal targeted fatty alcohol production has been
demonstrated in Y. lipolytica, a promising approach to produce short to medium chain
fatty alcohols in the future.
¥

This work will be included in a future publication with co-authors Michael Spagnuolo, Matthew
Brabender, Cory Schwartz, Ian Wheeldon, and Mark Blenner.
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Introduction
Fatty alcohols are an important class of biological molecules that can range from as short
as 4-6 carbons to as many as 22-26 carbons. Depending on the chain length, fatty
alcohols can have a wide range of applications in industry ranging from personal care &
cosmetics, soaps & detergents, textiles, oil, and gas. The global fatty alcohols market is
estimated at USD 4.7 billion in 2017 and projected to reach USD 6 billion by 2022 [299].
Traditional means to produce these aliphatic compounds via catalysis route can be
costly and require energy-intensive reactions. Furthermore, synthesis of unique metal
catalysts is required to produce fatty alcohols with different chain length specificities
[300, 301]. In comparison, biological means of fatty alcohol production bypass these
issues because in nature, several naturally occurring biocatalysts have chain length
specificity but also enable the production of these biomolecules in a more energy friendly
sustainable manner by utilizing cheap, cost-effective feedstock [65, 302].
In recent years, microbes have been explored as an alternative route for fatty
alcohol production [303-305]. S. cerevisiae and E. coli are target hosts because of the
wide array of genetic tools, ease of genome editing, and an extensive body of literature
that already exists well establishing the metabolic pathways. Yeast systems are more
industrially relevant because of the ability to grow them to high density at large-scale
fermentation, resistance to phage infections, and higher tolerance to toxic inhibitors and
products [306].
There are essentially two main pathways to produce fatty alcohols in yeast (Figure
5.1). One strategy is the conversion of fatty acyl-CoA to fatty alcohol via a single four-
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electron reduction step using a bifunctional acyl-CoA / aldehyde reductase. The
commonly used enzymes are TaFAR1 (Tyo alba), MmFAR1 (Mus musculus) and
MAACR (Marinobacter aquaeoli) [65, 91, 92, 307]. The other strategy is to convert fatty
acids to aldehydes via a carboxylic acid reductase (CAR) and then convert the aldehydes
to fatty alcohols via an alcohol dehydrogenase or aldehyde reductase.
The earliest work in S. cerevisiae relied on pushing flux to fatty acyl-CoA from
acetyl-CoA and using a fatty acyl-CoA reductase, MmFAR1, to convert fatty acyl-CoA to
fatty alcohol [90]. This led to almost 100 mg/L fatty alcohols and the production yield
was 5 mg/g (glucose and galactose). Another strategy was to block triacylglycerol
synthesis by deleting DGA1, accumulating fatty acyl-CoAs in the cytosol [308]. The fatty
acyl-CoA was converted to fatty alcohols using a fatty acyl-CoA reductase from TaFAR1
[308]. The authors used the word “yield” to describe titers, reporting 100 mg/L fatty
alcohols produced in the engineered strain. If total substrate consumption is considered,
the yield would be 1.6 g/g galactose.
It was not until recently that d’Espaux et. al. showed significant improvements in
fatty alcohol production. First, the push to fatty acyl-CoA from acetyl-CoA was
engineered by overexpressing an acetyl CoA carboxylase (ScACC1), the first committed
step in fatty acid synthesis. Proteomics revealed that this enzyme was naturally present in
low abundance. Many competing pathways for the fatty acyl-CoA were blocked, the
more significant knockout being ScDGA1. A strong pull on fatty acyl-CoA pools for fatty
alcohol production was accomplished by overexpressing MmFAR1 [65]. They
determined that MmFAR1 was a more efficient four-electron reducing reductase than
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TaFAR1. Titers of 1.2 g/L and yield of 70 mg/g glucose were reported (Table 5.1). This
is the best fatty alcohol yield reported to date in S. cerevisiae using glucose as substrate.
This experiment, however, was performed in rich YPD media, which is not suitable for
industrial production because of its high costs, complex make up, and variable
composition.
The other strategy in S. cerevisiae was the conversion of free fatty acids to fatty
alcohols. A pull towards free fatty acid production was engineering by over-expressing a
heterologous ATP-dependent citrate lyase, MmACL1 (Mus musculus), to convert citrate
to acetyl CoA, and then overexpressing the endogenous ScACC1p. Intracellular fatty acid
pools were increased by blocking fatty acid activation and degradation [309]. Conversion
of fatty acids to fatty alcohols was accomplished by overexpressing a heterologous
Mycobacterium marinum CAR, MmCAR, an endogenous aldehyde dehydrogenase,
ScADH5. A build-up of C18 fatty aldehydes suggested that overexpression of ScADH5
was not sufficient, therefore, MAACR was overexpressed to contribute to more efficient
fatty aldehyde reduction. This strategy produced only 120 mg/L fatty alcohols in shake
flasks and a low yield of 6.3 mg/g glucose [309].
More recently, inducible promoters have been demonstrated to fine-tune
metabolic pathways to dynamically control fatty alcohol production. A glucoserepressible promoter from the HXT1 gene was used to control the expression of FAA1,
encoding for an enzyme that converts fatty acids to fatty acyl CoA. Fatty alcohol
accumulation improved by ~41% while FFAs decreased by ~63% relative to the
control strain [310]. In a separate study, a bifunctional reductase from Arabidopsis
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thaliana, AtFAR, and upstream enzymes were placed under the control of a galactoseinducible promoter. This enabled separation of growth from production and prevented
the build-up of toxic compounds from the mevalonate pathway. The engineered strain
produced close to 85 mg/L of C22 alcohols, about four times higher than fatty alcohol
titers in the strain containing constitutive expression promoters [311].
In addition to producing fatty alcohols in high enough titers, it is important to
design a microbial production platform that is efficient and provides the means to
manipulate chain length specificity. The global demand for short to medium chain fatty
alcohols (C6-C14) accounts for more than half of the fatty alcohol market volume and is
projected to increase in the next few years [312]. This is due to the broad range of
industrial applications for medium-chain fatty alcohols while short-chain fatty alcohols
are specialty chemicals because they are not abundant in nature. As a result, these fatty
alcohols have a larger global demand resulting in higher market costs. Our analysis
shows that given the current market value for fatty alcohols and glucose, lower yields of
short and medium chain fatty alcohols would need to be produced to “break even” on the
cost of glucose (Table 5.1). This does not account for production and separation costs
suggesting that we would have to produce higher than the break-even yield (Table 5.1) to
eventually make the process economically feasible.
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Table 5.1. Average market value of fatty alcohol based on chain length and yield required
to meet the cost of glucose [313]. Shaded in grey is the market price for un-refined
glucose [314].
Fatty Alcohol Price
Break-Even Yields
Fatty Alcohol Range
(cents / g alcohol)
(mg alcohol / g glucose)
Short (C6-C8)
32
180
Medium (C8-C14)
25
250
Long (>C14)
16
400

One method to create short-chain fatty alcohols is compartmentalizing the
production pathway to the peroxisome. This strategy can be used to produce shorter chain
fatty acids that can then be reduced to alcohols [65, 315]. In S. cerevisiae short to
medium chain fatty alcohols (C6-C12) have been produced in the peroxisome with a high
degree of efficiency (43 mg/g glucose) compared to other studies [315]. The other
strategy to create shorter chain fatty alcohols is premature termination of fatty acid
elongation by using chain length specific acyl-thioesterases that convert fatty acyl-ACP
(Acyl Carrier Protein) to fatty acids, which can then be converted to fatty alcohols via a
reductase. The latter strategy has been explored in Y. lipolytica to produce C10 fatty
alcohols [93]. Y. lipolytica is a promising host for production of fatty alcohols because of
its ability to produce lipids [157, 162, 257, 316, 317] and fatty acids [149], which can
serve as precursors for fatty alcohols.
By expressing bacterial and plant acyl-ACP thioesterase, fatty acid elongation
was terminated to produce a large abundance of C10 fatty acids [318]. Overexpression of
native fatty acyl CoA synthase, YlFAA1, converted C10 fatty acids to fatty acyl-CoAs
followed by AtFAR overexpression to produce upwards of 500 mg/L of C10 fatty
alcohols in the cytosol with a yield of ~10 mg/g glucose [93]. The strain lacked
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peroxisomes which resulted in four times weaker growth than the wildtype, W29 strain.
We have observed that knocking out the peroxisomes in the PO1f auxotrophic strain
causes weaker growth and slower growth rates, which for industrial purposes makes the
strain more difficult to use. Table 5.2 summarizes other accomplishments to date of fatty
alcohol production in Y. lipolytica and a comparison the best engineering feats in S.
cerevisiae. The theoretical yield is calculated based on the total glucose supplied to the
media while yield coefficient is calculated based on how much glucose was consumed.
To date, the highest fatty alcohol production achieved from Y. lipolytica via scale
up into a 3-L bioreactor is 2.5 g/L [91] while in 40 mL shake flask fermentations, the titer
was 205 mg/L [91]. Various pathways were accessed for fatty alcohol production but the
most promising strategy was pushing flux from fatty acids to fatty acyl-CoA using a
heterologous fatty acyl-CoA synthetase from E. coli, EcFadD, and pulling on fatty acylCoA pools to fatty alcohols using MAACR reductase [91].
In this work, we compartmentalized fatty alcohols production inside the
peroxisome that houses all enzyme necessary for beta-oxidation (Figure 5.2). This
strategy, which has not been reported in Y. lipolytica before provides access to the
machinery to tune fatty acid chain length by manipulating the POX1-6 genes. The native
fatty acid synthesis pathway creates predominantly C16 and C18 fatty acids while our
goal is to produce short and medium chain fatty alcohols (C6-C14). In addition to
achieving chain length specification, localizing the pathway into the peroxisome allows
spatial compartmentalization of the enzymes that facilitate the transfer of metabolites
from one enzyme to the next. This generates a more efficient assembly line for the
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process and has been shown in eukaryotes to increase overall metabolic output [319] and
prevent undesired side reactions that hinder production efficiency.
We first localized MAACR into the peroxisome by fusing it to a peroxisomal
targeting sequence (PTS). The first strategy relied on increasing the cytosolic fatty acylCoA pool by knocking out expression of YlDGA1. We hypothesized that this would
create a cellular increase fatty acyl-CoA concentrations that would also translate into the
peroxisome. The second strategy that showed more success, was increasing the
intracellular free fatty acid pools. We accomplished this by blocking fatty acid activation
(ΔYlFAA1) and beta-oxidation inside the peroxisome (ΔYlMFE1). The peroxisomal fatty
acyl-CoA synthetase, YlAAL1, was kept in-tact. The fatty acid hybrid promoter reported
the strongest GFP expression from this strain and thin layer chromatography (TLC)
showed that >50% of the intracellular lipid content were free fatty acids. This strategy
resulted in titers of 530 mg/L although the yield was a little over 7 mg/g glucose
suggesting that more work needs to be done to improve the efficiency of the pathway.
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Table 5.2. Comparison of fatty alcohol production in S. cerevisiae and Y. lipolytica.
Highlighted in blue are peroxisomal targeted strategies for S. cerevisiae and Y. lipolytica.
Yield coefficient is yield based on glucose consumed while yield was calculated with
how much glucose was initially added to the media. N.R. means not reported data.
Titer
Titer
Yield
Shake
Yield
Host
Bioreactor
Coefficient
Ref.
Flask
(mg/g glucose)
(mg/L)
(mg/g glucose)
(mg/L)
S. cerevisiae
1200
6000
58
70
[65]
S. cerevisiae
330
1100
16.5
30
[320]
S. cerevisiae
837
1300
40
43
[315]
Y. lipolytica
690
N.R.
4.3
18
[92]
Y. lipolytica
550
N.R.
11
N.R.
[93]
Y. lipolytica
167
N.R.
5.5
N.R.
[321]
Y. lipolytica
205
2500
3.4
N.R.
[91]
This
study
Y. lipolytica
530
N.R.
7
12

Experimental Methods
Chemicals and Reagents
All restriction enzymes used in cloning were purchased from New England
Biolabs (NEB, Ipswich, MA) unless otherwise stated. Oligos designed for all experiments
were synthesized by Eurofins Genomics. Plasmid minipreps were performed using the
Zyppy™ Plasmid miniprep kit (Zymo Research, Irvine, CA). PCR purifications and
restriction digest purifications were performed using the DNA Clean and Concentrator kit
(Zymo Research). Fatty alcohol and fatty acid standards were purchased from Nu-Check
Prep. All chemicals were purchased from Sigma Aldrich unless otherwise stated.

Transformation, Cell Culture and Media Formulations
Plasmid propagation and cloning were performed using E. coli DH10β competent
cells (NEB). The heat shock transformation method was used. All Y. lipolytica

138

transformations were performed using the lithium acetate method as previously described
[106] with a minor modification to the final step. In brief, post heat-shock for 10 minutes
at 39ºC, transformed cells were mixed with 1.2 mL of 0.1M LiAc (pH 6.0) solution prior
to spinning down at 3,000xg for 2 mins and re-suspending the pellet in 0.1 mL of 0.1 M
LiAc (pH 6.0). 0.03 mL of the mixture was transferred into 2 mL of the desired synthetic
media containing 6.7 g/L yeast nitrogen base (YNB) without amino acids (BD
Diagnostics, Hunt Valley, MD) and complete synthetic media either without leucine
(0.69 g/L CSM-LEU) or without leucine and uracil (0.67 g/L CSM-LEU-URA) (Sunrise
Science Products, San Diego, CA). The cells were precultured in media containing 20 g/L
glucose and grown in culture tubes to propagate cell growth for 40-48 hours. The cells
were then transferred into their respective auxotrophic cultures at an initial OD600 of 0.2.
For fatty alcohol production, experiments were performed in synthetic culture
media containing 1.7 g/L YNB without amino acids and ammonium sulfate (Difco) and
CSM-LEU or CSM-LEU-URA. Final ammonium sulfate concentrations in the culture
were 2.5 g/L and 5 g/L to accomplish C:N molar ratios 60:1 and 30:1, respectively. Each
of the cultures contained 80 g/L glucose. Total culture volume was 20 mL grown in 50
mL baffled flasks. The cultures were overlaid with a 10% (v/v) dodecane layer to capture
fatty alcohol excreted and prevent volatilization [322]. Cells were grown at 215 rpm for 5
days prior to harvesting cells for fatty alcohol quantification.
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Plasmids and DNA Cloning
The TEF(404)-Intron and AAL1 were cloned into pSL16-cen1-1(227) ARS/CEN
with a URA3 selection marker using primer pairs F1/R1 and F2/R2. To create the
MAACR-PTS vector, the plasmid pSL16-UAS1B8-GFP-ScCYC1t referenced in Chapter
2 was digested with BssHI/NheI to clone a PCR amplified MAACR-PTS using SLIC
primers F3/R3. Primers can be found in Supplementary Table 5.1. For intracellular fatty
acid detection, a plasmid containing A1R1x3A3-GFP (created in our lab) harboring a
leucine auxotrophic was transformed in each of the strains.

CRISPR-Cas9 to Create Knockout Strains
The base strain used for all subsequent knockouts was PO1f (MATa leu2−270
ura3−302 xpr2−322 axp1). CRISPR-Cas9 [83] was used to create the knockouts strains
described in this chapter. The gRNA sequences used to create each knockout can be
found in Supplementary Table 5.1. CRISPR-Cas9 / gRNA cassettes were made using a
base vector that was redesigned to contain a NsiI cut sight where all subsequent gRNA
were cloned by using SLIC. The design of the modified CRISPR vector containing the
NsiI cloning site was described in Chapter 4. Table 5.3 highlights the strains engineered
for fatty alcohol production and intracellular fatty acid reporter experiments. The
POf1Δfao1 strain was created as the base strain for all fatty alcohol experiments. gRNA
oligos were first annealed together prior to using SLIC to clone the gRNA sequence into
CRISPR vector digested with NsiI. The same strategy was used to create all strains
except for the PO1fΔpex10 and PO1fΔmfe1Δfaa1Δpex10 where two gRNA sequences
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were used to remove the PEX10 gene instead creating a frameshift mutation. First, two
separate plasmids were cloned containing gRNA sequences that cut upstream and
downstream of PEX10. The annealed gRNA oligonucleotides were F8/R8 and F9/R9,
respectively.

Next, the CRISPR plasmid harboring the gRNA sequence that cuts

downstream of PEX10 was PCR amplified using primer pairs F10/R10 to obtain the
SCR1-tRNA-gRNAPEX10down-tracrRNA. This insert was cloned into the CRISPR
vector containing the gRNA that cuts upstream of PEX10 that was digested with a single
enzyme XmaI, placing the second gRNA sequence in the same expression cassette
harboring the first gRNA sequence. Sanger sequencing was used to verify screened
colonies post-transformation. A greater than 50% cut efficiency of the CRISPR system
was achieved using this strategy.
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Table 5.3. List of engineered strains used for fatty alcohol production and tested for
intracellular fatty acid production. Not in study – reported in Supplementary Figure 5.1.
Fatty alcohol production strains
PO1f (Wild Type)
Not tested
PO1fΔfao1 + MAACR (leucine)
Not tested
PO1fΔfao1 + MAACR (leucine) + AAL1 (uracil)
In study
PO1fΔdga1Δfao1 + MAACR (leucine)
In study
PO1fΔdga1Δfao1 + MAACR (leucine) + FAA1 (uracil)
In study
PO1fΔdga1Δfao1 + MAACR (leucine) + TGL4 (uracil)
In study
PO1fΔmfeΔfaa1 + MAACR (leucine)
In study
PO1fΔmfeΔfaa1 + MAACR (leucine) + AAL1 (uracil)
In study
Intracellular fatty acid sensor strains
PO1f (Wild Type)
Not tested
PO1f + hrGFP FA sensor (leucine)
In study
PO1fΔdga1 + hrGFP FA sensor (leucine)
In study
PO1fΔmfe1 + hrGFP FA sensor (leucine)
In study
PO1fΔmfe1 + hrGFP FA sensor (leucine) + FAA1 (uracil)
Not in study
PO1fΔpex10 + hrGFP FA sensor (leucine)
In study
PO1fΔfaa1 + hrGFP FA sensor (leucine)
In study
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine)
In study
PO1fΔmfeΔfaa1Δpex10 + hrGFP FA sensor (leucine)
In study
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + AAL1 (uracil)
In study
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + DGA1 (uracil)
Not in study
PO1fΔmfeΔfaa1 + hrGFP FA sensor (leucine) + TGL4 (uracil)
Not in study

Fluorescence Spectroscopy for Intracellular Fatty Acid Detection
The Biotek Synergy MX fluorescence spectrophotometer was used for all
fluorescent studies. Cells were inoculated into 48-well plates containing 0.250 mL of
synthetic media prepared as described above. The spectrophotometer was set to gain 140
with fast orbital shaking. Cells were grown in plates and for ~60 hours past stationary
phase

with

cell

growth

and

fluorescence

measured

every hour

excitation/emission wavelength 485/510 nm and a bandwidth of 9.
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Total Lipid and Free Fatty Acid Extraction
To identify and quantify lipids in cell biomass, extracted cellular lipids were
transesterified to FAMEs as described previously with minor modifications [95]. Briefly,
1 mL cell culture was harvested and spun down at 13,000 rpm for 3 minutes at 25 °C.
100 L glyceryl triheptadecanoate at a concentration of 2 mg/mL methanol was added to
the cell pellet as an internal standard. Lipids were transesterified to FAMEs with 500 μL
of 0.5 N sodium methoxide followed by 30 min of vortexing at 2,000 rpm. The solution
was neutralized with 40 μL sulfuric acid. FAMEs were extracted by adding 850 μL
hexane followed by 20 min of vortexing at 2,000 rpm. The mixture was centrifuged for 1
min at 8,000 rpm, and 800 μL of the organic layer was collected for GC-FID analysis.
For free fatty analysis, the blot on the TLC plate (Millipore, Burlington, MA) is scraped
off and run subject to the same fatty acid methylation and quantification process as
described in this section.

Thin Layer Chromatography for Determination of Percentage Lipid Classes
Cell cultures, normalized to OD600 of 17, were collected and centrifuged. The
same extraction protocol was employed for cellular lipid and fatty alcohol extraction as
described in the fatty alcohol methods section below with a minor modification. At the
final step, instead of re-suspending the sample in ethyl acetate, the dried lipid extract was
re-suspended in 0.1 mL hexane to be run on TLC. A protocol for silica plate-based thin
layer chromatography has been described before [323, 324]. TLC plates were activated
by heating the plate immediately before use for 10 min at 105 °C to remove the water.
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The solvent system was prepared by thoroughly mixing hexane/diethyl ether/acetic acid
(70/30/1, v/v) and poured into the chamber to a level up to approximately 1 cm from the
bottom. The chamber was closed to enable solvent saturation. A pencil line was drawn
on the plate approximately 2 cm from the bottom. The lipid sample was then applied to
the plate using either a microsyringe or a sample applicator device incubated at room
temperature for 1-2 min to allow for the hexane to evaporate. The plate was quickly
placed inside the saturated chamber, standing vertically and submerged in ~ 1cm of
solvent. At the end of separation (once the solvent has migrated to the top of the plate),
the plate was dried by passing gently passing nitrogen gas over the plate. The plate was
then placed in a chamber containing crystal of iodine (non-destructive) for several
minutes until yellow or brown spots appear. A pencil was used to demarcate lipid regions
of interest for further processing. An image of the chromatogram was analyzed using the
Image J software [325] to determine proportions of the lipid fractions on the plate.

Fatty Alcohol Extraction
Ten mL of culture from each flask were spun down in centrifuge tubes at 3000xg
for 10 minutes. The dodecane overlay (top layer) was extracted and directly used in GCFID analysis to determine fatty alcohols in the dodecane layer. To extract fatty alcohols
from the supernatant, 2 mL of ethyl acetate was added to 10 mL of the supernatant in a
closed glass vial and allowed to shake for 2 hours. The mixture was then incubated at 4ºC
overnight to facilitate separation of both layers. One mL of ethyl acetate was extracted
for GC-FID analysis. To extract fatty alcohols from the cell pellet, 10 mL of cell culture
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was centrifuged and washed once with 1xPBS (Sigma) to prevent any carry-over from
the supernatant. Fatty alcohol, including lipids, were extracted as described before [159,
326]. Briefly, cells were resuspended and in 1 mL of 2:1 (v/v) Chloroform: Methanol
mixture and vortexed at 5000xg for 1 hour. The mixture was spun down and 0.9 mL of
the liquid was extracted. 0.225 mL of 0.85% (w/v) NaCl (Saline solution) was added and
vortexed for 5 minutes. The mixture was then centrifuged and chilled on ice for 5 minutes
to improve the separation of the organic and aqueous phase. The aqueous layer (top
phase) was removed and the organic layer was evaporated under vacuum and room
temperature overnight. Ethyl acetate (0.9 mL) was added to each of the dried tubes to
resuspend the fatty alcohols for GC-FID analysis. Each of the samples was spiked with
0.1 mL of 0.5 mg/mL C17:0 alcohol, heptadecanol, prior to any of the above-mentioned
extraction processes.

GC-FID for Fatty Acid and Fatty Alcohol Analysis
Both methylated FFAs and fatty alcohols were quantified using GC-FID (Agilent
7890B). For fatty acid analysis, FAME species were separated on an Agilent J&W DB23 capillary column (30 m × 0.25 mm ×.0.15 μm), with helium carrier gas at a flow rate
of 1 mL/min. The temperature of the oven started at 175°C and was ramped with a
gradient of 5°C/minute until 200°C. The FID was operated at a temperature of 280 °C
with a helium makeup gas flow of 25 mL/min, hydrogen flow of 30 mL/min, and airflow
of 300 mL/min. Fatty alcohols were separated on an Agilent DB-Waxter capillary
column (30 m × 0.25 mm × 0.15 μm) using helium carrier gas at a flow rate of 1 mL/min.
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The initial temperature of the oven was 100 °C and was ramped to 220°C at a rate of
20°C per minute and held for 2 minutes. The temperature was then ramped to 300°C at a
rate of 20°C per minute and held for 5 mins. The temperature of the inlet was maintained
at 250°C and the injection volume was 1uL with a split ratio of 1:10.

Figure 5.1. Two commonly used pathways in yeast to produce fatty alcohols. The first
pathway (above) utilizes two two-electron reducing steps to convert fatty acids to fatty
alcohols. The second pathway (below) utilizes a single four-electron reducing enzyme to
convert fatty acyl-CoA to fatty alcohol.
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Figure 5.2. Fatty alcohol production pathway starting with glucose as the primary carbon
source. Cytosolic fatty acyl-CoA can either be transported and produced in the
peroxisome or shuttled into the ER for neutral lipid synthesis (TAGs, SEs).

Results
Increasing Cytosolic Fatty Acyl-CoA pools
The first attempt at engineering a strain to increase peroxisomal fatty acyl-CoA
pools was to knockout DGA1 (Figure 5.2) thereby reducing the loss of cytosolic acylCoAs to TAG synthesis. This engineered strain, PO1fΔdga1Δfao1, has been previously
used for fatty alcohol production resulting in greater than 600 mg/L produced with a yield
of 18 mg/g glucose [92]. However, their strategy used a different FAR that showed
strong specificity towards C16 fatty alcohol production. To reach the reported titers, five
copies of the FAR had to be expressed in the cytosol using media containing very little
nitrogen (0.273 g/L) and very high glucose (160 g/L) amounting to a C:N ratio of
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~1000:1. Severely retarded growth was reported that they attributed the cause being fatty
alcohol production inhibiting growth.
Our engineered strain employed an episomally expressed a single FAR from
Marinobacter aquaeolei VT8, MAACR, that included a C terminus PTS that should
target it to the peroxisome. MAACR is known to have a broader range of activity towards
fatty acyl-CoA substrate [327] with high activity toward short-chain acyl-CoAs (C8C12), which is of special interest to our future goals. Furthermore, lower glucose
concentrations (80 g/L) and ~10 times higher nitrogen conditions than Chen. et. al. [92]
were used (C:N of 60:1) that resulted in better overall cell growth.
The initial hypothesis was that increasing the cytosolic fatty acyl-CoA pools
should increase overall cellular fatty acyl-CoAs including that in the peroxisome.
Cytosolic acyl-CoAs exists at the core of the metabolic pipeline and can be directed to
various pathways such as beta-oxidation in the peroxisome, desaturation, elongation in
the endoplasmic reticulum (ER), production of storage molecules such as TAGs in the
ER then form into lipid bodies or conversion to FFAs that are excreted from the cell
(Figure 5.2). The base engineered strain, PO1fΔdga1Δfao1 with peroxisomal targeted
fatty alcohol biocatalysis produced ~150 mg/L total fatty alcohols (Figure 5.3 A). To
further increase the cytosolic acyl-CoA concentrations, a gene encoding for fatty acylCoA synthesis from free fatty acids, FAA1, was over-expressed. Surprisingly, this strain
showed less fatty alcohol production dropping the total titers by ~ 33% compared to the
original engineered strain.
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High C:N ratios have been shown as a mechanism to upregulate pathways for
lipid accumulation in Y. lipolytica [328, 329]. Although the DGA1 knockout should
dramatically drop total neutral lipid accumulation, the high C:N ratio should still
upregulate pathways favoring TAG accumulation. To release TAGs, the native TGL4
lipase was overexpressed. After 5 days of growth in synthetic media, over 200 mg/L fatty
alcohols were produced, a ~25% increase compared to the base engineered strain (Figure
5.3A). The results indicate that increasing cytosolic fatty acid pools rather than fatty acylCoAs were more beneficial to peroxisomal fatty alcohol production. In either of the three
engineered strains, the fatty alcohol distribution did not change (Figure 5.3B), showing
higher percentages of C18 alcohols produced. This result is unique because C18 fatty
acyl-CoA specificity has never been reported with MAACR before.
We were also able to detect C12 and to a lesser extent C10 fatty alcohols in the
dodecane layer (Supplementary Figure 5.2 B) amounting to a total yield of greater than
100 mg/L for each strain (Supplementary Figure 5.2A). Since no C14 alcohols were
detected, we hypothesize the production of the C12 and C10 medium chain fatty alcohols
was a result of the active alkane metabolism in Y. lipolytica, oxidizing C12 alkanes to
fatty acids that are then converted to fatty alcohols. C10 fatty alcohols are a result of a
single cycle of beta-oxidation to produce C10 fatty acyl-CoAs that are converted to fatty
alcohols. Although not initially expected, this result suggests that peroxisomal localized
MAACR is a promising strategy to capitalize on the native beta-oxidation pathway to
produce fatty alcohols. This result needs to be validated with dodecane fed as the sole
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carbon source to determine whether C10 and C12 alcohol production were a result of
alkane oxidation and not beta-oxidation of fatty acids synthesized from glucose.

Figure 5.3: (A) Peroxisomal fatty alcohol production from increasing cytosolic acyl-CoA
pools by knocking out DGA1p, a critical enzyme in TAG synthesis, or over-expressing
the primary fatty acyl-CoA synthetase enzyme, FAA1p. TGL4 lipase over-expression, an
enzyme that metabolizes TAGs to fatty acids in the cytosol, shows best titers. (B)
Distribution of fatty alcohols produced in the three engineered strains. Samples were run
in technical replicates (n=3) and represented error is a standard error.

Utilizing a Fatty Acid Responsive Promoter to Detect Intracellular Fatty Acid Production
In the second strategy, we wanted to build intracellular free fatty acid pools
instead of fatty acyl-CoA to determine if this would improve fatty alcohol production.
Therefore, our first goal was to engineer a strain capable of producing high amounts of
free fatty acids. In Chapter 3, a fatty acid GFP based sensor was engineered to show high

150

sensitivity and induction when extracellular fatty acids were used in the media. We were
interested in testing whether the hybrid promoter can also be used to detect real-time
changes in fatty acid pools produced intracellularly. If successful, this could serve as a
powerful tool for engineering strains for high fatty acid production.
The episomally transformed hybrid fatty acid promoter fused to a GFP reporter
was used to detect intracellular fatty acids in various engineered strains with knockouts
and TLC was used to determine relative percentages of the two more important lipid
classes, FFAs and TAGs (Figure 5.4A). Normalized fluorescence is a measure of cell
fluorescence per OD600, an indication of GFP accumulation in each cell over time. We
wanted to determine if this signal would correspond to fatty acid accumulation over time.
The PO1f wildtype strain shows no fluorescence and can be correlated to very little fatty
acids as observed on TLC plates. The knockout strains, PO1fΔdga1 and PO1fΔpex10
both shows a slight change in fluorescence profile relative to the WT and also produced
slightly higher free fatty acids. The two highest fatty acid producing strains were the
PO1fΔfaa1 and PO1fΔmfe1Δfaa1 which resulted in intracellular fatty acid percentages of
30% and 54%, respectively. The intracellular GFP fluorescence profile in the PO1fΔfaa1
first drops slightly and then increases suggesting an accumulation of fatty acids over
time. The highest and most stable GFP expression profile was observed from the
PO1fΔmfe1Δfaa1 which correlated well with the high proportions of free fatty acids on
TLC plates.
Interestingly, the PO1fΔmfe1 strain also showed a dramatic increase in
fluorescence followed by a sharp drop, although fatty acid abundance from TLC does not
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explain this phenomenon if we hypothesize that intracellular fatty acids can be correlated
to in vivo GFP expression from the fatty acid inducible promoter. This led us to believe
that there is complexity associated with detection that needs further understanding.

Figure 5.4. Fatty acid sensor (A1R1x3A3-GFP) used to detect intracellular fatty acid
pools in Y. lipolytica engineered strains. The experiment was performed in a 48-well
plate with cell growth and fluorescence recorded over time. Normalized fluorescence
represents the ration of cell fluorescence to cell density to provide fluorescence
quantification per OD600. Densiometric analysis on TLC plates is performed to quantify
percentages of fatty acids and TAGs in each of the engineered strains.
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Characterization of Fatty Acid Hybrid Reporter
In Figure 5.4, the fluorescence profile PO1fΔmfe1 shows a transient increase in
GFP signal prior to tailing off rapidly. TLC profiles, however, show minimum
proportions of fatty acids but the highest accumulation of TAGs from all engineered
strains. From Figure 5.2, knocking out MFE1, a gene encoding the second step of betaoxidation inside the peroxisome, should prevent fatty acyl-CoAs from shunting through
the beta-oxidation pathway. The notable spike in expression from PO1fΔmfe1 does bring
into question whether this behavior could be related to a transient flux of fatty acyl-CoAs
or free fatty acids into the peroxisome that cannot be degraded and is therefore
transported back into the cytosol to be activated to TAGs. This raises two questions. Is
the transient spike in GFP a result of transient fatty acid or fatty acyl-CoA pools inside
the peroxisome? Is the hybrid promoter reporting fatty acids, fatty acyl-CoAs or both?
First, to test the impact of peroxisomes on GFP expression, cellular peroxisome
formation was knocked out by deleting the peroxisome biogenesis factor, PEX10 gene in
the engineered strain that showed highest free fatty acid accumulation, PO1fΔmfe1Δfaa1.
As

a

result,

we

observed

a

dramatic

drop

in

fluorescence

from

the

PO1fΔmfe1Δfaa1Δpex10 (Figure 5.5A). TLC analysis showed a similar quantity of
intracellular free fatty acids although the PO1fΔmfe1Δfaa1Δpex10 had ~7-fold higher
TAG accumulation. In the absence of peroxisomes, fatty acids were directed into storage
as TAGs. This result suggests that intact peroxisomes are required for activation of the
hybrid promoter. The regulatory process behind this association needs to be investigated
further.
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Next, we wanted to determine if the peroxisomal dependent intracellular hybrid
promoter was detecting fatty acids or was it also exhibiting responsiveness to the
activated form, fatty acyl-CoA. To test this hypothesis, the native peroxisomal fatty acid
synthase gene, YlAAL1, was over-expressed to activate free fatty acids into fatty acylCoAs inside peroxisome (Figure 5.2). YlAAL1 was reported to be a peroxisomal fatty
acyl-CoA synthetase [330]. This experiment was also performed in the high fatty acid
producing strain. AAL1 overexpression caused a drop in intracellular fluorescence over
time (Figure 5.5B). From TLC, total free fatty acid pools remained the same between the
two strains but ~5 times more intracellular TAGs were produced in the engineered strain
overexpressing AAL1 (Figure 5.5B). This suggests that there is increased activation of
fatty acyl-CoA activation resulting in the assimilation into TAGs. The experiment,
however, falls short in answering if the hybrid promoter responds to fatty acids and/or
fatty acyl-CoAs in the peroxisome. Metabolite analysis of fatty acids and fatty acyl-CoAs
inside the peroxisome is required to know which exists in more abundance. The
experiments required to elucidate the process will be discussed further in Chapter 6.
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Figure 5.5. Characterization of intracellular sensor A1R1x3A3-GFP. (A) Removal of
peroxisome via ΔPEX10p shows a significant drop in fluorescence. From the
densitometric analysis of TLC plates, the fatty acid percentage remains the same between
both strains while TAG accumulation increases 7-fold in PO1fΔmfe1Δfaa1Δpex10 strain.
(B) Over-expression of AAL1 in high fatty acid producing strain, PO1fΔmfe1Δfaa1,
causes the fluorescence signal to drop over time. Densiometric analysis on TLC plates
shows similar percentages of FFAs while TAG accumulation increases 5-fold.
Fluorescence experiments were performed in a 48-well plate with cell growth and
fluorescence measured over time. Normalized fluorescence represents the ration of cell
fluorescence to cell density to provide fluorescence quantification per OD600. Cells from
growth experiments were harvested for TLC experiment.

Fatty Alcohol Production from Engineered Fatty Acid Producing Strain
PO1fΔmfe1Δfaa1 has previously been shown to produce large amounts of
intracellular and extracellular fatty acids surpassing 2 g/L combined [89] making it a
good starting point for a fatty alcohol production platform. Analysis of the fatty acid
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distribution of the intracellular pool revealed that there is a predominant percentage of
C14 and C16 fatty acids produced which is different to the fatty acid profiles of total
lipids,

containing

predominantly

unsaturated

fatty

acids,

C16:1

and

C18:1

(Supplementary Figure 5.3 A, B). Therefore, we anticipated C14 alcohol production.
However, to our surprise, no C14 fatty alcohols were produced.
The media used had a lower C:N ratio of 30:1 to facilitate peroxisome formation.
High nitrogen concentration switches the cells global regulatory circuit from lipid
accumulation to fatty acid degradation which requires peroxisomes [331]. In the wildtype
overexpressing AAL1, very little fatty alcohols were produced, predominantly being
C16:0 and C18:0 (Figure 5.6 A, B). In PO1fΔmfe1Δfaa1, we observed a 10-fold
improvement in fatty alcohol production reaching 530 mg/L and 14% of dry cell weight
(Supplementary Figure 5.5). In addition to a predominant abundance of C16:0 and C18:0,
small proportions of monounsaturated alcohol peaks C16:1, and C18:1 were detected.
In attempts to further increase the fatty acyl-CoA pools inside the peroxisome,
AAL1 was over-expressed. Surprisingly, this perturbation to the pathway resulted in a
35% drop in fatty alcohol production. The hybrid promoter was previously used to test
GFP expression in PO1f Δmfe1 Δfaa1 over-expressing AAL1 (Figure 5.5B). We observed
fluorescence drop over time relative to PO1fΔmfe1Δfaa1. Whether this effect can be
attributed to an increase in peroxisomal fatty acyl-CoA pools needs to be determined.
However, higher TAG accumulation was observed in the AAL1 over-expressing strain
suggesting higher levels of fatty acid activation to fatty acyl-CoA.
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Figure 5.6. (A) Peroxisomal fatty alcohol production from increasing cytosolic fatty acid
pools and beta-oxidation by knocking out fatty acid synthase, FAA1 and multifunctional
enzyme, MFE1 produced highest titers exceeding 500 mg/L fatty alcohols. Overexpression of AAL1 in engineered strains leads to a ~30% drop in titers. (B) Percentage
fatty alcohol distribution of all three strain show similar profile except the engineered
strains, PO1fΔmfe1Δfaa1Δfao1 and PO1fΔmfe1Δfaa1Δfao1 with AAL1 over-expression
shows production of unsaturated fatty alcohols, C16:1 and C18:1. Samples were run in
technical replicates (n=3) and represented error is a standard error.

Discussion and Conclusion
Developing microbial platforms to produce fatty alcohols has garnered a lot of
interest in recent years with the exploitation of several microbes ranging from bacterial
systems such as E. coli, cyanobacteria and Marinobacter aquaeoli [322, 332-334] to
yeasts, predominantly S. cerevisiae [308, 310, 315, 335]. One of the benefits of exploring
yeast systems for this function is that metabolic processes are naturally separated into
specialized yet distinct subcellular compartments called organelles. For example, in
yeasts, beta-oxidation of fatty acids is localized into the peroxisome or transported into
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the ER to be stored in the form of TAGs. Furthermore, fatty acids produced in the cytosol
via the fatty acid biosynthesis are bound to acyl-CoA binding proteins and can be
transported either into the peroxisome or the ER. In comparison to conventional
engineering of pathways in the cytosol, compartmentalization provides additional
advantages such as enabling faster reaction rates due the ability to concentrate
metabolites and enzymes. One of the more predominant advantages of pathway
localization is the capacity to segregate the biochemical process of interest from
competing pathways and mitigating regulatory responses at the protein level [336].
The metabolic strategy we propose is a novel method to explore fatty alcohol
production in Y. lipolytica inside the peroxisome. This provides the ability to highjack the
hydrocarbon chain processing capabilities via beta-oxidation to eventually produce
shorter chain fatty alcohols. By increasing the cytosolic fatty acid pools instead of the
cytosolic fatty acyl-CoA pools, we were able to produce more than 2-fold higher fatty
alcohol titers in the peroxisome. These results suggest that fatty acids may enter the
peroxisome more readily than fatty acyl-CoA. The observation can be validated by
quantifying fatty acid and fatty-acyl CoA pools in the peroxisome.
PO1fΔmfe1Δfaa1 strain produced the most amounts of fatty acids as evidenced by
the hybrid promoter signal and TLC analysis. We believe this strategy of over-producing
fatty acids enables better diffusion of fatty acids to enter the peroxisome for fatty alcohol
conversion.
In attempts to improve the efficiency of fatty alcohol production inside the
peroxisome, AAL1 gene was over-expressed to pull fatty acids towards fatty acyl-CoA
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production, which are direct precursors to MAACR. This strategy, however, led to a
~30% drop in fatty alcohol titers and increase in TAGs as evidenced by TLC. Given that
AAL1 expression is peroxisomal, we could at this point only hypothesize that higher
production of fatty acyl-CoA is imbalanced by a less active MAACR leading to
activation of fatty acyl-CoA export from the peroxisome to the cytosol to be available for
TAG synthesis. This bottleneck can be overcome by improving the activity of FARs,
regulating peroxisomal fatty acyl CoA pools, and blocking TAG synthesis.
To improve the fatty alcohol reductase activity, a codon optimized version of the
MAACR gene will be expressed. We anticipate better translation efficiency of the gene,
thereby increasing enzyme concentration and overall kinetics of the reaction. Codonoptimized versions of other FARs, particularly, TaFAR1 and MmFAR1 should be tested.
TaFAR1 has already been shown to be functional in Y. lipolytica [92]. Meanwhile,
MmFAR1, from the mouse, Mus musculus, is yet another fatty alcohol that has proven to
show high activity when expressed in S. cerevisiae, greater than TaFAR1 [65]. There is
no published literature to date on its activity in Y. lipolytica. The activity and fatty
alcohol profiles generated from these FARs in our engineered strain may provide new
alcohol distributions and improve the overall efficiency of the final production step,
thereby improving yields.
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The PO1fΔmfe1Δfaa1 strain produced significant C14 fatty acids (Supplementary
Figure 5.3) although, with MAACR, no C14 fatty alcohols were produced. We
hypothesize MAACR has a lower affinity to C14 when there is a high abundance of C16
fatty acyl-CoA. Furthermore, lower specificity of MAACR to C14 aldehydes has been
demonstrated before [332]. The inability to convert abundant C14 fatty acids to fatty
alcohols affects the yields and titers of the process and therefore motivates our work to
investigate additional FARs.
We can attempt to engineer higher accumulation of fatty acyl-CoA inside the
peroxisome but this is challenging because there is little known about the mechanism of
fatty acyl-CoA transport and regulation to and from the peroxisome [169]. The dimeric
ATP- dependent transporter, YlPxa1p/ Pxa2p, is hypothesized to transport fatty acyl-CoA
into the peroxisome, whether this transport is reversible is unknown. This transporter has
been knocked out previously to increase cytosolic acyl-CoA pools, however, no change
to fatty alcohol production was observed [92]. This result suggests that fatty acyl-CoA
transport to the peroxisome may be more regulated than we currently understand.
Another approach would be to place the expression of YlAAL1 under the expression of
the fatty acid hybrid promoter. Instead of attempting to create stagnant fatty acyl-CoA
pools, dynamically regulating the expression of the protein by placing the gene under a
fatty acid hybrid promoter could improve process efficiency.
Since we are observing more TAG accumulation due to peroxisomal AAL1 overexpression, it would also be beneficial to block TAG formation via ΔDGA1 in the
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engineered PO1fΔmfe1Δfaa1Δfao1. This strategy could push fatty acyl-CoA flux back
into the peroxisome to improve production efficiency inside the peroxisome.
While glucose may be a convenient substrate, it may not ideal from a standpoint
of making fatty alcohol production economically viable (Table 5.2). The advantage to
using Y. lipolytica as the model yeast to engineer fatty alcohol production as opposed to
S. cerevisiae provides several benefits, notably, its ability to uptake and metabolize
hydrocarbons efficiently. This opens opportunities to utilize cheaper and more abundant
alternatives as feed such as crude glycerol from the biodiesel waste stream or rendered
animal fats. Reducing feed cost can bias economic profitability of the process.
Two alternate methods have been explored for localized production of fatty
alcohols inside the peroxisome of Y. lipolytica. In the first pathway, we attempted to
increase cytosolic acyl-CoA pools by knocking out the lipid storage capabilities. Higher
fatty acyl-CoA pools were expected inside the peroxisome, however, this strategy proved
less efficient with the production of slightly over 200 mg/L of fatty alcohols. In the next
strategy, that proved more promising, higher fatty acid production was engineered in Y.
lipolytica by knocking out the cytosolic acyl-CoA activation step and preventing fatty
acid degradation via beta-oxidation. Using a fatty acid inducible promoter fused to a GFP
reporter gene, real-time production of intracellular fatty acids was monitored. Using this
strategy, close to 600 mg/L of fatty alcohols were produced. Attempts to further increase
production were tested by overexpressing the fatty acyl-CoA production pathway inside
the peroxisome, however, this led to a decrease in fatty alcohol production with increased
TAG accumulation. The work presented here highlights the need to explore mechanisms
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to improve the efficiency of fatty acyl-CoA conversion to fatty alcohol, better
characterization of the hybrid promoter so it could be utilized more efficiently, and
engineering fatty acyl-CoA pools inside the peroxisome. This work is the first of its kind
to engineer localized fatty alcohol biosynthesis in Y. lipolytica.
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CHAPTER SIX
Conclusions
The work in this dissertation establishes tools to improve engineering efforts in
the industrial yeast, Yarrowia lipolytica. Metabolic pathways in microbes were
constructed with enzymes and controlling the time and strength of expression can
improve the efficiency of biochemical processes. A large part of this work focused on
understanding and developing better gene expression systems in Y. lipolytica. Hybrid
promoters with tunable and predictable strengths can be engineered by combining
different elements that constitute a promoter, namely, UASs, proximal sequences, TATA
element and core promoters. In particular, UAS elements in hybrid promoters were used
to control strength and timing of expression. Identifying UASs, however, is a limitation
in non-conventional yeasts such as Y. lipolytica where there is little known about
regulatory elements such as transcription factors or its binding motifs. Therefore, we
explored a novel method to screen for new UASs from differences in DNA accessibility
profiles in native promoters under different conditions. We explored this concept with the
POX2 promoter and anticipate using it to determine novel UAS elements in other native
promoters. Finally, a fatty acid hybrid promoter detailed in this dissertation was used to
guide the engineering of a fatty acid producing strain of Y. lipolytica. By localizing the
final step of fatty alcohol biosynthesis to the peroxisome, the engineered strain shows
promise for future metabolic engineering geared to short and medium chain fatty alcohol
production. There are still a number of interesting opportunities for further investigation
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of hybrid promoters and application of these promoters to improve fatty alcohol
production efficiency.

Future Work
In Chapter 1, libraries of hybrid promoters were built by investigating the
architecture of native promoters in Y. lipolytica. In addition to Upstream Activating
Sequences (UASs), we studied the role of sequences near the transcriptional start site,
namely the proximal, TATA box and core promoters from four promoter systems
upstream of the genes, YlPOX2, YlPAT1, YlLEU2, and YlTEF1-α. The goal of this work
was to elucidate how each these elements contributed to promoter activity, which of the
elements had modular properties and most importantly, which elements contributed the
most to promoter activity.
The TATA box is a highly conserved element across all eukaryotic species and is
the recruitment site for the pre-initiation complex (PIC) machinery that initiates
transcription [337]. Although the TATA element itself is conserved, there is a lot of
sequence variability surrounding this element that can affect transcription [338]. The
TATA element from the TEF1-α promoter elicited the strongest transcriptional response
of the four promoters tested. Another interesting result was that the POX2 promoter
contained two TATA boxes. Removing one TATA element severely weakened
transcription. Our experiments were limited to four promoters with an 8 bp window
around the TATA sequence.
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I recommend increasing this sequence space to test more base pair diversity
around the TATA box. It would be beneficial to determine if there is a maximum
threshold for transcriptional activation using TATA elements by varying sequence
diversity around the conserved TATA box. This information can be leveraged to increase
the strength of inherently weak native promoters or applied to the development of hybrid
promoters. The dual TATA box activity of the POX2 promoter strongly suggests that
adjacent sequence can play a pivotal role for PIC affinity to the TATA element.
This experiment can be performed on one core promoter such as the POX2 core
promoter than can be used as the control of the experiment. Oligo mixes of ~60 bp can be
synthesized with 6-8 random base pairs (N) before and after a conserved TATA box.
Each end in the mix of forward oligos should have the same 20 bp sequence while the
ends of reverse oligo mix should be complementary to the ends of the forward oligos.
This would allow the oligo mix to be PCR amplified. The PCR amplified product can
then be cloned downstream of a UAS sequence and upstream of a GFP reporter in the
pSL16 shuttle vector. By transforming these vectors into E. coli DH10β cells, a library of
vectors with variations to the sequence before and after the conserved TATA element can
be created and sequence verified via Sanger sequencing. As a first round, around twenty
different sequence variations can be transformed into Y. lipolytica and fluorescence can
be measured in 48-well plates to determine which sequence provides the strongest
expression relative to POX2 core promoter. Sequences of the optimal expressing core
promoters from Y. lipolytica can be screened using colony PCR and Sanger sequencing
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The initiator sequences in the core promoter are another under-studied promoter
element that was not covered in Chapter 2. In Supplementary Figure 2.1, we identified
potential initiator regions in the four promoters based on homology to metazoan
sequences. In S. cerevisiae, RNA polymerase II performs a downstream scan in search of
transcriptional start sites (TSSs) [339] that results in transcriptional initiating occurring
40-120 bps downstream of the TATA box [197]. Given that core transcriptional
machinery is strongly conserved in eukaryotes [340], it is likely that the identified
initiator regions in Y. lipolytica have some impact the transcription process. Therefore,
the significance of initiator sequences for transcriptional regulation needs to be further
examined.
The experimental set up to test for the effect of initiator sequences is similar to the
process explained above for TATA elements. In this instance, we have mapped out
putative initiator sequences in four core promoters, therefore, we have an idea of the
sequence length that needs to be randomized using oligos.
In Chapter 3, we set out to engineer the first hybrid fatty acid inducible promoter
by identifying a key promoter element for transcription, enhancer binding regions, found
within UASs. The focus, however, was to search for UAS elements that elicited inducible
activation towards fatty acids. The POX2 promoter of Y. lipolytica was used because it
was induced by fatty acids and repressed in glucose and oleic acid [110]; however, its
inducibility was weak, which makes its application in metabolic engineering limited. A
heuristic approach was used to dissect the native promoters and fused to a GFP
fluorescence reporter to quantify expression strength. We identified three oleic acid-
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inducible UASs, A1, R1, and A3 via truncations of the promoter. Tandem repeats of R1
enabled strong activation when oleic acid was used as an extracellular inducer.
Substituting in stronger core promoters led to higher activation of the hybrid promoter.
The strongest hybrid promoter had an ~10-fold increased activation in oleic acid
compared to the native POX2 promoter.
The promoter was truncated such that we conserved the putative YlPOR1p
binding sites within the truncations. Furthermore, in Chapter 4, we discuss DNA
accessibility in relation to where the POR1p motifs are located on the promoter.
However, to date, there has been no direct line of evidence suggesting that POR1p
physically binds the POX2 promoter. BLAST analysis of the POR1p reveals a conserved
DNA binding and activator domain belonging to the zinc finger transcription factor
family.
We should first demonstrate that POR1p binds to the POX2 promoter, and to
determine DNA binding specificities to leverage this information towards building a
library of hybrid promoters using smaller, well defined yet optimal UASs. As discussed
in this dissertation, a commonly used approach to building stronger hybrid promoters
relies on using tandem repeats of UASs. If the binding affinity of a transcription factor is
weak in a UAS, then the tandem repeats of a UAS improves transcription strength by
increasing number of transcription factors, thereby increasing the strength of
transcription. The more efficient method would be to use few UASs containing motifs
with higher binding affinity sites. The question remains as to how we search for these
motifs.
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To answer this question, I recommend an in vivo approach to determining POR1p
DNA binding motifs by not only looking at the POX2 promoter but the whole genome.
Chromatin Immunoprecipitation (ChiP) combined with either PCR tiling arrays or high
throughput sequencing (ChiP-seq) can be used to locate POR1p binding sites in the
POX2 promoter or the entire genome. POR1p attached to an epitope tag (Myc, V5 or
HA) can be immunoprecipitated using antibodies after crosslinking the cells in
formaldehyde (Figure 6.2). Proteinase digest of the pull-down should expose DNA
protected by POR1p.
In addition to elucidating the role of POR1p, we are also interested in identifying
other co-regulators that associate with POR1p to mediate transcription. For this, I
recommend ChiP combined to tandem mass spectrometry (ChiP-MS). The crosslinked
and immunoprecipitated protein sample is subjected to enzymatic or chemical
degradation to produce peptides that can then be sequenced using MS. The peptide
sequences can be blasted against the Y. lipolytica protein database to identify the
transcription factors.
Usually, ChiP this may yield a larger than desired library of proteins due to nonspecific binding of the antibody or proteins. Therefore, there may be a need to narrow
down the pool of proteins that are potential co-regulators. For this purpose, I recommend
a yeast 2-hybrid promoter using POR1p as the bait and other identified proteins (preys)
fused to a well-characterized activation domain. Using this system, we can elucidate the
mechanism of oleic transcription activation and apply this system to engineer new types
of hybrid promoters in Y. lipolytica.
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In Chapter 4, we wanted to investigate whether UASs in native promoters can be
identified by scanning DNA accessibility on the promoter. To test this, we used the fatty
acid inducible POX2 promoter that was characterized in Chapter 3. The conclusion from
this chapter was that we could begin to investigate new UASs based on differences in
DNA accessibility between conditions that induce or repress transcription. Choosing
UASs using this method reduces the number of combinations of UASs to be tested
compared to using a truncation method in Chapter 3 that can generate many truncated
sequences.
We would like to test this in other native promoters where there is no
understanding of transcription factors or putative binding sites. We hope to determine
whether differences in DNA accessibility across the promoter can guide the selection of
UASs. We are currently in the process of testing this on another promoter that is induced
by glycerol [224] from the gene, glycerol kinase (YlGUT1) that converts glycerol to
glycerol-3-phosphate (G3P) [341]. Prior to publishing work in Chapter 4, there are other
aspects of the project I would recommend testing, detailed below.
Recently, it was reported that there is an inherent bias in mononucleosome DNA
preparation using micrococcal nuclease (MNase) [342]. Higher MNase activity by using
higher concentrations of MNase releases mononucleosome DNA from regions of low
DNA accessibility while low MNase activity has been used to map positions of “fragile”
nucleosomes, which are nucleosomes harboring post-translational modification that make
its interaction with DNA weak [343]. Crosslinking the histones to DNA can mitigate this
issue. The approach that we used to “standardize” occupancy maps was to test more than
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one MNase concentration and choosing a sample that showed a >90% mononucleosome
DNA fraction but this still does not remove the inherent bias that MNase cleavage can
have on reliably determining nucleosome probability.
The purpose of nucleosome profiling is to quantify the probability of a
nucleosome forming in a region of the promoter in a DNA. When two nucleosomes are
close to one another, and if the probability of this event happening is high, our data can
be skewed by the MNase digestion affinity to separate the two nucleosomes because they
are in proximity to one another. This leads to different populations of MNase-resistant
and MNase-sensitive nucleosome that biases the DNA accessibility profiles (Figure 6.2).
My recommendation to troubleshooting this issue is (1) test nucleosome profiles
for more than one MNase digestion condition and see if the DNA accessibility profiles
are reproducible (2) attempt another method such as sonication to shear DNA into
mononucleosome fragments after crosslinking, and (3) using ChiP to separate association
of transcription factors and nucleosomes in DNA accessibility profiles.
When MNase digestions are performed, more than one digestion condition can
provide greater than >90% mononucleosome DNA fractions. At this point, it is left up to
the discretion of the experimenter to select a sample to move onto PCR tiling for DNA
accessibility profiles. My recommendation here is that if we have more than one
digestion condition that yielded >90% mononucleosome DNA fraction, then we should
do DNA accessibility on all MNase digested samples with very high mononucleosome
DNA and investigate the reproducibility of the profiles. We need to access the level of
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variability and determine whether this could significantly affect our experimental goals,
i.e. to efficiently identify UAS elements on the promoter.
My second recommendation is to attempt another method to retrieve
mononucleosome DNA. If the chemical means such as MNase activity causes technical
bias, then a physical process of preparing mononucleosome DNA such as sonication
should be used to investigate if it is a better solution.
My final recommendations for Chapter 4 are to separate the difference between
transcription factor binding to the DNA and nucleosomes occupancy. To obtain DNA
accessibility profiles in Chapter 4, we used formaldehyde crosslinking to covalently bind
the nucleosomes to the DNA, however, this also covalently binds transcription factors to
the DNA (Figure 6.1B). How transcription factors bind to DNA in the presence of
nucleosomes can vary depending on the type of mechanism. In S. cerevisiae alone,
nucleosome eviction [277] and sliding [280] have been reported. More recently,
nucleosome “loosening” due to post-translational modifications enable transcription
factors to access binding motifs wrapped in nucleosome [342]. This mechanism does not
change nucleosome profiles. Therefore, looking at the DNA accessibility data in the
presence and absence of transcription factors can provide some mechanistic insight into
transcription factors association with nucleosomes to regulate gene expression.
One method I propose is to investigate DNA accessibility without crosslinking
with formaldehyde (Figure 6.1C). Transcription factors are known to have weaker DNA
interactions that nucleosome. Without crosslinking, transcription factors would
disassociate from the DNA easily. This experiment will be difficult to interpret because

171

crosslinking fixes nucleosomes to DNA that are otherwise dynamic. Without
crosslinking, nucleosome can move during MNase treatment but the extent of this effect
is not known in S. cerevisiae or Y. lipolytica. Without crosslinking, we would also not be
protecting fragile nucleosomes on the promoter. The results from this experiment
compared to the crosslinking data would be beneficial to predict promoter regions where
nucleosomes have undergone post-translational modifications or regions protected by
transcription factor complexes. Without performing the experiment, it is difficult to
determine how important this data would be to better elucidate transcriptional regulation
via nucleosomes and transcription factors.
ChiP for histones is a better-suited method prevent the interference of histones
being dynamic and yet provide us with nucleosome occupancy data in the absence of
transcription factor-DNA interactions. Cross-linking is possible in this step and
immunoprecipitation is done using histone antibodies or beads targeted at histone
modifications [344]. The difference in nucleosomes profiles between of histone
modifications between repressed and induced conditions can provide insight into
potential UASs.
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Figure 6.1. ChiP can be used for the detection of protected DNA regions either protected
by nucleosomes and transcription factors via crosslinking or nucleosome protected DNA
by not crosslinking linking the reaction. Protected DNA on a single locus of the genome
can be analyzed using PCR Tiling or protected DNA across the entire genome can be
sequencing using a high throughput sequencing technique.
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Figure 6.2. MNase digestion can bias DNA accessibility profiles based on cutting
efficiency of the MNase. This biases nucleosome occupancy data that should capture
probability of finding a nucleosome in a given region of the promoter. shows MNase
cleavage sites

In Chapter 5, a novel pathway for fatty alcohol production is examined in Y.
lipolytica by docking the final step of the enzymatic reaction, conversion of fatty acylCoA to fatty alcohol, inside the peroxisome using a peroxisome targeting signal (PTS).
The enzyme used to convert fatty acyl-CoA to fatty alcohols is a fatty acyl-CoA /
aldehyde reductase (FAR) from Marinobacter aquaeoli, MAACR. We demonstrate that
by engineering the strain to produce intracellular fatty acids, upwards of 500 mg/L fatty
alcohols can be produced, although additional work needs to be done to improve the
efficiency of the process. The current process yields 7 mg fatty alcohols / g glucose. The
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future work for Chapter 5 will address two key issue. (1) Improving the efficiency of
fatty alcohol biosynthesis in Y. lipolytica, and (2) characterization of the fatty acid hybrid
promoter for future strain engineering applications.
The work demonstrated in Chapter 5 is a promising route for fatty alcohol
production, however, there are different aspects of the metabolic pathway that need to be
addressed to improve its efficiency. These are separated into modules as depicted in
Figure 6.3.

Figure 6.3. Five modules identified to improve the efficiency of engineering fatty alcohol
production in Y. lipolytica.

Module 1:
Improving final reaction step. Figure 5.6A showed that attempting to increase
fatty acyl-CoA inside the peroxisome, by overexpressing YlAAL1, led to lower fatty
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alcohol production. Fatty acyl-CoA are direct precursors for MAACR therefore, we
anticipated that this strategy would yield better fatty alcohol titers. One hypothesis to
explain this result is that the expression of MAACR is not optimal because the MAACR
is not codon optimized for Y. lipolytica. The MAACR is being expressed using the
UAS1B8-TEF hybrid promoter, shown to be strong and constitutively expressed [82].
However, codon biases in microbes can have a large impact on the efficiency of gene
expression [345]. We believe that codon optimization of MAACR for Y. lipolytica
should relieve this bottleneck.
Additionally, two more FARs, MmFAR1 (mouse) and TaFAR1 (barn owl) will be
tested in Y. lipolytica to observe if better fatty alcohol production and different chain
length specificities can be attained. We are unable to produce C14 alcohols although the
engineered strain, PO1fΔmfe1Δfaa1Δfao1, produces a large abundance of C14 fatty acids
(Supplementary Figure 5.3B). One of the goals is to investigate whether changing the
FAR could improve selectivity for C14 fatty alcohol production.
Module 2: Chain shortening using native β-oxidation.
One of our primary objectives for compartmentalizing fatty alcohol synthesis to
the peroxisome was to use the β-oxidation pathway to produce short and medium chain
fatty alcohols. The work described in Chapter 5 does not test chain shortening since the
MFE1 knockout in our engineered strain impairs beta-oxidation. To test fatty alcohol
distribution via natural beta-oxidation, MFE1 function will be restored in the engineered
strain to create PO1fΔfaa1Δfao1. This strain capable of beta-oxidation and yet
accumulates fatty acids. Biasing the chain length specificity to short and medium-chain
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fatty alcohols can be accomplished by knocking out the POX3 gene. POX3 has been
shown to be a short chain fatty acyl-CoA oxidase [170].
Module 3: Dynamic regulation of fatty alcohol production.
Our current engineering strategy utilizes two constitutively hybrid promoters to
express AAL1 and MAACR genes encoding enzymes for fatty acyl-CoA and fatty alcohol
production, respectively. To increase peroxisomal fatty acyl-CoA, AAL1 was placed
under the expression of an early phase, strong constitutive promoter, PTEF-intron from the
YlTEF gene of Y. lipolytica. The expression of MAACR was driven by UAS1B8-TEF, a
strong late phase hybrid promoter. While AAL1 over-expression should have created
more fatty acyl-CoA precursor for MAACR, a negative effect on fatty alcohol production
was observed in PO1fΔfaa1Δmfe1Δfao1 + AAL1 relative to the engineered strain without
AAL1 over-expression. An inadequate pull on fatty acyl-CoA pools as described in
module 1 coupled to up-regulation of pathways to transport fatty acyl-CoA outside the
peroxisome to maintain homeostasis could be a reason for the result we observe. I
propose using a fatty acid inducible promoter to regulate AAL1 expression thereby using
intracellular fatty acids to dynamically regulate fatty acyl-CoA production inside the
peroxisome (Figure 6.4). In addition, it would be beneficial to test if improvement to fatty
alcohol production is attainable via combinations of constitutive and hybrid promoters to
drive expression of the AAL1 and FAR genes.
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Figure 6.3. Using fatty acids to dynamically regulate fatty acyl-CoA pools inside the
peroxisome should prevent fatty acyl-CoA build-up. Coupled with constitutive
expression of a codon-optimized FAR, the process should improve fatty alcohol
production efficiency. FA = Fatty Acids; FA-CoA = Fatty acyl-CoA; AAL1 = fatty acyl
CoA synthetase

Module 4: Maintaining high intracellular fatty acid pools.
While PO1fΔmfe1Δfaa1 and PO1fΔmfe1Δfaa1+AAL1 creates large amounts of
intracellular fatty acids (>1 g/L), we also observed high levels of extracellular fatty acids
secreted to the media (Figure 6.4)
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Figure 6.4. (A) Thin Layer Chromatography (TLC) for analysis of lipids in secreted to
the media in strains PO1fΔmfe1Δfaa1 and PO1fΔmfe1Δfaa1+AAL1. (B) Visible turbidity
in media due to fatty acids for both strains.
The same analysis has not been performed on the engineered strain overexpressing
MAACR, therefore, validating similar extracellular fatty acid accumulation is necessary
prior to engineering the strain to accumulate intracellular fatty acids.
To date, there has been no published record for fatty acid transporters in Y.
lipolytica, therefore, how fatty acids are transported in and out of peroxisomes or cells are
unknown. Our results suggest that there may be no current limitation to fatty acid
transport into the peroxisome to be activated for fatty alcohol production. However, we
would need to first identify transporters responsible for fatty acid transport in and out of
the cell to engineer a strain capable of higher intracellular fatty acid accumulation.
Another strategy would be to bind the internal free fatty acids to fatty acid binding
proteins. Fatty acid binding proteins have been characterized in Y. lipolytica [346] and
binding free fatty acids to these proteins are required for activation of fatty acids to fatty
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acyl-CoA [169]. Currently, there are no data to ascertain whether binding free fatty acids
to fatty acid binding proteins would prevent fatty acids from being secreted to the
extracellular matrix. Therefore, this strategy needs to be experimentally tested.
Module 5: Investigating fatty alcohol production in the cytosol.
Our immediate goal is to produce fatty alcohols inside the peroxisome. We
accomplished this knocking out fatty acid activation to fatty acyl-CoA in the cytosol
(ΔYlFAA1p) while maintaining this function in the peroxisome (YlAAL1p). However, we
have yet not tested cytosolic fatty alcohol production capabilities of the engineered strain
by expressing MAACR in the cytosol of Y. lipolytica. This would establish if fatty
alcohol production predominantly occurs in the peroxisome for the current engineered
strain. From an efficiency standpoint, this is important because we want to leverage
peroxisomes for chain shortening and therefore, if significant fatty alcohols are produced
in the cytosol, we would need to revisit our strategy and re-engineer the strain.
Furthermore, this experiment would inform us whether there is a need to delete fatty
alcohol oxidase deletion, ΔYlFAO1, which is cytosolic. FAO1p is responsible for the
degradation of fatty alcohols.
Final Recommendation: Further characterization of the fatty acid hybrid promoter
In Chapter 3, we demonstrate the development of a hybrid promoter that is
inducible by extracellular fatty acids while in Chapter 5, we utilize this hybrid promoter
to profile real-time changes in intracellular fatty acid. What has not been established to
date is whether the response from the hybrid promoter is directly related to fatty acids or
products that are a result of fatty acid being processed. Activation of fatty acids to fatty
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acyl-CoA is the first step of β-oxidation. In chapter 5, we show that by overexpressing
the AAL1 enzyme that catalyzes this reaction in the peroxisome, we can observe a
reduction in fluorescence from the hybrid promoter (Figure 5.5B). This experiment still
does not tease out if the hybrid promoter is responding to concentrations of fatty acids,
fatty acyl-CoA or both.
Therefore, I recommend two experiments to characterize the responsiveness of
the hybrid promoter. First, we need to knock out the fatty acid activation step inside the
peroxisome (ΔAAL1) in the fatty acid producing strain, PO1fΔmfe1Δfaa1. AAL1 is the
predominant fatty acyl-CoA synthetase, which should severely limit fatty acyl-CoA
production. As a result, the fluorescence signal from the hybrid promoter should increase
if the promoter is responding to fatty acids. Liquid chromatography coupled to mass
spectrometry (LC-MS) can then be used to determine fatty acid and fatty acyl-CoA inside
the peroxisome and total cellular pools. The same analysis should be used on the current
engineered strain, PO1fΔmfe1Δfaa1 to determine how these metabolite pools change in
comparison to PO1fΔmfe1Δfaa1Δaal1.
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Appendix A
Supplementary Tables for Chapter 2

Supplementary Table 2.1 gBlock® and primer pairs used to construct base hybrid
promoter containing restriction sites for cloning promoters.
Name
Sequence
gBlock®
GATCCCCCGGGTTCGAAGCTAGCCCTAGGGGCGCGCCATGGTG
AGCAAGCAGATCCTGAAGAACACCGGCCTGCAGGAGATCATGA
GCTTCAAGGTGAACCTGGAGGGCGTGGTGAACAACCACGTGTT
CACCATGGAGGGCTGCGGCAAGGGCAACATCCTGTTCGGCAAC
CAGCTGGTGCAGATCCGCGTGACCAAGGGCGCCCCCCTGCCCT
TCGCCTTCGACATCCTGAGCCCCGCCTTCCAGTACGGCAACCGC
ACCTTCACCAAGTACCCCGAGGACATCAGCGACTTCTTCATCCA
GAGCTTCCCCGCCGGCTTCGTGTACGAGCGCACCCTGCGCTACG
AGGACGGCGGCCTGGTGGAGATCCGCAGCGACATCAACCTGAT
CGAGGAGATGTTCGTGTACCGCGTGGAGTACAAGGGCCGCAAC
TTCCCCAACGACGGCCCCGTGATGAAGAAGACCATCACCGGCC
TGCAGCCCAGCTTCGAGGTGGTGTACATGAACGACGGCGTGCT
GGTGGGCCAGGTGATCCTGGTGTACCGCCTGAACAGCGGCAAG
TTCTACAGCTGCCACATGCGCACCCTGATGAAGAGCAAGGGCG
TGGTGAAGGACTTCCCCGAGTACCACTTCATCCAGCACCGCCTG
GAGAAGACCTACGTGGAGGACGGCGGCTTCGTGGAGCAGCAC
GAGACCGCCATCGCCCAGCTGACCAGCCTGGGCAAGCCCCTGG
GCAGCCTGCACGAGTGGGTGTAAGCTAGCCTCATGTAATTAGT
TATGTCACGCTTACATTCACGCCCTCCCCCCACATCCGCTCTAA
CCGAAAAGGAAGGAGTTAGACAACCTGAAGTCTAGGTCCCTAT
TTATTTTTTTATAGTTATGTTAGTATTAAGAACGTTATTTATATT
TCAAATTTTTCTTTTTTTTCTGTACAGACGCGTGTACGCATGTAA
CATTATACTGAAAACCTTGCTTGAGAAGGTTTTGGGACGCTCGA
AGGCTTTAATTTGCA
F1
ACAATTTCGAATGCGGTACCCGAATTCCT
R1
AAGCTTCTGCAGGCATGC
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Supplementary Figures for Chapter 2

Supplementary Figure 2.1. Identification of predicted transcription initiation sites in the
TEF and POX2 core promoter region.
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Appendix B
Supplementary Tables for Chapter 3
Supplementary Table 3.1. Detailed list of vectors and primers used to construct hybrid
promoters tested in this study.
F1
CCGGGTTCGAAGGTACCAAGGAAGCATGCGATATTCCGGTCCCG
AAACCCGAT
F2
CCGGGTTCGAAGGTACCAAGGAAGCATGCTTCTCCCCCCTTTCA
CACTCTG
F3
CCGGGTTCGAAGGTACCAAGGAAGCATGCCCGTCTCCTCTATAT
GTGTATCCG
F4
CCGGGTTCGAAGGTACCAAGGAAGCATGCAAGTGAGACTGGCG
ATCGG
F5
CCGGGTTCGAAGGTACCAAGGAAGCATGCGAGAAGCGATCGCC
CGTC
F6
CCGGGTTCGAAGGTACCAAGGAAGCATGCGGTACCAGCGGGAG
GTTAC
F7
CCGGGTTCGAAGGTACCAAGGAAGCATGCGGGATACCGGAATA
ACCCTGGCT
F8
CCGGGTTCGAAGGTACCAAGGAAGCATGCATGTTTGTTTTTCCG
ATCTTTCGG
F9
CCGGGTTCGAAGGTACCAAGGAAGCATGCCATGAAAACTATAA
CCTAGACTACACG
F10
CTAAATTTGATGAAAGGGGGATCCCCCGGGTTCCTAGGGATATT
CCGGTCCCGAAACCC
F11
TTGACGTGGTGAATGTCGCCCGTTCTCACGTGACAAGTGAGACT
GGCGATC
F12
CCCTAAATTTGATGAAAGGGGGATCCCCCGGGTTCCTAGGCAAG
TGAGACTGGCGATC
F13
AAGTATATTGAATGTGAACGTGTACAATATCACAATTGGACATG
TTTGTTTTTCCGA
F14
GAATGTCGCCCGTTCTCACGTGAGCATGCAATTGGACATGTTTG
TTTTTCCGATCTTT
F15
AAAGTATATTGAATGTGAACGTGTACAATATCACCCCGTCTCCT
CTATATGTGTATCCG
F16
GTGGTGAATGTCGCCCGTTCTCACGTGAGCATGCCCCGTCTCCT
CTATATGTGTATCCG
F17
GCACAAGGGGTAGGCGAATGGTACGATTCCGCCCCGTCTCCTCT
ATATGTGTATCC
F18
AAGGGGTAGGCGAATGGTACGATTCCGCAATTGGACATGTTTGT
TTTTCCGA
F19
TTCTCCCTCGGCTCTCGGTATTTCAGCATGCTTGTGGTTGGGACT
TTAGCC
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F20
F21
F22
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
gBlock®

GACCAGCACTTTTTGCAGTACTAACCGCAGGTGAGCAAGCAGAT
CCTGAAGAACACC
GATGAAAGGGGGATCCCCCGGGTTCCTAGGCCCGTCTCCTCTAT
ATGTGTATCC
TTGATGAAAGGGGGATCCCCCGGGTTCCTAGGGATATTCCGGTC
CCGAAACCCCAGAGT
CTTCAGGATCTGCTTGCTCACCATGGCGCGCCGGCGTCGTTGCTT
GTGTGAT
CACCAACCCTTCTCCCGATCGCCAGTCTCACTTGTCACGTGAGA
ACGGGCGAC
CGTGTAGTCTAGGTTATAGTTTTCATGGCATGCTGATATTGTACA
CGTTCACATTCAAT
CGAAAGATCGGAAAAACAAACATGTCCAATTGTGATATTGTAC
ACGTTCACATTCA
GTGTAGTCTAGGTTATAGTTTTCATGGCATGCTGAAATACCGAG
AGCCGAGG
AAGATCGGAAAAACAAACATGTCCAATTGCATGCTCACGTGAG
AACGGGCGAC
GCCCGAAAGATCGGAAAAACAAACATGTCCAATTGCGGAATCG
TACCATTCGC
CCCTTGGCTAAAGTCCCAACCACAAGCATGCTGAAATACCGAGA
GCCGAGG
GCGTGACATAACTAATTACATGAGGCTAGCTTACACCCACTCGT
GCAGG
ATGTAAGCGTGACATAACTAATTACATGAGTTACACCCACTCGT
GCAGGCTGCC
GTAGTCTAGGTTATAGTTTTCATGGCATGCGCGGAATCGTACCA
TTCGC
GTAGTCTAGGTTATAGTTTTCATGGCATGCGGGCAGTGACGGAA
ACGACA
GGTTTCGGGACCGGAATATCCCTAGGCGGAATCGTACCATTCGC
CTACCC
CCCGCCCACCTCGATCCGGGCATGCCTGCAGAAGCTTTTGTGGT
TGGGACTTTAGCCAAGGGTATAAAAGACCACCGTCCCCGAATTA
CCTTTCCTCTTCTTTTCTCTCTCTCCTTGTCAACTCACACCCGAAA
TCGTTAAGCATTTCCTTCTGAGTATAAGAATCATTCAAAATGGT
GAGTTTCAGAGGCAGCAGCAATTGCCACGGGCTTTGAGCACAC
GGCCGGGTGTGGTCCCATTCCCATCGACACAAGACGCCACGTCA
TCCGACCAGCACTTTTTGCAGTACTAACCGCAGGGCGCGCCTGC
ATCGCATTGGATAGCCATTCTCCGAGTGTTTTAGCGTTAATTAA
AACCACAGAGCATAAAGAGAACCTCTAGCTGGCGATGCTTTGCT
AGCCTCATGTAATTAGTTATGTCACGCT
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Supplementary Figures for Chapter 3

Supplementary Figure 3.1. Additional hybrid promoters tested. A. New promoters were
designed by combining parts of the POX2 promoter upstream of the POX2 core
promoter. Activating (A1, A2, A3) sequences and regulatory (R2) sequences were
defined by 5’ truncations. B. Promoter strength is determined by expression of hrGFP
and measured as mean fluorescence of an equal number of transformed cells. The data
are the average of mean fluorescence measurements from biological triplicates. The error
bars are the standard deviation of biological triplicates.
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Supplementary Figure 3.2. Engineering stronger fatty acid-responsive promoters based
on the A1(R1x3)A3 hybrid promoter. A. Schematic of different promoters based on the
A1(R1x3)A3 promoter. B. Promoter strength is determined by expression of hrGFP and
measured as mean fluorescence of an equal number of transformed cells. Fluorescence
from hybrid promoters containing TEF core and intron sequence improves oleic acid
expression relative to the POX2 native promoter by 5 fold and 10 fold, respectively.
Glucose samples are shown on the left and oleic acid on the right. C. Promoter induction
using oleic acid as the carbon source relative to glucose as carbon source. In (B) and (C)
the data are the average of mean fluorescence measurements from biological triplicates.
The error bars are the standard deviation of biological triplicates.

Supplementary Figure 3.3. Sensitivity and inducibility of the A1(R1x3)A3 hybrid
promoter. Titration of the A1(R1x3)A3 hybrid promoter with 0.25% - 8.0% oleic acid
resulted in identical activation. The data are the average of mean fluorescence
measurements from biological triplicates. The error bars are the standard deviation of
biological triplicates. Red is 0.25%, Orange is 0.5%, Green is 1.0%, Cyan is 4.0%, Purple
is 8.0%.
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Supplementary Figure 3.4. Promoter strength is determined by expression of hrGFP and
measured as mean fluorescence of an equal number of transformed cells grown in 2% ndecane or 2% oleic acid.
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Appendix C
Supplementary Tables for Chapter 4
Supplementary Table 4.1: Primer sequences used to create the vectors containing
mutations to the POR1p binding sites.
Oligo
Sequence
Description
F1
ATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAA
Vector Primer
CCATTATTATCATGACATT
Forward
F2
GATGGAGAGCGCCAGACGAGCAGAATAAATAGAC
A1 Mutation
AGCGGATCGGGGGAGGGCTGT
Forward
F3
AGACGAACAAGTGATAGGCCGAGAGTAAATAACGA
R1 Mutation
GGTGGAGTGCACAAGGGGTAG
Forward
F4
GTTAAGCTTGTAGCGAATTTCGCTAAATAACATCACC
A2 Mutation
CCATACGACGGACACA
Forward
F5
GTCCAAATACCCCCGTTTATTCTCTAAATACTCTCGG
A3 Mutation
TATTTCACATGAAAACTATA
Forward
R1 TAATGTCATGATAATAATGGTTTCTTAGACGTCAGGT Vector Primer
GGCACTTTTCGGGGAAAT
Reverse
R2 ACAGCCCTCCCCCGATCCGCTGTCTATTTATTCTGCTC A1 Mutation
GTCTGGCGCTCTCCATC
Reverse
R3 CTACCCCTTGTGCACTCCACCTCGTTATTTACTCTCG
R1 Mutation
GCCTATCACTTGTTCGTCT
Reverse
R4 GTCCGTCGTATGGGGTGATGTTATTTAGCGAAATTC
A2 Mutation
GCTACAAGCTT
Reverse
R5 TTTCATGTGAAATACCGAGAGTATTTAGAGAATAA
A3 Mutation
ACGGGGGTATTTG
Reverse

Supplementary Table 4.2. gRNA oligos used to create CRISPR based vectors and
verification primers used in colony PCR.
gRNA
Sequence
Purpose
AATTCCGGGTCGGCGCAGGTTGACGTACT
gRNA_POR1_F CACAAGCCCTGGAAGCTCGGTTTTAGAGC
Forward Oligo
TAGAAATAGCAAGTTA
TAACTTGCTATTTCTAGCTCTAAAACCGAG
gRNA_POR1_R CTTCCAGGGCTTGTGAGTACGTCAACCTGC Reverse Oligo
GCCGACCCGGAAT
AATTCCGGGTCGGCGCAGGTTGACGTGAG
gRNA_CFU1_F GTCACAGAGACCCCCGAGGTTTTAGAGCT
Forward Oligo
AGAAATAGCAAGTTAA
TTAACTTGCTATTTCTAGCTCTAAAACCTC
gRNA_CFU1_R GGGGGTCTCTGTGACCTCACGTCAACCTG
Reverse Oligo
CGCCGACCCCGGAAT
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POR1_Ver_F
POR1_Ver_R
CFU1_Ver_F
CFU1_Ver_R

ATGTCTTCCAAGGTCAAAGAGGAG
CCTGCTGAAAGTGCATGAGC
ATGCTTCCCGAGCTGGAAA
GCAAATGGGGCACTGGAATG

Colony PCR

Supplementary Table 4.3. Primer pairs used to tile the POX2 native promoter.
Forward Primer
Reverse Primer
1
CACGGTGGGACGTGTCTG
CACGTGGCCCAAAAGCTC
2
CACGGTGGGACGTGTCTG
GTGTGAAGCCGGGAGGTC
3
GACCTCCCGGCTTCACAC
AAATGTGGGGGCAGATTCA
4
GTGACCTCCCGGCTTCAC
TGTGGGGGCAGATTCAGA
5
CGGCTTCACACGTGGTTG
GAGATAAAATGTGGGGGCAGA
6
TCTGAATCTGCCCCCACA
CGGTGCGGGGTTTATGTA
7
CCCCCTTTCACACTCTGCT
ACACCTAACGGCGGCTTC
8
CCGCACCGTTTGGAACTC
GGCGCTCTCCATCTGACA
9
CCGCCGTTAGGTGTGTCA
CGTCAACAGTGCCCTTCG
10
GCAGAACCGAGGGACAGC
TGAGAACGGGCGACATTC
11
CGAAGGGCACTGTTGACG
CCAAACAAAGAGGCGGATACA
12
GAATGTCGCCCGTTCTCA
CCAAACAAAGAGGCGGATACA
13
TCCGCCTCTTTGTTTGGTT
CAGGACGATGCAGATGTCTACTTT
14
TCCGCCTCTTTGTTTGGTT
TGGAATGCAGGACGATGC
15
CCACCCCAATCACATGCT
CCTCGGCTCTCGGCCTAT
16
CCTGCATTCCATCCCACA
CCATTCGCCTACCCCTTG
17
AGAGCCGAGGACGAGGTG
CCCGATCGCCAGTCTCAC
18
CAAGGGGTAGGCGAATGG
ATCCCCCATGACCACCAA
19
CGATCGGGAGAAGGGTTG
TCCGCTACTCGTAGTGGTTTTT
20 TGGTCATGGGGGATAGAATTT
CTTGCACTCCCACCATTGC
21 ACCACTACGAGTAGCGGATTTG
CTTGCACTCCCACCATTGC
22
GCAATGGTGGGAGTGCAA
CCGTATTGCCCCGTTTCT
23
AGAAACGGGGCAATACGG
TCGGACTTGTGGCGATTG
24
CGTCTGTTCAATCGCCACA
TGGCGCTTGTCCAGTATGA
25
CCTGTCAATCATGGCACCAC
CTCTGGCGCTTGTCCAGT
26
ACTGGACAAGCGCCAGAG
CCGTCGTATGGGGTGATG
27
GAATTTCGCCCTCGGACA
CAGCTACAATAAGAGAGGCTGTTTG
28
CACCCCATACGACGGACA
CCCGCTGGTACCTGATATTG
29
CAGGTACCAGCGGGAGGT
CCATCTCCAAGCCAGGGTTA
30
CAGGTACCAGCGGGAGGT
TGGACCGACCATCTCCAA
31
CCCTGGCTTGGAGATGGT
TCCAATTGGGGCAGTGAC
32
CCCTGGCTTGGAGATGGT
GCCCGAAAGATCGGAAAA
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33
34
35
36
37
38
39
40
41
42
43
44

TCCGTGTCGTTTCCGTCA
GCGCCCTCTCCTTGTCTC
GCGCCCTCTCCTTGTCTC
TGGACTGTTGCTACCCCATT
CATTGGTTCCTCCCCGTCT
CCCGTCTTTCACGTCGTC
GGGGTCTAGATGGAGGCCTAA
ATTGGGGCGAGAAACACG
CGTGGACATGGTGCAAGG
GGTTGATTCGACGCTTTTCC
TATTCTCCCTCGGCTCTCG
CCCTCGGCTCTCGGTATT

AGCAACAGTCCAGGAGACAGA
GAACCAATGGAGGCCAAAG
GACGGGGAGGAACCAATG
AGGGAAACCATGCAACCAT
AACATGTGACTGTGGGGAAAA
CCCCTTGCACGTCAAAATTA
GCCTTGCACCATGTCCAC
CGGAAAAGCGTCGAATCA
CGAGAGCCGAGGGAGAAT
CGAGAGCCGAGGGAGAATA
GGTTGCCCGTGTAGTCTAGGT
GCGTCGTTGCTTGTGTGA
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Supplementary Figures for Chapter 4

Supplementary Figure 4.1. Flow Cytometry data for expression of native POX promoter
fused to GFP.

Supplementary Figure 4.2. Frameshift mutations to create POf1Δpor1, POf1Δcfu1, and
POf1Δpor1Δcfu1 strains.
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Supplementary Figure 4.3. (A) BLAST of YlCFU1p (YALI0D18678) against fungal
database did not reveal ScADR1p as strong homolog. (B) 65% sequence similarity
between ScADR1p and YlCFU1p DNA zinc finger binding domain.
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Appendix D

Supplementary Tables for Chapter 5
Supplementary Table 5.1: gRNA oligos for CRISPR vectors and primers for PCR
amplification of genes tested in the study.
Oligo
Sequence
Description
F1
GAGGCCCAGATCCTCTAGAGTCGAAG
TEF(404)CGGCCGCAGACCGGGTTGGCGGCGTAT
Intron
F2
GCACTTTTTGCAGTACTAACCGCAGCC
AAL-PTS
CCAAATCATTCACAAATCTGC
F3
TATAAGAATCATTCAAAGGCGCGCAT
MAACR-PTS
ATGGCCATTCAGCAGGTCCATC
F4
GGTCGGCGCAGGTTGACGTAGTTGTTC
Forward Oligo
GTTCCACCTCCAAGTTTTAGAGCTAGA
AATAGC
F5
GGTCGGCGCAGGTTGACGTATACTACC
Forward Oligo
CTCTGGACGTCCGTTTTAGAGCTAGAA
ATAGCA
F6
Forward Oligo
F7
GGTCGGCGCAGGTTGACGTAAGATATG
Forward Oligo
AAGATCTACACCAGTTTTAGAGCTAGA
AATAGC
F8
TTCCGGGTCGGCGCAGGTTGACGTAGATA
Forward Oligo
GGATATCTGCAACCCG
F9
TTCCGGGTCGGCGCAGGTTGACGTATGCT
Forward Oligo
GCATAGCAGTGCACAG
F10
ATTTGATGAAAGGGGGATCCCCCGG
Dual gRNA
CCCAGTTGCAAAAGTTGACA
vector
R1
CTGCGGTTAGTACTGCAAAAAGTGC
TEF(404)TGGTCG
Intron
R2
GACATAACTAATTACATGAGGCTAG
AAL-PTS
CTTACAACTTACTCACATCAATGCC
R3
ACATAACTAATTACATGAGGCTAGTTAATT
MAACR-PTS
AATTAGAGCTTAGCGGCAGCCTTTTTTC
R4
TGCTATTTCTAGCTCTAAAACTTGGAGGTG
Reverse Oligo
GAACGAACAACTACGTCAACCTGCGCCGAC
R5
CCTCGGGCTCCGAACTTAACGTTTTAGAGC
Reverse Oligo
TAGAAATAGCAAGTTA
R6
AACTTGCTATTTCTAGCTCTAAAACCGGG
Reverse Oligo
TTGCAGATATCCTATC
R7
TGCTATTTCTAGCTCTAAAACTGGTGTAGA
Reverse Oligo
TCTTCATATCTTACGTCAACCTGCGCCGAC
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R8
R9
R10

AACTTGCTATTTCTAGCTCTAAAACCGGG
TTGCAGATATCCTATC
AACTTGCTATTTCTAGCTCTAAAACCTG
TGCACTGCTATGCAGCA
GCTTCCTTGGTACCTTCGAACCCGG
AAAAGCACCGACTCGG

196

Reverse Oligo
Reverse Oligo
Dual gRNA
vector

Supplementary Figures for Chapter 5

Supplementary Figure 5.1. GFP expressing strains from Table 5.3.

Supplementary Figure 5.2. Fatty alcohol production in the PO1f ΔDGA1ΔFAO1
ΔDGA1ΔFAO1 + FAA1 and ΔDGA1ΔFAO1 + TGL4 strains due to oxidation of
dodecane resulting in dodecanol (C12:0). Some decanol (C10:0) is observed due to intact
β-oxidation pathway.
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Supplementary Figure 5.3. (A) Fatty acid distribution from whole cell lipid analysis of
PO1fΔfaa1Δmfe1 strain. (B) Fatty acid distribution from TLC extracted FFA component
of PO1fΔfaa1Δmfe1 strain showing higher proportions of C14:0 FFAs.

Supplementary Figure 5.4. Fatty alcohol production in the PO1fΔfao1, PO1fΔfaa1Δmfe1
Δfao1 and PO1fΔfaa1Δmfe1Δfao1 + AAL1 due to oxidation of dodecane (C12:0) to
produce dodecanol.
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Supplementary Figure 5.5. Fatty alcohol production as a percentage of dry cell weight
(DCW) in the PO1fΔfao1, PO1fΔfaa1Δmfe1 Δfao1 and PO1fΔfaa1Δmfe1Δfao1 + AAL1.
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